Development and Evaluation of ADME Models Using Proprietary and Opensource Data by Trapotsi, Maria-Anna
Page 1 of 148 
 
 
 
 
     
Development and evaluation of ADME models using 
proprietary and opensource data 
 
 
By 
Maria-Anna Trapotsi 
July 2017 
 
 
 
 
 
 
 
 
A thesis submitted to the University of Hertfordshire in partial fulfilment of the requirements 
for the degree of Master of Science by Research 
Page 2 of 148 
 
Abstract 
Absorption, Distribution, Metabolism and Elimination (ADME) properties are important factors 
in the drug discovery pipeline. Literature ADME data are often collected in large chemical 
databases like ChEMBL, which might be an asset to improve the prediction of ADME 
properties. Pharmaceutical companies build ADME Quantitative Structure Property 
Relationships (QSPR) models using proprietary data and thus the inclusion of literature data 
might be a valuable source for the development of predictive models. The aim of this study 
was to investigate whether merging literature and proprietary data could improve the predictive 
activity of proprietary models and enlarge their applicability domain (AD).  
ADME predictive models for Caco-2 (A to B) permeability and LogD7.4 were built with data 
extracted from Evotec and ChEMBL database. Predictive models were developed for each 
property and three different training sets were used based on: proprietary compounds (Evotec 
models), literature compounds (ChEMBL models) and a merged set of proprietary and 
literature compounds (Evotec+ChEMBL models). The Random Forest (RF), Partial Least 
Squares (PLS) and Support Vector Regression (SVR) were used to develop the models. The 
performance of the models was evaluated by using two types of test sets:  a diverse test set 
(20 % compounds of available data randomly selected) and a temporal test set (data published 
after the models were built). The descriptors that used were the physiochemical descriptors, 
the structural Molecular Access System (MACCS) descriptors and the Partial equalisation of 
orbital electronegativity – van der Walls surface areas (Peoe-VSA) descriptors. The AD of the 
models was evaluated with four distance to model metrics, which were the: kNN with Euclidean 
distance, kNN with Manhattan distance, Leverage and Mahalanobis distance. 
The ability of an existing Evotec Caco-2 permeability model to assess literature compounds 
(extracted from ChEMBL) was evaluated. The literature test set was predicted with a higher 
RMSE compared to the RMSE in prediction for internal compounds. Additionally, a number of 
literature compounds was found to be outside the AD of the Evotec model, thus highlighting 
an area of improvement for proprietary Evotec models. Furthermore, the effect of the inclusion 
of literature data in the existing Caco-2 permeability and LogD7.4 Evotec proprietary models 
was evaluated. The RF algorithm was the highest performing method for the development of 
Caco-2 permeability models and the SVR for the LogD7.4 models. In addition, the leverage 
method proved to be the most appropriate for the evaluation of the models’ AD. The 
permeability model built merging literature and proprietary data (Evotec+ChEMBL model) 
predicted a literature temporal test set with an RMSE of 0.68 while the Evotec model showed 
an RMSE of 0.74. Even in the case of the Evotec temporal test set, the two models performed 
similarly and the AD of the mixed models (incorporating both literature and proprietary data) 
was enlarged. The 86.15% of the compounds in the proprietary temporal test set were within 
the AD of the Evotec+ChEMBL model, while 76.50% of the compounds of the same test set 
appeared to be within the AD of the Evotec model. Similarly, the LogD7.4 Evotec+ChEMBL 
model predicted a literature temporal test set with an RMSE of 0.77 while the Evotec model 
showed an RMSE of 0.83. Even in the case of the Evotec temporal test set, the two models 
performed similarly but the AD of the mixed models (incorporating both literature and 
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proprietary data) was enlarged. The 94.86% of the compounds in the proprietary temporal test 
set were within the AD of the Evotec+ChEMBL model, while 88.49% of the compounds of the 
same test set appeared to be within the AD of the Evotec model. 
This study demonstrated that the inclusion of public ADME data into proprietary models 
improved the performance of proprietary models and enlarged at the same time their AD. The 
methodology presented herein will be applied by Evotec computational scientists to re-build 
the Caco-2 and LogD7.4 Evotec proprietary models considering literature data as discussed in 
this thesis. 
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1 INTRODUCTION 
1.1 ADME properties in drug development process 
The pharmaceutical drug design and development process is time consuming, complex and 
characterised by high risk and cost (Wang & Urban, 2004). It has been estimated that the 
probability of success in Phase II clinical trials is only 34 % (Cumming, Davis, Muresan, 
Haeberlein, & Chen, 2013). The efficacy and ADME (Absorption, Distribution, Metabolism, 
Elimination) properties play a significant role in the drug mechanism (Thompson, 2000) and 
are considered as an integral part of the drug design process (Di & Kerns, 2016).  
A molecule should be able to exhibit both a pharmacological effect and also to have the 
appropriate ADME properties to reach the market as a drug. Or in other words, a drug should 
not only be efficacious for the target disease but also with an acceptable pharmacokinetic and 
safety profile (Davies et al., 2015). Some of these parameters include the lipophilicity, 
ionisation, solubility and molecular mass (Livingstone & Davis, 2012). For example, a highly 
lipophilic drug can be more permeable (i.e. greater absorption) (Riley, Parker, Trigg, & 
Manners, 2001), can undergo greater metabolic clearance (Patrick, 2013) and it can be better 
absorbed in the GI tract (Avdeef & Tam, 2010). In addition, lipophilicity can affect the ability of 
a drug to cross the Blood Brain Barrier (BBB) and the volume of distribution (Poulin & Theil, 
2002) because of the drug ability to bind to serum albumin (Patrick, 2013). As a result, 
parameters such as lipophilicity should be taken into account from the early stages of drug 
design in order to exclude compounds with unwanted properties. 
The total loss rate due to poor ADME properties was near 50% in 2004 (Khanna, 2012). 
Although the failure rate was reduced to 14% (Tsaioun, 2007) due to the preclinical testing, 
there is a potential to improve cost-effectiveness of the drug discovery and development by 
using predictive ADME predictive models. Therefore, it is of major significance for 
pharmaceutical industries to improve the productivity of the drug design process (Paul et al., 
2010) and reduce failure due to poor ADME properties. Computational chemistry can be a 
great asset in drug discovery process (Liao, Sitzmann, Pugliese, & Nicklaus, 2011),  as its 
application can reduce the risk and cost of the drug design process (Tan et al., 2010). A useful 
tool of the computational medicinal chemistry is the in-silico predictive ADME models. The 
great advantage of these models is the prediction of a molecule’s ADME properties (Zhang, 
Luo, Ding, & Lu, 2012) prior to chemical synthesis and in-vitro or in-vivo testing, which will save 
time and money (Zhang & Surapaneni, 2012) in preclinical testing (figure 1). Therefore, the 
number of compounds that have to be synthesised to obtain the required biochemical and 
physicochemical profile is reduced (Moroy, Martiny, Vayer, Villoutreix, & Miteva, 2012). 
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Figure 1:  Computer Aided Drug Design (CADD) in drug design and development process 
(adapted from Kore, Mutha, Antre, Oswal, & Kshirsagar, 2012). 
1.2 QSAR and QSPR modelling 
Quantitative Structure Activity Relationship (QSAR) and Quantitative Structure Property 
Relationship (QSPR) modelling are major and commonly employed computational tools in 
medicinal chemistry to help the lead optimization process in drug discovery (Cramer, 2012; 
Kore et al., 2012). QSAR is widely used to provide optimisation of the pharmacological activity, 
and QSPR can provide information about pharmacokinetic or ADME properties (Puzyn, 
Leszczynski, & Cronin, 2010). QSPR models are mathematical models, which relate the 
chemical structure of the compound to a physiochemical property and this relation can be used 
to predict ADME properties (Yee & Wei, 2012). QSPR modelling can provide exploration and 
exploitation of the relationship between the chemical structure of the compounds and their 
ADME properties (Tropsha, 2010) prior to the synthesis of a compound (Park et al., 2014). The 
introduction of QSAR/QSPR models, has raised concerns for the predictability and applicability 
of these models (Jaworska, Nikolova-Jeliazkova, & Aldenberg, 2005). Therefore, five 
principles have been established for QSAR/QSPR model validation: 1. a defined endpoint, 2. 
an unambiguous algorithm, 3. a defined domain of applicability, 4. appropriate measures of 
goodness-of-fit, robustness and predictivity and 5. a mechanistic interpretation, if possible 
(Sahigara et al., 2012). One of the most important principles is the applicability domain, which 
will be further discussed. 
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Figure 2: The steps of the QSPR development process (adapted from Cherkasov et al., 2014). 
1.3 Data collection and curation 
Figure 2 is schematically depicting the process of building a QSPR. The first step of that 
process involves the data collection and curation. This is a significant part of the QSPR 
development because the performance of the model depends on the quality of the training set 
(Yee & Wei, 2012). Literature data and databases can be considered as an increasingly 
important source for collection of compounds and these data have been used for the 
development of QSPR models (Wang, Cao, Zhu, & Yun, 2015; Wang et al., 2016). 
1.3.1 Literature data and databases for ADME data collection for QSPR modelling 
Literature data are published in journal articles (peer-reviewed or scientific) and thus it is 
usually difficult to manually search and extract information. For example, literature chemical 
structures are usually depicted as images and that is making the extraction and use of literature 
data in QSPR development difficult (Gaulton et al., 2012). Therefore, in the recent years a 
variety of publicly available databases have been developed due to the high demand for easy, 
free and open access to the literature information. As a result, the construction of QSPR 
models is greatly assisted by the development of large publicly available compound databases 
like PubChem BioAssay (Li, Cheng, Wang, & Bryant, 2010; Y. Wang et al., 2010), ChemBank 
(Seiler et al., 2008), ZINC (Irwin, Sterling, Mysinger, Bolstad, & Coleman, 2012), ochem.eu 
(online chemical database with modelling environment) (Wang et al., 2016) and ChEMBL 
(Bento et al., 2014; Gaulton et al., 2012).  
The three databases that store information for ADME assays are the PubChem BioAssay, 
ochem.eu and ChEMBL. The other databases like ZINC is used mainly for ligand discovery 
(Irwin et al., 2012) and ChemBank has been developed to guide chemists in the synthesis of 
Data Collection and 
Curation
Calculation of 
Molecular Descriptors
Feature Selection
ADME Model Building
Model Validation
Page 17 of 148 
 
novel compounds and biologists to search for small molecules that catalyse a specific process 
(Seiler et al., 2008). ChEMBL is the database, which is considered as a key representative of 
the current plethora of publicly available data (which also include the majority of the information 
available in PubChem BioAssay and ochem.eu) (Papadatos & Overington, 2014; Wang et al., 
2009) and has dramatically changed the way that the drug discovery community shares and 
deposits experimental data. Moreover, CHEMBL extracts the information from the medicinal 
chemistry literature (Papadatos, Gaulton, Hersey, & Overington, 2015), mainly from 12 
prominent chemistry journals (Bender, 2010). Moreover, companies like AstraZeneca 
deposited compounds into ChEMBL (Clark et al., 2015).  
ChEMBL contains information obtained by various assays, which are divided into four 
categories: 1. Binding (B), Functional (F), Toxicity (T) and ADME (A) and additionally include 
annotations related to the relevant assays. This is a great advantage of ChEMBL, which other 
databases lack. These supplementary annotations are useful and help the data curation 
process but the level of detail of annotations is not always sufficient to truly identify the 
protocols of the ADME assays (Papadatos et al., 2015). Even when the assay conditions seem 
to be the same, a significant variability is observed between measurements by different 
laboratories (Kalliokoski et al., 2013). Therefore, ChEMBL team has set future plans to improve 
the quality and consistency of the data by including more detailed description of the assays’ 
parameters (Papadatos et al., 2015). One of the main disadvantages in ChEMBL is the quality 
and reliability of the literature sources. For example, an error in chemical structure might result 
into an erroneous descriptor calculation (Tropsha, 2010), which will ultimately affect the 
predictability of the model. Manual curation of the data downloaded from public databases can 
substantially improve the accuracy of prediction (Young, Martin, Venkatapathy, & Harten, 
2008). The error in commercial or public databases ranges from 0.1% - 3.4% (Fourches, 
Muratov, & Tropsha, 2010) and another example is that of WOMBAT (world of molecular 
bioactivity) database with an overall error rate of 8% (Young et al., 2008). Therefore, it is 
important to curate the data extracted from large chemical databases before the development 
of the models.  
1.4 Calculation of molecular descriptors 
After the first step in QSPR process, which is the data collection and curation (figure 2), the 
next step is the calculation of molecular descriptors. Molecular descriptors are a basic tool for 
cheminformatics, which is used to transform chemical information (like physiochemical 
properties) into a numerical data and they can be theoretically (derived from symbolic molecule 
representation) or experimentally derived (Puzyn, Leszczynski and Cronin, 2010). 
 
Topological descriptors are widely used for QSPR modelling and they refer to 2D molecular 
descriptors (Rajkhowa & Deka, 2014), which are based on the distances between atoms 
calculated by the number of intervening bonds (Puzyn et al., 2010) and thus considering the 
internal arrangement of compound’s atoms (Pillai, 2015). Therefore, topological descriptors 
can give numerical information about molecular size, presence of heteroatoms, multiple bonds 
(Gozalbes & Doucet, 2002) and enable for the identification of the individual atoms and the 
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bonded connections between them (Roy, Kar, & Das, 2015). The Molecular Access System or 
“MACCS keys” is considered as the best known and the prototype of key-based fingerprints 
(Chackalamannil, Rotella, & Ward, 2017). MACCS are  structural descriptors and are based 
on pattern matching of the chemical structure of a compound to a pre-defined set of structural 
fragments, (166 MACCS keys) (Wale, Watson, & Karypis, 2008). Another set of descriptors 
that can be used are the partial equalization of orbital electronegativity - van der Walls surface 
areas (Peoe-VSA) descriptors, which capture the direct electrostatic interactions (Bajorath, 
2004). For example, electrostatic interactions play a role in the metabolism and protein binding, 
because these interactions can affect the binding of a compound to the active site of the 
metabolic enzyme and the plasma proteins (Cyprotex, 2015). 
 
Other important 2D descriptors that can be used for ADME models are Polar Surface Area 
(PSA), number of hydrogen bond acceptors/donors, LogP, LogD at various pH (which can be 
either experimentally or theoretically calculated) and pKa (Hou, Li, Zhang, & Wang, 2009). For 
example, the H bonding behaviour of a compound can be useful for the description of drug 
permeability because as the number of hydrogen bonds increases, the polarity of the 
compound increases too and the lipophilicity becomes weaker. As a result the compound is 
less able to cross the cell membrane by passive diffusion (Wang et al., 2016) because 
hydrogen bonds are formed with the outer phase of the membrane. In addition, PSA is one of 
the most significant molecular descriptors in QSPR studies and is a measure of polarity of the 
compound, which indicates the presence of a dipole moment (Caron & Ermondi, 2016). PSA 
is an area of Van der Waals surface, which results from oxygen, nitrogen or hydrogen atoms 
bound to polar areas (Danielle, 2014). As a result, PSA is related to the hydrophobicity and 
polarity of a molecule and is useful in estimating the compound’s absorption, BBB permeability 
and other ADME characteristics (Kubinyi, Folkers, & Mannhold, 2008). For example, PSA 
should be low (60-70Å2) for BBB penetration and no more than 140 Å2 for cell membrane 
permeation (Pajouhesh & Lenz, 2005) and generally PSA gives excellent correlation with drug 
permeability in Caco-2 monolayers (Artursson, Palm, & Luthman, 2012). 
 
In addition to the 2D QSAR descriptors, there also the 3D descriptors for QSAR modelling (3D 
QSAR) like randic molecular profiles, geometrical descriptors etc. One of the most widely used 
3D QSAR method is the Comparative Molecular Field Analysis (CoMFA), which concerns 
mainly the electrostatic field and steric relationships between the ligand and biological target 
(Cherkasov et al., 2014). However, it is considered as a computationally intense process 
(Goodarzi & Dejaegher, 2012) and one example might be the conformational analysis to find 
the best conformer. 
1.5 Feature Selection 
A feature selection or variable selection is usually performed to choose the descriptors with 
goal to reduce the dimensionality and the redundancy of the descriptors that are chosen. 
Feature selection usually depends on two parameters. The first is the correlation and variance 
of descriptors and the second is the algorithm that is applied to the training set. Correlated 
descriptors are those which are different views of the same molecular aspect (Puzyn et al., 
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2010). Therefore, some algorithms like MLR cannot produce meaningful results with correlated 
descriptors, whereas other methods like PLS and SVR can handle sets that contain correlated 
descriptors. In addition, zero or very low variance descriptors can be removed. They do not 
carry any information because they are constant for all the chemical compounds. There are 
various methods to perform feature/variable selection and they are categorised into three 
groups:  filters, wrappers and embedded methods. The filter methods use a metric or score for 
each feature, based on a statistical measure and based on their score are excluded or included 
(Brownlee, 2016). An example of a filter method is the ReliefF, which randomly picks dataset 
points and finds their nearest neighbours. Then it assigns weight to the features/descriptors 
based on how good they can discriminate the observations from their neighbours (Eklund, 
Norinder, Boyer, & Carlsson, 2014). The wrapper methods use a learning algorithm and 
identify descriptors subsets. Models are developed and assess which descriptor combinations 
can result in a good model accuracy (Brownlee, 2016). The embedded methods incorporate 
the feature selection during the application of learning algorithm (Eklund et al., 2014). 
However, it was shown that the use of different feature selection methods did not improve the 
prediction accuracy of models developed with “state-of-the-art” algorithms (RF, ANN, SVM) 
(Eklund et al., 2014). The reason is that these algorithms can handle correlated descriptors.  
1.6 Model Building and Machine learning in QSPR model development  
One of the most significant factor in QSPR building process is the selection of an appropriate 
method. QSPR models have evolved significantly since scientists decided to utilise 
approaches from recent developments in other fields like data mining, pattern recognition, 
machine learning and artificial intelligence (Dudek, Arodz, & Gálvez, 2006; Geppert, Vogt, & 
Bajorath, 2010). Various algorithms are used to identify patterns and correlations within a 
dataset/training set, and through data mining process, a model is derived (Lavecchia, 2015). 
Each compound is considered as a vector and each molecular descriptor corresponds to 1 
dimension/variable. The resulting model relates a set of descriptors with biologically relevant 
properties like lipophilicity and other parameters, which can affect ADME properties. There are 
various types of models and they are usually divided into two broad categories: continuous 
(regression) and classification (categorical) (Dudek, Arodz, & Gálvez, 2006) (figure 3). 
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Figure 3: Summary of the QSAR or QSPR building methods (adapted from Dudek, Arodz and 
Gálvez, 2006; Danielle, 2014). 
1.6.1 Multiple Linear Regression (MLR)  
MLR is a supervised machine learning method that is able to establish a linear mathematical 
relationship between a property of the training compounds and a set of descriptors that encode 
the chemical information (Ventura, Latino, & Martins, 2013). MLR is a  commonly used method 
for constructing QSPR models (Liu & Long, 2009) and the prediction is derived as a linear 
function of all descriptors (Sethi, 2012). The following equation gives the linear relationship 
between the target value and the compounds’ features/descriptors: 
 
ݕ = ߚ଴ + ߚଵݔଵ + ߚଶݔଶ + ⋯ + ߚ௡ݔ௡                          (Equation 1), 
where n is the number of descriptors, x1, x2, …, xn are the molecular descriptors, β1, β2, ..., 
βn are descriptors’ coefficients and β0 is the model constant 
 
Equation 1 represents a hyperplane in a space of n-dimensions. In addition, the coefficients of 
that equation are calculated with methods like the least-squares method, which minimizes the 
sum of squared residuals (Dehmer, Varmuza, & Bonchev, 2012). However, there are 
disadvantages related to MLR. For example correlated descriptors and a large descriptors to 
compounds number ratio are two factors that MLR cannot handle and result in unstable 
predictions (Dudek, Arodz & Gálvez, 2006). The underlying reason is that descriptors influence 
the calculation of the coefficients and therefore correlated descriptors could result in erroneous 
estimation. Additionally, the number of compounds should be at least five times the number of 
descriptors to reduce the possibility of erroneous coefficient calculation. 
Page 21 of 148 
 
1.6.2 Partial Least Squares (PLS) 
PLS is a more popular method compared to MLR because it overcomes the disadvantages of 
MLR mentioned above. PLS uses similar principles with Principal Component Analysis (PCA)  
and it is suitable to overcome the issues related to the multicollinearity and the high ratio of the 
number of descriptors over the number of compounds (Dudek, Arodz & Gálvez, 2006). PLS is 
able to project the original variables (i.e. descriptors) into latent variables (LVs) and thus 
reducing the dimensionality (Xing et al., 2014). LVs do not only explain the variation in the x 
variables (descriptors) as the PCA does. They also take into account how the variation in the 
x variables corresponds to the variation of the dependent variable y (target value) (Brown, 
2015). The following equations correspond to the latent variables (LVi), which are linear 
combinations of the variables/ descriptors (xi). 
 
ݕ = ܽଵܮ ଵܸ + ܽଶܮ ଶܸ + ⋯ + ܽ௡ܮ ௡ܸ                             (Equation 2), 
where y is the target value, α is the regression coefficient and LV are the latent variables 
in a chemical space with n descriptors/dimensions 
ܮ ଵܸ = ଵܾ.ଵݔଵ + ଵܾ.ଶݔଶ + ⋯ + ଵܾ.௡ݔ௡ 
ܮ ଶܸ = ܾଶ.ଵݔଵ + ܾଶ.ଶݔଶ + ⋯ + ܾଶ.௡ݔ௡ 
. 
. 
. 
ܮ ௜ܸ = ܾ௜.ଵݔଵ + ௜ܾ.ଶݔଶ + ⋯ + ௜ܾ.௡ݔ௡                           (Equation 3), 
where LV are the latent variables, i the number of the LVs, b are the variable coefficients, 
x are the molecular descriptors and n the number of descriptors. 
 
Each LV (equation 3) is a linear combination of the x values and also their corresponding 
coefficient (b), which gives an approximation to the variation of the target value (y) (Leach & 
Gillet, 2007). This method decomposes the input matrix of descriptors into loadings and LVs 
and the later are orthogonal and are capturing the descriptor information (Sethi, 2012).  
1.6.3 Decision Trees (DTs) and Random Forest (RF) in machine learning 
Decision Trees (DTs) are algorithms that are used for both regression and classification 
models and thus they are usually referred as Classification And Regression Trees (CART) 
(Brownlee, 2016). The DTs are predictive models that map observations to target values 
(Lodhi, 2010). DTs as every machine learning algorithm has an input and output. In ADME 
predictive modelling, the aim is to develop a model that can predict the value of a target (e.g. 
permeability, lipophilicity, protein binding etc.) based on a set of input variables (descriptors) 
(Tsaioun & Kates, 2011). The input data are in the form of (x, y) = [(xଵ, xଶ, … , x௡), y], where n 
is the number of descriptors and y represents the target value. In a DT, there are three types 
of nodes: a root node, internal nodes, and leaf nodes. Leaf nodes are also known as terminal 
nodes. An example of how a DT works is shown in figure 4. It is an example of a classification 
problem and thus the DT classifies the compounds on target property y1 or y2. The 
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classification of the test compounds is based on the leaf/terminal node that they reach after 
going through a series of questions (Yee & Wei, 2012). For example, according to the DT 
shown in figure 4, a test compound will be assigned with the y1 if it displays a certain condition 
for molecular descriptor A. If it does not fulfil that condition, then the molecular Descriptor B is 
examined. If the molecular descriptor B has a value less than 1, then the test compound will 
be assigned with the target property y1 or if it has a value greater or equal to 1, then the test 
compound will be assigned with the target property y2. 
 
Figure 4: Schematic representation of a decision tree (adapted from Dehmer et al, 2012).  
As the example above shows, a DT works by systematically subdividing the information within 
a training data (in the root and internal nodes) based on rules and there are various algorithms 
to define these rules (Dehmer et al., 2012). One of them is the recursive binary splitting 
(Brownlee, 2016). According to that algorithm, different split points are tried and evaluated with 
a cost function. The cost function that is used for regression models is expressing the sum 
squared residuals and is the following: 
∑ (ݕ௜ − ݌ݎ݁݀݅ܿݐ݅݋݊௜)
ଶ௡
௜ୀଵ                                     (Equation 4), 
where i is the number of compounds and y the experimental value 
 
The output of this algorithm represents the assignment of y value of each leaf for the test set 
compounds. However, this procedure provides a greedy approach because at each step a split 
point is defined, which might be good for that specific step but not for the overall of the DT. 
This limitation of the DTs can be overcome with the use of ensembles DTs like Random Forest 
(RF). 
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RF is based on an ensemble of DTs (Mitchell, 2014; K. Roy et al., 2015), which are built by 
training data of multiple features. Ensemble is the procedure that combines the 
results/predictions from multiple predictive algorithms in order to make a more accurate 
prediction compared to each individual prediction (Brownlee, 2016), as it benefits from the 
“wisdom of crowds” effect (Mitchell, 2014). RF is an improvement of the DTs because the 
learning algorithm is limited to a random sample compared to DTs, which are searching all the 
data to identify the ideal split point based on the minimisation of the sum of the squared 
residuals. The data are partitioned into progressively increasing homogeneous group through 
the tree. As a result, each terminal node of the DTs is comprised by molecules, which exhibit 
a similar value of the ADME property evaluated (Mitchell, 2014). RF is generally a unique 
combination of prediction accuracy, model interpretability and it is able to handle missing 
values and a variety of variables (binary, continuous, categorical) (Qi, 2012). RF can be used 
to perform both classification and regression models (Bajorath et al., 2012; Oprea, 2006) and 
the choice depends on the property that is predicted. Therefore, it is increasingly used in the 
field of biological computational sciences (Yang, Yang, Zhou & Zomaya, 2010). RF is an 
algorithm used in the literature to develop ADME predictive models like lipophilicity (Rodgers, 
Davis, Tomkinson, & van de Waterbeemd, 2011; Schroeter et al, 2007;  Wang et al., 2015), 
permeability (Fredlund, Winiwarter, & Hilgendorf, 2017) and solubility (Palmer,  O’Boyle, Glen, 
& Mitchell, 2006). The main disadvantage of RF method is that its performance can be 
influenced by a small sample size and also by the number of trees selected (Dehmer et al., 
2012).  The selection of optimal parameters can be achieved through cross validation 
(Statnikov, Wang, & Aliferis, 2008).  
1.6.4 Support Vector Machines (SVM) 
The SVM is an algorithm developed by Vapnik and co-workers and it is a widely used algorithm 
in the field of data mining in cheminformatics. It can be used for both classification and 
regression problems and when it is used for continuous/regression models can be referred as 
Support Vector Regression (SVR). It is an algorithm extensively used to predict properties like 
hERG blockade (Doddareddy, Klaasse, & IJzerman, 2010; Li, Jørgensen, Oprea, & Brunak, 
2008), toxicity related properties (Mitchell, 2014), protein inhibition (Dong et al., 2009) etc. It 
has also been used to predict physiochemical properties like LogD7.4 (Schroeter et al., 2007; 
Wang et al., 2015), melting point (Hughes, Palmer, & Nigsch, 2008) and pKa (Harding & 
Wedge, 2009). For example, for a two class classifier in a 2D space, where the data are linearly 
separable, the SVM algorithm aims to find the maximum margin hyperplane that divides the 
data in  a way that all the data with target value +1 lie on the opposite site from those with 
target value -1 (Basak, Pal, & Patranabis, 2007). This hyperplane is also referred as separate 
hyperplane and the margin is the distance between the separating hyperplane and data 
samples that are closest to that hyperplane and are called support vectors (Raschka, 2015) 
(figure 5). Therefore, the SVM for a classification problem aims to identify the optimal 
hyperplane for which the margin of separation between the chemical compounds is maximised 
(Khan, 2012). If w is a normal vector to the hyperplane then the hyperplane equation can be 
written as:  
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 ݓ ሬሬሬሬԦݔԦ − ܾ = 0 (Equation 5)  
and the equations of the two parallel hyperplanes can be written as: 
 ݓ ሬሬԦݔ+ሬሬሬԦ − ܾ = 1 (Equation 6), 
 ݓ ሬሬሬሬԦݔିሬሬሬሬԦ − ܾ = −1 (Equation 7).  
As the w vector is perpendicular to the hyperplane it is also perpendicular to the parallel 
hyperplanes and therefore the vector from the x(-) to x(+) is scalar multiple (r) of the vector w 
and the following equation can be written:  
 Ԧݔା ሬሬሬሬሬԦ= ݔିሬሬሬሬԦ + rݓ ሬሬሬሬԦ (Equation 8).  
By using equation 6 and substitute equation 8 to the x(+), the equation 9 is obtained:  
(Eq.6)
(ா௤.଼)
ሳልልሰ ݓ ሬሬሬሬԦ(ݔିሬሬሬሬሬሬԦ + ݎݓሬሬԦ) − ܾ = 1 ⇒ 
⇒ ݓ ሬሬሬሬԦݔିሬሬሬሬԦ + ݎห|ݓ|ห
ଶ − ܾ = 1 ⇒ 
⇒ ݓ ሬሬሬሬԦݔିሬሬሬሬԦ − ܾ + ݎห|ݓ|ห
ଶ = 1 ⇒ 
⇒ −1 + ݎห|ݓ|หଶ = 1 ⇒ 
⇒ ݎห|ݓ|หଶ = 2 ⇒ 
⇒ ݎ = 2/ห|ݓ|หଶ (Equation 9) 
The Margin (M) is the half of the distance between x(-) and x(+). Therefore: 
2ܯ = ห|ݔା − ݔି|ห = ห|ݎݓ|ห
(ܧݍ.5)
ሳልልሰ 
⇒ ห|ݎݓ|ห =
2
ห|ݓ|ห2
ห|ݓ|ห ⇒ 
⇒ 2M =
2
ห|ݓ|ห
(ܧݍݑܽݐ݅݋݊ 10) 
Therefore, this margin distance should be maximised to identify the optimal hyperplane.  
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Figure 5: Schematic representation of two data classes in a 2D space by the SVM algorithm. 
The case outlined above is the simplest case, where the data are linearly separable in a 2D 
space and can be easily schematically represented. In more complicated cases, where the 
data i) are not linearly separable, ii) exist in a higher dimensional space and iii) the aim is the 
development of a regression model, there are additional strategies to follow. In the non-linearly 
separable cases, the data are projected in a higher dimension space with the aim to be able 
to linearly separate them. The kernel trick is used to map the training set data into a higher 
dimensional space with a mapping function (Φ) (Khan, 2012). There are various kernels that 
could be used and one of the most widely used is the radial basis function (rbf) kernel (ܭ(ݔ, ݔ௜)) 
for two samples/vectors ݔ, ݔ௜ of the input space (Raschka, 2015). The rbf kernel can be 
expressed as the inner product of the projected ݔ, ݔ௜ and uses the following equation to map 
the data in a higher dimension: 
ܭ(ݔ, ݔ௜) = ݁ିఊ ௫ ∑((௫ି௫೔)
మ)                                         (Equation 11), 
where ݔ, ݔ௜ are two vectors of the input space and γ is a hyperparameter. 
                                      
To train the data with the SVM algorithm and the rbf as a kernel, three hyperparameters (ε, γ 
and C) should be optimised. The ε parameter is affecting the number of support vectors and it 
can have a value in the range of 0-1. The larger the ε value is, the lower is the number of 
support vectors (Khan, 2012). The γ parameter is also taking values in the range of 0-1 and 
the usual default value is 0.1. If the γ increases, the influence of each data sample is also 
increased (Raschka, 2015). The C parameter is one of the most important parameter because 
it can affect both the trained and predicted data (Wang et al., 2015). The C value represents a 
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balance between the margin maximisation and the training error minimisation (Khan, 2012). If 
the C is too large then the SVM algorithm will produce an overfitted model (Brownlee, 2016) 
and if it is too small, insufficient stress is introduced on fitting the training data (Khan, 2012;  
Wang et al., 2015). A grid search is usually used to find an optimal combination for the three 
hyperparameters described above. 
1.6.5 Konstanz Information Miner (KNIME) in QSPR model building 
Literature databases have significantly increased the availability and accessibility of data 
(Schadt, Linderman, Sorenson, Lee, & Nolan, 2010) and as a result there is a high demand of 
data mining tools that respond to these needs.  KNIME is a data mining workflow framework, 
which has significantly evolved to meet the new demands of automating predictions and 
machine learning. It is a pipeline package, which provides a user friendly workspace 
(Mazanetz, Marmon, Reisser, & Morao, 2012). It uses nodes for data input and various nodes 
are interconnected to create a pipeline, where information is flowing through them (a process 
known as “visual programming”). This software offers the advantage of preparing workflows, 
which can be quickly customised to manage data and information in order to automatize tasks 
(Mazanetz et al., 2012). KNIME is used in both academia and industry and special nodes have 
been designed for the KNIME software, which can be used in chemistry, biology and in drug 
design process. For example, two cheminformatics node packages that are widely used for 
the development of ADME models are the: ChemAxon/Infocom Marvin package and the Weka 
(Waikato Environment for Knowledge Analysis). Other examples of package nodes, which are 
developed from the KNIME community contributions are: Enalos (Melagraki, Afantitis, 
Sarimveis, & Koutentis, 2009; Melagraki & Afantitis, 2013) and RD-kit, Chemical Development 
Kit (CDK) (Mazanetz et al., 2012). The KNIME software is coded in Java based on an Eclipse 
environment (Warr, 2012) and thus it is an extensible programme through plug-ins, which 
offers additional functionality (Berthold et al., 2009). KNIME also offers nodes, which are 
serving as interfaces for statistic/mathematic programmes (Matlab, R), programme languages 
(Python) and database readers (Jagla, Wiswedel, & Coppée, 2011). Finally, KNIME can be 
used in the development of ADME models because data mining and specialised KNIME nodes 
can be used for the development of predictive models. 
1.7 Model Validation  
Model validation is a very important process that should be performed after the model training. 
Model validation can be internal or external (Chackalamannil et al., 2017). An example of 
internal validation is the k-fold cross-validation, which partitions the initial dataset in k samples. 
Then a subsample is excluded and a model is built with the k-1 subsamples as training set. 
This procedure is repeated for k times and every subsample has been used once as the 
validation test set (Alpaydin, 2014). Moreover, an external validation set should also be used 
because it investigates the generalisability of the model to predict new chemicals (Puzyn et 
al., 2010). There are also measures that estimate the goodness-of-fit of the model. Two of the 
most commonly used are the Root Mean Square Error (RMSE) in prediction and the Pearson 
Correlation coefficient or the coefficient of variation in the fit to training set (R2) 
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(Chackalamannil et al., 2017). The RMSE is a useful measure as it has the same units as the 
units in the QSPR experiment and provides indication of the likely error associated with the 
model’s predictions. The RMSE (equation 12) is generally used as a statistical metric to 
establish model performance (Chai & Draxler, 2014) and the lower the values of RMSE the 
higher the accuracy of the model. The R2 (equation 13) is often used to measure model quality 
(Wermuth, 2008).  According to Wermuth (2008) the R2 can be misleading because it depends 
heavily on the variation, whereas RMSE relates directly to the experimental variability but it is 
meaningful to report both values (Alexander & Tropsha, 2015).   
ܴܯܵܧ =  ට(ை௕௦௘௥௩௘ௗି௉௥௘ௗ௜௖௧௘ௗ)
మ
ே
                        (Equation 12), 
where N is the number of compounds 
ܴଶ = 1 − ∑(ை௕௦௘௥௩௘ௗି௉௥௘ௗ௜௖௧௘ௗ)
మ
∑(ை௕௦௘௥௩௘ௗିை௕௦௘௥௩௘ௗ ௠௘௔௡)మ
                       (Equation 13) 
 
Another important way to validate and assess the QSPR models is the evaluation of their 
Applicability Domain (AD). A focus on methods for the AD evaluation is given in this thesis.  
1.7.1 Applicability domain (AD) 
Applicability domain is considered as one of the most important problems in the QSPR analysis 
(Tropsha, 2010). AD can establish the scope and limitations of QSPR models (Netzeva et al., 
2005) and it can estimate the range of chemical compounds whose properties can be reliably 
predicted (Jaworska et al., 2005). AD is actually estimating the confidence in predictions or in 
other words it is predicting the predictability (Dragos, Gilles, & Alexandre, 2009) and it is 
considered as a tool to avoid predictions with a large error probability. Moreover, it is generally 
accepted that the compounds that are “close” to the model’s chemical space (based on the 
training set) have higher chances to have their properties more accurately predicted than 
compounds that are “far” (Cumming et al., 2013). Therefore, the chemical space of the model 
must be defined and then asses if the compounds in the test set fit into that space. The AD is 
dependent on the descriptors that are used for the model. The descriptors are numerical 
representations of the chemical space (Todeschini & Consonni, 2009) and thus by changing 
the descriptors, the chemical space is also altered (Mathea, Klingspohn, & Baumann, 2016). 
Moreover, there is also a possibility of presence of compounds that are “far” from the model’s 
chemical space and they are called prediction outliers. These can be present in both train and 
test sets (Furusjö, Svenson, Rahmberg, & Andersson, 2006).  
1.7.1.1  Distance to model metrics 
There are various ways to establish the AD of a model and one of them is the distance to 
model metrics. These approaches calculate the distance of the test compounds from a defined 
Page 28 of 148 
 
point within the chemical space of the training compounds (Sahigara et al., 2012). The 
distances are compared between this defined point and compared to a user-pre-defined 
threshold. Some of the most commonly used methods are the following: Euclidean, Manhattan 
and Mahalanobis distance and Leverage test. 
1.7.1.2 Mahalanobis distance 
Mahalanobis distance (MD) is measuring the distance of a given compound (i.e. a test 
compound) from the distribution of the training set compounds (equation 14). MD takes into 
account the correlation in the data since it uses the inverse of the covariance matrix of 
descriptors (Netzeva et al., 2005). Other methods like Euclidean distance and Manhattan 
distance cannot do that automatically and other pre-treatments like PCA are necessary 
(Gadaleta et al., 2016). Moreover, MD is a method that can be used to detect potential 
multivariate outliers, which are actually compounds really far from the compounds’ distribution 
and also squared MD approximately follows a chi-square distribution (Varmuza & Filzmoser, 
2016). These features can be used to set a threshold and distinguish between compounds that 
are within an acceptable distance from the model.  
ܯܽℎ݈ܽܽ݊݋ܾ݅ݏ ܦ݅ݏݐܽ݊ܿ݁ (ܯܦ) =  ඥ(ݔ − ߤ)ܵିଵ(ݔ − ߤ)்            (Equation 14), 
where MD is the distance of an observation x from a set of descriptors with mean ߤ and S 
(covariance matrix) and T is the transpose of the matrix. 
 
1.7.1.3 Leverage  
Another distance to model metric to estimate the AD is the Leverage method, which is based 
on the concept of the extent of extrapolation (Melagraki et al., 2009). The model space is 
comprised by a k-Dimensional space of the n chemicals (rows) and k variables (columns) and 
this is the X = k x n, the descriptor matrix. The leverage method measures the distance of each 
compound from the centroid of X matrix (Netzeva et al., 2005), by manipulating the Hat matrix 
(H), which is the following: 
ܪ =  ܺ(்ܺݔ ܺ)ିଵ்ܺ                                       (Equation 15), 
where X is the descriptor matrix and XT is the transpose matrix of X. 
 
The next step involves the calculation of the leverages (hi), which are the diagonal elements 
of the H matrix and are calculated with the following equation:  
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ℎ௜ =  ௜்ܺ(்ܺݔ ܺ)ିଵ ௜ܺ                                   (Equation 16), 
where Xi is the descriptor row vector of the query compound and X is the descriptor matrix. 
 
The final step of the leverage method involves the estimation of the threshold, which is fixed 
at 3p/n, where p is the number of variables/descriptors plus one and n is the number of 
compounds in the training set (Gadaleta et al, 2016; Puzyn et al., 2010; Sahigara et al., 2012). 
1.7.1.4 Other Distances  
There are also other distances that are used for the estimation of AD like the Euclidean 
distance (ED) and the Manhattan distance (ManD). ED is the square root of the squared 
differences between the corresponding elements in the descriptor matrix of two compound A 
and B (equation 17). ManD, between two compounds A and B, is the sum of the absolute 
differences of their coordinates in the n-variable/descriptor space (equation 18). 
ܧݑ݈ܿ݅݁ܽ݊ ܦ݅ݏݐܽ݊ܿ݁(ܧܦ) =  ඥ(ݔ஺ଵ − ݔ஻ଵ)ଶ + (ݔ஺ଶ − ݔ஻ଶ)ଶ +  … + (ݔ஺௡ − ݔ஻௡)ଶ (Equation 17), 
where ED is the distance of 2 compounds A and B with n descriptors. 
 
ܯܽ݊ℎܽݐݐܽ݊ ܦ݅ݏݐܽ݊ܿ݁ (ܯܽ݊ܦ) =  ∑ |ܣ݊ − ܤ݊|௡௡ୀଵ                (Equation 18), 
where A and B are two compounds and n is the number of descriptors. 
 
1.7.2 k-Nearest Neighbour (kNN) 
This method is establishing the distance of a test/query compound from its nearest k 
compounds in the training set (Sahigara et al., 2012). However, this method is not a pure 
distance to model metric method because it also takes into account the structural or chemical 
similarity of the compounds (Sahigara, Ballabio, Todeschini, & Consonni, 2013). The similarity 
of the test compounds to the training compounds can be assessed by using: a) descriptors, b) 
Principal Components (PCs) and c) Extended Connectivity Fingerprints (ECFP4). The distance 
between the compounds can be computed using different distance functions. The ED and the 
ManD can be used to calculate distance between compounds with the descriptors and 
Tanimoto and Dice coefficients can be used to calculate similarity with the ECFP4 fingerprints.  
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1.7.3 Fingerprints and Similarity measures used with kNN 
Fingerprints are a popular method to evaluate chemical similarity due to their ability to translate 
the chemical complexity into a numeric string (Gadaleta et al., 2016). ECFP have been 
developed as a modified Morgan algorithm methodology (Leach & Gillet, 2007) to represent 
molecular characteristics, which are associated to their molecular activity (Rogers & Hahn, 
2010) and they can also be used for other purposes like chemical similarity. In addition, they 
exhibit several advantages like that they are rapidly calculated, they can represent a great 
number of different molecular features and they are able to reflect both the absence and the 
presence of a chemical functionality (Kovacs, 2016). 
Tanimoto (equation 19) and Dice (equation 20) coefficients are similarity measures, which 
take into account the overlapping of chemical fingerprints to quantify molecular similarity 
(Jasial, Hu, Vogt, & Bajorath, 2016). The difference between Dice and Tanimoto is that Dice 
gives twice the weight to the positive common bits and as a result emphasises more on the 
positive matches (Al-Shamri, 2014), whereas Tanimoto is really popular because in includes 
a degree of size normalisation with the denominator term (Leach & Gillet, 2007). Both give a 
range of 0-1, where 0 means no similarity and 1 means highest similarity. 
Tanimoto 
• ࢀ =  ࡺࢉ
ࡺࢇାࡺ࢈ିࡺࢉ
  (Equation 19), where  
 Na the number of bits set to “1” in 
molecule A,  
 Nb the number of bits set to “1” in 
molecule B and  
 Nc the number of bits in both A and B. 
Dice 
•  ࡰ =  ૛࢞ࡺࢉ
ࡺࢇାࡺ࢈
 (Equation 20), where 
 Na the number of bits set to “1” in 
molecule A,  
 Nb the number of bits set to “1” in 
molecule B and  
 Nc the number of bits in both A and B. 
 
1.8  Principal Component Analysis (PCA) 
PCA is a method used in multivariate data analysis, in which the observations are described 
by inter-correlated quantitative dependent variables (Abdi and Williams, 2010). PCA could be 
used as part of the model validation process to establish if the compounds in the test set 
occupy a similar chemical space as the training compounds. The aim of this method is to 
reduce the dimensionality of the data, to extract the important information from the data table 
and express this information as a set of new variables (Abdi & Williams, 2010). As a result, the 
data are represented with a smaller number of variables, which are the result of the reduction 
of dimensionality and are called principal components (PCs) (Ringnér & Ringner, 2008; 
Yousefinejad, Bagheri, & Moosavi-Movahedi, 2015). The concept behind the PCA is to find 
PCs (e.g. PC1, PC2, …, PCn), which are linear combinations of the original variables (Varmuza 
& Filzmoser, 2016), which in this case are the QSPR descriptors. In addition, the PCs are 
chosen in a way that the first principal component (PC1) accounts for the most of the variance 
Page 31 of 148 
 
in the data, the PC2 for the next largest variance etc. (Miller & Miller, 2010) The PCs are 
orthogonal linear combination transforms of the original descriptors (Hemmateenejad, Miri, & 
Elyasi, 2012).  
To calculate the PCs of a matrix, which is composed by x compounds and n-descriptors (i.e. 
n-dimensional space), four simple steps should be followed. Firstly, the mean of each 
dimension is calculated and the mean is subtracted from each dimension, producing  a data 
set whose mean is zero (Smith, 2002). The second step is the calculation of the covariance 
matrix, which is formed by measuring covariance values (Equation 21) between all the 
dimensions (Fukunaga, 2013). The covariance matrix is a square matrix, from which the 
eigenvalues and eigenvectors are calculated, which can reveal information for the data (Tran, 
Vu, & Wang, 2013). The eigenvalues and eigenvectors are special features of a matrix. An 
eigenvector  x (x ϵ Rn) is a non-zero vector of a matrix A, when Ax is a scalar multiple (λ) of x: 
ܣݔ = ߣݔ (Anton, 2010). The scalar multiple λ is called eigenvalue of matrix A and corresponds 
to x eigenvector. 
ܿ݋ݒ(ܼ, ܻ) = ∑ (௓೔ି௓೘೐ೌ೙)(௒೔ି௒೘೐ೌ೙)
೙
೔సభ
(௫ିଵ)
                          (Equation 21), 
where z and y are 2 dimensions of the n-dimensional space and x is the number of 
compounds (i.e. sample size). 
 
An eigenvalue decomposition of the matrix is performed to obtain the eigenvalues, which 
represent the total variance explained by the corresponding eigenvector, which indicates the 
direction of the new axes (Smith, 2002). At the beginning, the compounds’ dataset is described 
with values, which cannot relate to the rest of the data, whereas the new data points (scores, 
equation 22) of PCs show how the points are related to the rest of the data. 
ܵܿ݋ݎ݁ݏ = ݋ݎ݈݃݅݊ܽ ݀ܽݐܽ ݔ ݁݅݃݁݊ݒ݁ܿݐ݋ݎ                        (Equation 22) 
 
1.9 Permeability  
Permeability is considered as a valuable parameter during the drug discovery process because 
it can significantly affect the ADME properties and it correlates to the velocity of a compound 
passage through a biological membrane barrier (Di & Kerns, 2016). Permeability extendedly 
affects the absorption and thus the bioavailability because a low permeable compound is not 
able to cross the cell membranes and ultimately interact with the biological target. Permeability 
also affects Distribution because it relates to the ability of the drugs to penetrate BBB and cell 
membranes. The ability or inability of a drug to permeate a biological membrane barrier 
(usually the intestinal membrane barrier) impacts on the drug’s efficacy. Therefore, a low 
permeability value results in a reduced bioavailability, which ultimately prevents the formulation 
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of orally administered drugs. This is a major limitation because the oral route is the most 
desired and is associated with high patient compliance (Wang & Hou, 2015).  
1.9.1 Structure of the cell membrane and Drug Transport  
To appreciate the drug permeability through the biological cell membranes, it is significant to 
consider the morphology and structure of the cell membrane. The main structural component 
for all biological membranes is the lipid bilayer, which is consisted of amphipathic 
phospholipids (figure 6) (Yeagle, 2011). The chemical structure of phospholipids is 
characterised by a head group and long saturated lipophilic side chains. The variations in head 
group result in different types of phospholipids like Phosphatidylcholine (PC), Phosphatidic 
acid (PA), Phosphatidylglycerol (PG), Phosphatidylethanolamine (PE) and others.  
Additionally, cell membranes also contain membrane transporters like ion channels and uptake 
or efflux transporters (Goñi, 2014).  
                                            
Figure 6: Illustration of the lipid bilayer and the structural unit of the lipid bilayer, the 
phospholipids. 
The main methods that a drug can overcome biological barriers are the passive transport and 
active transport (figure 7). The passive transport mainly refers to either passive diffusion or 
paracellular permeability because no energy is required. In transcellular passive diffusion, the 
drug cross the cell membrane driven by Brownian motion (Di & Kerns, 2016) due to the 
concentration gradient (Tsaioun & Kates, 2011). The drug moves from the aqueous phase, 
where the drug is in high concentration, into the cell. Drugs that undergo paracellular 
permeability move between the tight junction of epithelial cells (figure 7). However, this route 
is only observed for a low percentage of drugs in the intestines (less than 5%) (Di& Kerns, 
2016). Passive diffusion is believed to be the main mechanism for intestinal absorption and it 
has been reported that about 95% of the commercial drugs undergo passive diffusion 
(Mandagere & Thompson, 2002). Active transport is mediated by protein transporters present 
in the cell membrane (Kell, Dobson, & Oliver, 2011; Kell & Oliver, 2014). 
 
Polar Headgroup 
Lipophilic Tail 
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Figure 7: A simplified view of the two main permeability mechanisms. 
1.9.2 In-vitro models of cell permeability 
Permeability can be measured by various assays and is correlated to drug absorption. 
Monolayers of Caco-2 cells are used as an in-vitro model to estimate intestinal absorption of 
compound. These cells are human epithelial colorectal adenocarcinoma cancer cell lines (van 
Breemen & Li, 2005) and are extensively used (Cyprotex, 2015; Li, Volpe, Wang, Zhang, & 
Bode, 2011). The Caco-2 cells have the ability to mimic the morphology and functionality of 
the human enterocytes (Press, 2011) and since the cells are derived from colon 
adenocarcinoma, they exhibit both colonocytic and enterocytic characteristics (Volpe, 2008). 
The assay is based on the ability of Caco-2 cells to undergo spontaneous enterocyte 
differentiation in cell culture and replicate into confluent monolayers (Ehrhardt & Kim, 2008). 
When they are at the confluent state on a semi-porous membrane they start to polarise and 
form tight junctions resulting in a polarised apical (side A) and a basolateral (side B) 
membranes, which are creating an environment similar to human enterocytes (figure 9). As a 
result, they can be used as a surrogate (Thomas, Brightman, Gill, Lee, & Pufong, 2008) to 
predict permeability and transport of drugs. 
This assay provides information related to in-vivo absorption of the small amounts of tested 
compound, as well as the rate of absorption, which consequently controls bioavailability 
(Pham-The et al., 2016). The Caco-2 assay is considered to be a ‘gold standard’ in calculating 
in-vitro permeability (Caldwell, Yan, Tang, Dasgupta, & Hasting, 2009) and it is also accepted 
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by the Food Drug Administration (FDA) as the assay to aid classification of compounds 
according the Biopharmaceutics Classification System (BCS) (Ku, 2008) (figure 8). 
 
Figure 8: Biopharmaceutics Classification System (BCS)(adapted from Benet, 2013) 
 
 
Figure 9: Schematic representation of the Caco-2 permeability assay (adapted from Li, 2001). 
This assay is usually conducted in 96 well plates (Sampson et al., 2014) and the compound of 
interest is introduced to apical side (side A) and then the flux of the compound through the 
monolayer is measured. After incubation time, the amount of compound, which crossed the 
Caco-2 cells into the basolateral side (side B) is established usually with LC/MS (Liquid 
Chromatography/Mass Spectroscopy) or MS (Cyprotex, 2015). Finally, the Papp (apparent 
permeability) is calculated (equation 23) with the following formula (Volpe, 2008): 
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௔ܲ௣௣ =
ௗெ/ௗ௧
஼బ × ௌ
                                           (Equation 23), 
where C0 is the initial concentration of the compound tested, S is the surface area of Caco-
2 cell membrane and dM/dt is the rate of the amount of the compound transported to side 
B. 
 
There are also other methods used to measure in-vitro permeability like the Parallel Artificial 
Membrane Permeability (PAMPA) and Mardin-Darby Canine Kidney (MDCK) assays. The 
PAMPA assay uses a an artificial lipid membrane to assess the likelihood of a drug to undergo 
passive diffusion (Avdeef & Tsinman, 2006). The MDCK assay is performed on cell lines 
derived from canine/dog kidney and this assay shows a good correlation with the Caco-2 assay 
(Cyprotex, 2015). However, the PAMPA assay can only predict passive diffusion and the cell 
lines used in MDCK assay exhibit differences in morphology between the canine and human 
cells. In addition, although Caco-2 assay is the best, it has some disadvantages. Caco-2 cells 
require a long culture period (~3 weeks) (Wang et al., 2016) and also under or overpredict the 
permeability of drugs that undergo active transport (Fredlund et al., 2017) due to the different 
expression levels of transporters in Caco-2 cell line. Therefore, pharmaceutical industries 
should develop efficient models for the in-silico prediction of permeability, which is less time 
consuming and expensive compared to the in-vitro Caco-2 assay. 
1.9.3 In-silico regression permeability models developed with Caco-2 data 
There are various regression permeability models based on Caco-2 permeability data. The 
models were developed using different training sets, descriptors and algorithms like MLR, PLS, 
ANN, Boosting, SVR and others (table 1). 
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Table 1: Regression permeability models developed with Caco-2 data reported in the literature 
during 1997-2010. 
Reference Method Number 
of 
Molecules 
Number of 
Descriptors 
AD 
Estimation? 
(Yes/No) 
(Norinder, Österberg, & Artursson, 
1997) 
PLS 17 9 No 
(Kulkarni, Han, & Hopfinger, 2002) GFA (genetic 
function 
approximation) 
38 6 No 
(Fujiwara, Yamashita, & Hashida, 
2002) 
ANN 87 5 No 
(Yamashita & Wanchana, 2002) GA-PLS 73 24 No 
(Nordqvist, Nilsson, & Lindmark, 
2004) 
PLS 51 70 No 
(Hou, Zhang, Xia, & Qiao, 2004) MLR 100 4 No 
(Guangli & Yiyu, 2006) MLR 
SVR 
100 4 No 
(Jung, Choi, Um, Kim, & Choo, 
2006) 
MLR 20 4 No 
(Fenza, Alagona, Ghio, & 
Leonardi, 2007) 
GA-ANN 41 5 No 
(Karelson, Karelson, Tamm, & 
Tulp, 2009) 
MLR 
ANN 
81 6 No 
(Paixão, Gouveia, & Morais, 2010) ANN 296 12 No 
 
Although many models reported in table 1 performed well, there are some limitations related 
to these studies, like the small size of the training set (table 1). This is an important factor in 
Page 37 of 148 
 
predictive modelling, as a small training set (e.g. less than 100 compounds) could possibly 
lead to models which are not robust. For example, there is a high chance of producing 
overfitted models and additionally the presence of outliers could significantly affect the 
predictive activity (Tropsha, 2010). Furthermore, a model developed with a small training 
dataset would exhibit a restricted AD and thus an evaluation of the AD would be of high 
significance.  As table 1 shows, the AD of the models (i.e. how close are the training 
compounds to the training set) was not established. This is a clear disadvantage because the 
AD can be a measure that explains a good or bad prediction based on the percentage of test 
compounds that fall within the AD. In addition, a small number of descriptors was used. This 
is a potential limitation because there is a variety of chemical features, which could be 
associated with ADME properties like permeability (Tao et al., 2015). Therefore, by using only 
a small number of descriptors, this variability might not be considered. Finally, most of the 
models reported (table 1) used training sets with existing drugs except the model developed 
by Fenza et al (2007), which was developed with proprietary only compounds. Furthermore, a 
model reported in 2010 (Paixão et al., 2010) used a reasonable training set, larger than the 
previous models, with 12 descriptors and achieved an RMSE of 0.60. An improved ANN 
methodology used was based on a pruning procedure and early stop approach that prevented 
overfitting by the model, which was a major issue noticed in the previous studies that used the 
ANN algorithm. However, the AD of the models was not established.  
The recently reported Caco-2 regression models overcame some of the limitations mentioned 
above and offered the advantage of a large training set which included data extracted from 
ChEMBL database (Wang et al., 2016) and both proprietary and ChEMBL data (Fredlund et 
al., 2017) (table 2). In addition, both models showed a good predictive ability and used a variety 
of algorithms to develop models. However, Wang et al (2016) used only one method to 
evaluate models’ AD and Fredlund et al (2017) did not evaluate or report the models’ AD. 
Furthermore, there are not models in the literature that investigate the effect of literature data 
in proprietary models in comparison to only proprietary models. The models developed by 
Fredlund et al (2017) merged proprietary with literature data and showed good results but the 
effect of merging proprietary with literature data is not reported. 
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Table 2: Regression permeability models developed with Caco-2 data reported in the literature 
during 2016-2017. 
Reference Method Number of 
Molecules 
Number of 
Descriptors 
AD 
Estimation? 
(Yes/No) 
(Wang et al., 2016) MLR 
PLS 
SVR 
Boosting 
1272 193 Yes: 
Leverage 
(Fredlund et al., 2017) PLS 
SVR 
RF 
2558 PLS, SVR: Standard 
AZ descriptor set 
RF: signature 
descriptors 
No 
 
1.10 Lipophilicity  
Lipophilicity is a property that majorly affects the ADME of a drug and correlates to other 
properties like permeability, solubility and protein binding. Lipophilicity is the ability of a 
compound to partition into a nonpolar lipid matrix against an aqueous (Di & Kerns, 2016) and 
there are two different ways of expressing and calculating lipophilicity: the partition coefficient 
(LogP) and the distribution coefficient (LogD) (Low, Blasco, & Vachaspati, 2016). LogP is the 
partition coefficient of a compound between octanol (organic layer) and buffer (aqueous layer) 
(equation 24), whereas the LogD is the distribution coefficient of a compound between octanol 
(organic layer) and buffer (aqueous layer) at a specified pH (equation 25) (Caron & Ermondi, 
2008). 
ܮ݋݃ܲ = ݈݋݃ଵ଴ ൬
஼೚ೝ೒ೌ೙೔೎
஼ೌ೜ೠ೐೚ೠೞ ೛ಹషೌ೗೗ ೘೚೗೐೎ೠ೗೐ೞ ೙೐ೠ೟ೝೌ೗
൰            (Equation 24) 
ܮ݋݃ܦ௣ு(௫) = ݈݋݃ଵ଴ ൬
஼೚ೝ೒ೌ೙೔೎
஼ೌ೜ೠ೐೚ೠೞ ೛ಹ(ೣ)
൰                   (Equation 25), 
where C is the concentration of the compound. 
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The LogP refers to the partitioning of the neutral form only, whereas the LogD takes into 
account any acidic or basic groups that ultimately affect the distribution in octanol/water, which 
becomes pH dependent (Tetko & Bruneau, 2004). Moreover, a LogD value at pH 7.4 (LogD7.4) 
represents the LogD at physiological pH and a value of about 1-3 is the optimal for orally 
available drugs (Hartmann & Schmitt, 2004).  This range is optimal as it results in an intestinal 
absorption of a drug due to a good balance between solubility and transcellular passive 
diffusion (Di & Kerns, 2016). Generally, a drug should exhibit a balance between lipophilicity 
and hydrophilicity in order to be able to dissolve and permeate cell membrane barriers (Wang 
et al., 2015). A LogD7.4 value of 3-5 shows a good permeability but the main disadvantage is 
that the intestinal absorption and bioavailability is reduced. A LogD7.4 value greater than 5 
results in a low solubility absorption and thus bioavailability. In addition, distribution is affected 
because the compound is too lipophilic and thus it gets trapped in biological tissues (Di & 
Kerns, 2016). 
Lipophilicity can influence the possibility of a drug to be considered as drug candidate. 
Lipophilicity along with the Topological Polar Surface Area (TPSA) have an impact on 
toxicological properties of a drug (Hughes et al., 2008) and a calculated LogP<3 and TPSA>75 
increase the risk of toxicity (Lu, Jessen, Strock, & Will, 2012). The toxicity increases because 
a calculated LogP<3 and a TPSA>75 increase the likelihood of promiscuous binding to off 
target pharmacology (Hughes et al., 2008). In addition, lipophilicity can affect the non-specific 
binding to albumin and phospholipids (Valko et al., 2012), which results in reduction of the in-
vivo available concentration (Tarcsay, Nyíri, & Keserű, 2012). Furthermore, the pKa value is 
another factor that should be considered along with the lipophilicity. The pKa represents the 
pH that the drug is 50% ionised (Heshmati et al., 2013) and both lipophilicity and pKa determine 
the pharmacokinetic, pharmacological and toxicological properties of a compound (Di & Kerns, 
2016).  
The assay that is used to determine the LogD of compounds is the shake flask method, which 
is considered as the gold standard of determining the lipophilicity (Baka, Comer, & Takács-
Novák, 2008). This method measures the compound’s concentration in octanol (organic 
phase) and the aqueous phase after equilibration on both phases (Andrés et al., 2015). 
However, there are several limitations related to that method. For example, the use of octanol 
as the organic phase has several limitations (Cyprotex, 2015) because it contains a relatively 
high amount of aqueous content of about (4%) (Allerton, Smith, Kalgutkar,Amit, van de 
Waterbeemd, & Walker, 2012). As a result, octanol supports hydrogen bonding (Will, McDuffie, 
Olaharski, & Jeffy, 2016), which creates a different environment from that of the inner 
hydrocarbon core of the cell membranes. Thus octanol can overestimate the lipophilicity of 
compounds that are able to form hydrogen bonds (Allerton et al., 2012). However, octanol 
remains the most popular organic solvent for these studies in industry (Cyprotex, 2015).  
1.10.1 Theoretical lipophilicity prediction and the importance in-silico lipophilicity models 
In the past, it was extensively reported the challenge of the theoretical prediction of LogD7.4 
(Tetko & Poda, 2004). LogD7.4 was usually measured by calculating the LogP and pKa values 
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with the following equation: (݌ܪ) = ܮ݋݃ܲ − log (1 + 10(௣ுି௣௄௔)௱೔) , where Δi is equal to 1 or -1 
for acids and bases respectively. However, this approach can be problematic and inaccurate 
due to the accumulation of errors from LogP and pKa calculations. The next evolutionary step 
in the theoretical prediction of LogP and LogD7.4 was the development of software. Therefore, 
pharmaceutical companies tried to evaluate the possible advantage of the available software 
like ACD labs, Pallas PrologD and ALOGPS in the theoretical calculation of LogD. In a study 
(conducted in Pfizer), the LogD7.4 for two proprietary sets of compounds was predicted with 
the ACD labs and the Pallas PrologD software, which resulted in very low accuracy in 
predictions. Pfizer (Tetko & Poda, 2004) and AstraZeneca (Tetko & Bruneau, 2004) utilized “in 
house” LogD data to evaluate prediction of LogD7.4 based on a software, which predicts LogP, 
the ALOGPS. This software used the Associative Neural Network (ASNN) method, which 
allowed the user to include new data without retraining the neural network (LIBRARY mode). 
By incorporating LogD7.4 data with the LIBRARY mode, the ALOGPS proved to be similar or 
superior compared to other software. However, the improvement was observed only for local 
predictions and it was difficult to produce accurate predictions for compounds with structural 
features not covered in the training set. Therefore, the importance of developing models for 
lipophilicity prediction was evident.   
One of the initial attempts to develop lipophilicity models based on logD7.4 data and the BRNN 
(Bayesian Regularised Neural Networks) algorithm, was conducted in AstraZeneca (Bruneau 
& McElroy, 2006). A set of 8200 “in house” compounds was clustered in 5000 clusters based 
on hierarchical clustering process and one compound from each cluster was selected to form 
the training set and the rest of the compounds used as “ex-cluster validation test set”. In 
addition, a global validation test set comprised by 16325 compounds was obtained from the 
AstraZeneca database for “global validation”. The advantage was that the model was 
developed with a consistent and large proprietary dataset. Model seemed to perform well for 
both test sets with an RMSE in prediction of 0.54 and 0.63. In addition, the AD of the models 
was established by using the Mahalanobis distance and the compounds were binned in 4 bins 
by increasing distance. The results showed a trend of increasing RMSE as the MD was 
increasing. However, the models were developed with only proprietary compounds.  
Moreover, there are LogD7.4 models (table 3) developed by AstraZeneca (Rodgers et al., 2011) 
and Bayer Schering Pharma AG (Schroeter et al., 2007) with proprietary compounds and other 
models developed with data extracted from the literature (Wang et al., 2015). The models could 
derive accurate predictions with various machine learning algorithms. However, none of these 
studies focus on the inclusion of literature data in the proprietary models to investigate the use 
of literature and opensource data in the realistic ADME evaluation in the drug discovery 
pipeline. 
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Table 3: Regression lipophilicity models developed with logD7.4 data reported in the literature. 
Reference Method Number of 
Molecules 
Number of 
Descriptors 
AD 
Estimation? 
(Yes/No) 
(Bruneau & 
McElroy, 2006) 
1. BRNN 5000 122 Yes 
Mahalanodis 
Distance 
(Schroeter et al., 
2007) 
1. Gaussian Process 
2. Linear ridge 
regression 
3. SVR 
4. RF 
14556 Dragon 
descriptors 
(1664) 
Yes 
Mahalanodis 
Distance 
(Rodgers et al., 
2011) 
1. RF 
2. PLS 
Number of 
molecules 
varied as the 
models were 
updated over 
a period of 3 
years 
In-house 
descriptor 
set 
(topological, 
geometrical 
and 
electronic) 
Yes 
Mahalanodis 
Distance 
(Wang et al, 2015) 1. SVR 
2. PLS 
1130 121 Yes 
Leverage 
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1.11 Research Hypothesis and Aims 
Pharmaceutical companies develop their ADME predictive models based on proprietary data. 
Therefore, these compounds are often novel and are not present in the literature. Thus, it is 
expected that literature data will introduce chemical diversity to the Evotec training space. This 
assumption is also based on a work conducted in AstraZeneca and Bayer Pharma AG, which 
concluded that data extracted form ChEMBL can introduce chemical diversity in proprietary 
databases (Kogej, Blomberg, Greasley, & Mundt, 2013). The results indicated a low molecular 
similarity between compounds extracted from ChEMBL database and two proprietary 
screening collections. In addition, various permeability and LogD7.4 models are described in 
the introduction in sections 1.9.3 and 1.10.1, and were developed with either proprietary or 
literature data. However, none of these studies focussed on the inclusion of literature data in 
the proprietary models. Only a permeability model was developed in AstraZeneca including 
both proprietary and public available data (Fredlund et al, 2017) but the effect of the public 
data on the models performance and applicability domain was not reported.  
Therefore, the aim of the present work is to evaluate the effects of the introduction of public 
data into the training set. In other words, it will be investigated whether literature compounds 
can be merged with proprietary data and consequently improve the ADME predictions of 
proprietary models. The objective is to build in-silico predictive ADME models by using internal 
and public data (i.e. literature data) and establish if the literature data can improve the 
performance of proprietary model and enlarge their AD. The objectives of that work are 
addressed in the three following parts: 
1. The first objective is to evaluate the ability of the existing Evotec permeability model to 
predict the permeability of literature compounds. In addition, the applicability domain of 
the existing Evotec permeability models is evaluated with four distance to model 
metrics, by calculating the distance of the test compounds (compounds downloaded 
from ChEMBL) from the Evotec training set.  
2. The second objective is to evaluate performance of Caco-2 A-to-B permeability models 
developed using three different algorithms and three different training sets: literature 
data, proprietary data and merged proprietary and literature data. Additionally, the AD 
of the models is evaluated to establish if the literature data could enlarge the AD of the 
models developed with proprietary data.  
3. The third objective is to evaluate performance and AD of LogD7.4 models using the 
same approach applied in the second objective. 
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2 MATERIALS AND METHODS 
2.1 Software Framework 
The data mining tool, Konstanz Information Miner (KMIME), an opensource data analysis 
platform, was used in automation of model development (KNIME, 2016). All the work was 
carried out within the KNIME 3.0 using proprietary and freely available KNIME nodes. 
Statistical work was carried out using the R statistical language through the R-Snippet node 
interface in KNIME and the software application R studio (www.rstudio.com), which is an 
opensource Integrated Development Environment (IDE) for R. The ChemAxon/Infocom 
(www.chemaxon.com) RDKit and Analytics nodes were also used. The ChemAxon KNIME 
nodes were used during the descriptor calculation for conversion of the Simplified Molecular 
Input Line Entry System (SMILES) into 2D structures, their standardisation and calculation of 
molecular descriptors. The RDkit was used to calculate the Peoe-VSA descriptors. The 
Waikato Environment for Knowledge Analysis (WEKA) data mining package nodes for KNIME, 
developed by the University of Waikato, was used for the implementation of the Support Vector 
Regression algorithm through the LibSVM node. Tibco Spotfire (www.spotfire.tibco.com) and 
Microsoft Excel was used for additional analysis and to generate plots and graphs. 
2.2 Methods used for the evaluation of existing Evotec Caco-2 A to B permeability 
model with literature data 
The existing Evotec Caco-2 A to B permeability model was evaluated with a test set. The test 
set included Caco-2 A to B permeability data extracted from the ChEMBL database. The 
predicted values of the ChEMBL test set (obtained with the existing Evotec model) were 
compared with the experimental values and the quality indicators (RMSE and R2) were 
calculated. Four different distance to model metrics were applied to assess how close are the 
literature compounds to the proprietary training set. Figure 10 shows a schematic summary of 
the methodology. 
 
Figure 10: Schematic summary of the work and the methods used for the evaluation of the 
existing Evotec Caco-2 A to B permeability model. 
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2.2.1 Literature data curation 
 
 
Figure 11: Schematic representation of the literature data filtering process for the compounds 
downloaded from ChEMBL. The arrow indicates the flow of the process. 
Public compounds with Caco-2 A to B permeability data obtained from ChEMBL database. A 
set of 9473 compounds with Caco-2 assay information have been downloaded from ChEMBL 
(https://www.ebi.ac.uk/chembl/) v.21. A filtering process was applied to improve the quality and 
reliability of data (figure 11). A similar filtering process has been described in the literature for 
the development of Caco-2 QSPR models with compounds downloaded from ChEMBL (Wang 
et al., 2016).The first step of the filtering process was to keep compounds with information only 
related to Caco-2 A to B permeability and compounds with MW lower  than 750, as the aim is 
to perform the work described on similar compounds to the Evotec data set. As a result, 2670 
compounds were retained. Moreover, only compounds with exact values were included and 
those molecules with non-descriptive or missing values were removed. Compounds with 
missing units have been removed. It is worth mentioning that measurement units are not 
consistent in ChEMBL and thus all experimental data were manually converted to a reference 
unit of 10-6 cm/s and then the Log10 of that value was calculated and used. Finally, where there 
were two or more entries of the same molecules, the permeability value mean and the standard 
deviation were calculated. When the standard deviation was more than one the compounds 
were excluded to minimise the error that could arise from a chance selection of one of the 
values.  
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2.2.2 Standardisation and Molecular descriptors calculation  
After the selection and curation of the chemical compounds, the molecular descriptors were 
calculated. The Advanced MolConverter from Chemaxon/Infocom node was used to convert 
the SMILES structures into chemical structures in “Marvin document” (mrv) file format and a 
“Standardizer” node was applied to convert the molecules representation into a standard form 
(figure 13). The standardisation is essential because chemical compounds might appear in 
different forms depending on the source that they are obtained form. The presence of 
tautomers or resonance might be a potential problem in the representations and thus 
standardisation is required. For example, the amino group might be represented in two different 
forms: the charged (NH3+) or the neutral (NH2) form (figure 12). Standardisation process 
ensures consistency in the way that chemical structures are represented prior to the descriptor 
calculation. The “Standardizer” KNIME node was configured by selecting the four following 
actions: “strip salts”, “neutralize”, “tautomerize” and “aromatize” (ChemAxon, 2016b). The “strip 
salt” removes predefined fragments from multi-fragment molecules (regarded as salts). The 
“neutralize” action neutralises the compounds with hydrogen manipulation on ionisable groups. 
The “tautomerize” action creates a canonical tautomer form of the molecule and the 
“aromatize” performs aromatisation based on the general Daylight type aromatisation.  
Figure 12: An example of different forms that a chemical can be represented 2016a) 
The dominant protonation state of a molecule at pH equal to 7.4 was predicted using the “Major 
microspecies” ChemAxon node in KNIME. Three sets of descriptors have been used on this 
work: general physiochemical descriptors, MACCS keys and Peoe-VSA (figure 13). The 
general physiochemical descriptors have been calculated within KNIME using 
Infocom/Chemaxon KNIME nodes. The physiochemical descriptors are the following: chiral 
centre count, rotatable bond count, stereo double bond count, aliphatic/aromatic ring count, 
fsp3 (fraction of sp3 hybridized carbons), H bond Donor/Acceptor, PSA, LogP, LogD, 
molecular weight (MW), pKa, electric state, heavy atom count, formal charge, negative/positive 
ionisable groups and not carbon Heavy Atom (HA) count. The “Topology Analysis” ChemAxon 
node was used to calculate the: chiral centre count, rotatable bond count, stereo double bond 
count, aliphatic ring count, aromatic ring count and fsp3. The “Chemical Terms” ChemAxon 
node was used to calculate the heavy atom count, the formal charge, the not carbon HA count, 
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the negative and positive ionisable groups. The “Java Snippet (Simple)” node was used to 
determine the electric state (acid, base or zwitterion) based on the formal charge and the 
positive/negative ionisable groups. The code used for the configuration of the “Java Snippet 
(Simple)” node can be found in Appendix, table S1. The “Elemental Analysis” ChemAxon node 
was used to calculate the MW. The rest of the physiochemical descriptors were calculated by 
the homonymous ChemAxon nodes as shown in figure 13. The “MACCS keys” node by CCG 
(Chemical Computing Group) was used to calculate 166 substructure compound descriptors, 
which account for the frequency of occurrence of 166 chemical features. Finally, the Peoe-
VSA descriptors have been calculated using “RD-kit descriptor Calculation” KNIME node.  
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a)  
b)  
c)  
d)  
Figure 13: KNIME workflow for the calculation of descriptors: a) overall descriptor calculation workflow, b) 
physiochemical descriptors, c) MACCS keys and d)  Peoe-VSA. 
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2.2.3 Prediction of Caco-2 permeability of compounds downloaded from ChEMBL by Evotec 
existing model 
The existing Evotec permeability model was written in an R model node and this node was 
used along with an R predictor node. The R predictor node gave the predicted value of 
permeability for the ChEMBL compounds. The existing Evotec Caco-2 model uses continuous 
Random Forest as QSPR algorithm (Appendix, table S2) with 500 trees. In addition, the 
apparent Caco-2 permeability values were modelled in their logarithmic form (LogPapp). 
2.2.4 Model Performance 
For performance statistics, the Pearson Correlation coefficient (R2) and the Root Mean Square 
Error (RMSE) were reported. The RMSE was calculated with the “RMSE calculator” node 
(KNIME community node) and the R2 was calculated by the “2D/3D Scatterplot” node (KNIME 
community nodes). 
2.2.5 Metrics to establish the Applicability Domain 
The evaluation of how close are the compounds in the descriptor and chemical space and also 
what percentage of test compounds are within the AD of the model was carried out using PCA 
and distance to model metrics. For the evaluation of AD two terms were used to refer to the 
space that the distance to model metrics were applied. The first term was the descriptor space 
and referred to the calculation of kNN with Euclidean distance, kNN with Manhattan distance, 
Mahalanobis distance and leverage with the descriptors and PCs. The second term was the 
chemical space and referred to the calculation of kNN with Tanimoto and kNN with Dice with 
the ECFP4 fingerprints. Moreover, the PCA was used to identify if the proprietary training set 
compounds occupied a similar space as the literature test set compounds. The distance to 
model metrics were used to estimate the amount of test set compounds within the AD of the 
proprietary model. 
2.2.5.1 Principal Component Analysis and Stopping Rule 
The PCA was conducted with the KNIME and the R Snippet, which allows execution of an R 
script from within KNIME. The data were auto-scaled. The “princomp” function from the R 
“stats” package was used (Appendix, table S2). The descriptors with zero variance were 
excluded prior the PC calculation because the “princomp” function in R cannot handle constant 
(i.e. zero variance) descriptors. The PCs for the Evotec compounds were first established and 
they were loaded into the R learner node in order to use the same loading matrix for the 
calculation of the PCs for the CHEMBL compounds. Thus, an R predictor node was used to 
calculate the PCs for CHEMBL compounds. The results were concatenated, visualised and 
further analysed with the Scatter Plot (JFree Chart) node in kNIME.  
An essential task, within a PCA analysis, is the identification of the significant number of 
principal components. This would minimize the dimensionality of the dataset and maximize the 
information retained. The average random method (Avg-R) (Peres-Neto, Jackson, & Somers, 
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2005) was used. Among a set of 20 tested methods, the Avg-R was particularly efficient in 
dealing with correlated descriptors. This method for identifying the number of significant 
principal components consisted of the following steps: 1. randomising the values within 
variables in the data matrix with R snippet (Appendix, table S2), 2. conducting a PCA in the 
reshuffled data matrix, 3. calculating the eigenvalues 4. repeating the steps1-3 for 1000 times 
and 5. Calculating the average eigenvalues. If an observed eigenvalue of a PC is greater than 
the average eigenvalue, that PC is considered as significant (non-trivial). 
2.2.5.2 Evaluation of AD with Distance to model metrics 
The distances between the test compounds (literature compounds downloaded from ChEMBL) 
and the training compounds (Evotec compounds) were considered on two different spaces: 1. 
descriptors (figure 14) space and 2. chemical space (figure 15). In the descriptor space the 
distances that were used were the Mahalanobis distance, Leverage and kNN with Euclidean 
and Manhattan. The descriptors were standardised with the “Normalizer” node by choosing 
the “Z-score normalisation” setting. Moreover, the distance measurements were performed 
with the PCs in the descriptor space.  
In the descriptor space, Mahalanobis distance was calculated with the R Snippet node in 
KNIME. The “Mahalanobis distance” function in R from the “stats” package was used 
(Appendix, table S2). This function returns/calculates the squared Mahalanobis distance. That 
distance was used for the evaluation of AD and will be simply referred as Mahalanobis 
distance. The function of Mahalanobis distance cannot handle highly correlated descriptors 
and descriptors with zero variance because it requires the matrix of the descriptors and 
compounds to be inverted. As a result, descriptors with correlation greater than 0.85 and 
descriptors with zero variance were filtered out. A correlation filter KNIME node, which worked 
in iterations, was used to filter out correlated descriptors. In the first iteration, it identified the 
descriptor with the most correlations and it kept that descriptor and filtered out the correlated 
descriptors. Then it continued the iterations until there were no correlated descriptors. The 
leverage method was conducted using the “Domain Leverage” KNIME node developed by the 
Novamechanics (Melagraki et al., 2009; Melagraki & Afantitis, 2013) and in this case the zero 
variance descriptors were also excluded. The kNN with Euclidean and Manhattan distance 
functions were calculated. The “Similarity search” node by Analytics was used in KNIME for 
the calculation of the k Nearest Neighbours. For the calculation of the kNN only the descriptors 
with zero variance were filtered out. In the chemical space, the ECFP4 topological fingerprints 
(256 bits) were generated from the chemical structure (SMILES) of the compounds with the 
“ECFP/FCFP” ChemAxon/Infocom KNIME node. Then, the kNN method was used with 
Tanimoto and Dice coefficients. The “Similarity search” node by Analytics was used in KNIME 
for the calculation of the k Nearest Neighbours. Different values for the number of Nearest 
Neighbours (k) were evaluated (k = 1, 3, 5, 10, 20 and 30) and the average distance of each k 
was calculated. The average distances were compared by calculating correlation coefficient 
for pairs of average distances for different k values. The values of correlation coefficients and 
the computational time needed to obtain the Nearest Neighbour (NNs) were used to select the 
k for further AD evaluations. 
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Figure 14: Screenshot of the workflow that was created for the PCA and the estimation of the 
AD with the four different distance to model metrics in the descriptor space. 
 
 
Figure 15: Overview of the workflow that was created for the PCA and the estimation of the 
AD with the four different distance to model metrics in the chemical space. 
2.2.5.3 Distance to model metrics and thresholds 
Distance thresholds were applied in the training sets to identify the test set compounds that 
are within and outside the AD of the Evotec proprietary models. The threshold that was applied 
for the leverage method is described in section 1.7.1.3. The AD threshold for the k-NN with 
Euclidean/Manhattan distance was calculated based on the compounds comprising the 
training set. The kNN distance for each of the training compound was calculated and the 5% 
of the most remote compounds of the training set were considered to be far from the model 
and false positives (Mathea et al., 2016). Therefore, the compounds were considered by 
increasing kNN distance and the threshold was applied at the compound representing the 95% 
Page 51 of 148 
 
of the compounds with the smallest distance. The Mahalanobis distance method is explained 
in 1.7.1.2. However, there isn’t a specific literature threshold for the Mahalanobis distance and 
therefore the following steps were conducted to establish the threshold: 1. estimation of the 
squared MD of the training set (Evotec compounds), 2. the threshold was set at the 99th 
quantile based on the training set squared Mahalanobis distance, 3. each ChEMBL compound 
was added one by one in the Evotec training set and the squared MD was established. The 
ChEMBL compounds that showed a value greater than the threshold, were considered not to 
be within the AD of the model. The 99th quantile was calculated in R with the quantile function 
“qchisq” and the degree of freedom was equal to the number of descriptors or PCs used. 
Therefore, the 99th quantile was set as the threshold. 
2.2.6 Statistical Analysis 
The statistical tests Mann-Whitney and Kruskall-Wallis were conducted with the homonymous 
nodes in KNIME. 
2.3 Overview of methods used for the Development of in-silico predictive models 
This methodology part refers to the development of in-silico Caco-2 A to B permeability and 
LogD7.4 predictive models. The objective was to establish if the literature data can be 
incorporated into the Evotec proprietary models and answer the two following questions: 1. 
Can literature data improve the performance of proprietary models?  and 2. Can literature data 
enlarge their AD? To provide answer to these two questions a procedure was followed and it 
is shown in figure 16.  
Three types of training sets were used for model development. The first one was the ChEMBL 
training set (C) with public ADME data extracted from the literature, the second was the Evotec 
set (E) developed with Evotec proprietary compounds and the third one was the merging of 
the two previous training sets (E+C). The descriptors were calculated as mentioned in the 
method section 2.2.2 and then three different machine learning algorithms were applied to 
each training set: Random Forest (RF), Partial Least Squares (PLS) and Support Vector 
Regression (SVR) with a radial basis function (rbf) kernel. In this study, the term SVR was 
used instead of SVM because all the models developed were regression/continuous models. 
For each algorithm, an optimisation process was performed. In addition, a model assessment 
was performed with temporal and diverse test sets.  The RMSE in prediction and the R2 were 
also calculated to measure the model performance. Finally, the AD of the models was 
established with four different methods, which were outlined in sections 2.2.5.2, 2.2.5.3: a) MD, 
b) Leverage, c) k-NN/ED and d) k-NN/ManhD. 
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Figure 16: Overview of the methodology process followed for the development of in-silico 
Caco-2 A to B permeability and LogD7.4 predictive models. 
Page 53 of 148 
 
2.3.1 Literature data curation for the development of in-silico Caco-2 permeability and 
LogD7.4 models 
 
Figure 17: Schematic representation of the literature data filtering process for the compounds 
downloaded from ChEMBL for the development of in-silico Caco-2 permeability and LogD7.4 
models. The arrow indicates the flow of the process. 
The same literature data curation was applied as the literature filtering process detailed in 
section 2.2.1 with only one difference. The difference was that for the Caco-2 permeability 
models, the analytical method (used in the experimental procedure) was considered. In 
Evotec, the Liquid Chromatography/Liquid Chromatography-Mass Spectrometry (LC/LC-MS) 
is used to analyse the compounds’ Caco-2 permeability, whereas in the literature various 
methods have been reported like: HPLC, UV etc. The majority of the literature sources did not 
mention the analytical method used. Therefore, all the papers were manually inspected and 
the data obtained with a different analytical method were excluded. Different analytical 
methods could give different results and thus, a cross validation of analytical method is 
necessary to ensure the optimal conditions to accurately reproduce an analytical measurement 
in different laboratories (Chau, Rixe, McLeod, & Figg, 2008). 
For the development of the LogD7.4 models, 4083 compounds with LogD7.4 information were 
downloaded from ChEMBL v. 22. Data were first curated based on the article description 
provided by ChEMBL. The compounds measured in a pH other than 7.4 and with a solvent 
other than octanol were excluded. The rest of the filtering process was identical to the process 
described above and a general workflow of filtering is shown in figure 17. The literature data 
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that were used as temporal tests set for the model assessment were also downloaded from 
ChEMBL and the same procedure was applied. 
2.3.2 Selection of training and test sets 
Three different types of training sets were used to develop models and more details about the 
source and number of compounds are shown in tables 4-7. The first type of training set was 
developed with only literature compounds downloaded from the ChEMBL database (“ChEMBL 
training set”) and the models developed with that training set are the “ChEMBL models”.  The 
second type was developed with only Evotec proprietary compounds extracted from the Evotec 
database (“Evotec training set”) and the models developed with that training set are the “Evotec 
models”. Finally, the third type was developed with merged proprietary Evotec and literature 
compounds (“Evotec+ChEMBL training set”) and the models developed with that training set 
are the “Evotec+ChEMBL models”.  
In addition, a temporal and a diverse test set were used to evaluate the goodness of the 
models. The temporal test set included compounds added to Evotec and ChEMBL databases 
after the initial training sets were created. The diverse test set was formed by randomly 
selecting 20% of compounds from the merged initial and temporal datasets. The rest 80% of 
the merged compounds were used as the training set to build the models.   
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Table 4: Training and Temporal test sets used in development of the in-silico permeability 
models. 
Training set Details Number of compounds 
Evotec Compounds until the 31/08/2016 2075 
ChEMBL Compounds downloaded from ChEMBL v21 (8/08/2016) 1628 
Evotec+ChEMBL Compounds were merged 3703 
Test set Details Number of compounds 
Evotec temporal Compounds from 1/09/2016 until 18/01/2017 166 
ChEMBL temporal Compounds downloaded from ChEMBL v22 (18/01/2017) 92 
Evotec+ChEMBL 
temporal 
Evotec temporal and ChEMBL temporal test sets were 
merged 
258 
 
Table 5: Training and Diverse test sets used in development of the in-silico permeability 
models. 
Training set Details Number of compounds 
Evotec 
80% of the Evotec training set (randomly selected) until 
18/01/2017 
1660 
ChEMBL 80% of the ChEMBL training set (randomly selected) 
from ChEMBL v22 (18/01/2017) 
1302 
Evotec+ChEMBL Compounds were merged 2962 
Test set Details Number of compounds 
Evotec diverse 
20% of the Evotec training set (randomly selected) until 
18/01/2017 
415 
ChEMBL diverse 20% of the ChEMBL training set (randomly selected) 
from ChEMBL v22 (18/01/2017) 
326 
Evotec+ChEMBL 
temporal 
Evotec temporal and ChEMBL temporal test sets were 
merged 
741 
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Table 6: Training and Temporal test sets used in development of the in-silico LogD7.4 models. 
Training set Details Number of compounds 
Evotec Compounds until the 31/12/2016 8400 
ChEMBL Compounds downloaded from ChEMBL v22 (2/05/2017) 1209 
Evotec+ChEMBL Compounds were merged 9609 
Test set Details Number of compounds 
Evotec temporal Compounds from 1/01/2017 until 2/05/2017 895 
ChEMBL temporal Compounds downloaded from ChEMBL v23 (19/05/2017) 86 
Evotec+ChEMBL 
temporal 
Compounds were merged 981 
 
Table 7: Training and Diverse test sets used in development of the in-silico LogD7.4 models. 
Training set Details Number of compounds 
Evotec 
80% of the Evotec training set (randomly selected) until 
2/05/2017 
7436 
ChEMBL 
80% of the ChEMBL training set (randomly selected) 
from ChEMBL v23 (19/05/2017) 
1036 
Evotec+ChEMBL Compounds were merged 8472 
Test set Details Number of compounds 
Evotec diverse 
20% of the Evotec training set (randomly selected) until 
2/05/2017 
1859 
ChEMBL diverse 
20% of the ChEMBL training set (randomly selected) 
from ChEMBL v23 (19/05/2017) 
259 
Evotec+ChEMBL 
diverse 
Compounds were merged 2118 
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2.3.2.1 Subsequent model assessment for Caco-2 permeability models 
In a subsequent model assessment of the Caco-2 permeability models, the permeability data 
in the temporal test sets were merged with the training test sets and used, all together, to 
develop an updated model (M2). Two new temporal test sets were generated including the 
latest proprietary permeability data (Evotec compounds synthesised four months after the 
compounds in the training set) and the freshly published public permeability data from ChEMBL 
version 23. These new temporal test sets were referred as “New Evotec temporal test set” and 
“New ChEMBL temporal test sets” and represented the compounds published in the literature 
and synthesised in Evotec four months after the initial models (M1). The new temporal test 
sets were used to assess both the initial models (M1) and the new models (M2).  
Table 8: Training and temporal test sets new temporal test sets used in the subsequent models 
assessment for the in-silico permeability models. 
Training set 
(M1) 
Details Number of compounds 
Evotec  Compounds until the 31/08/2016 2075 
ChEMBL Compounds downloaded from ChEMBL v21 
(8/08/2016) 
1628 
Evotec+ChEMBL  Compounds were merged 3703 
Training set 
(M2) 
Details Number of compounds 
Evotec  Compounds until the 31/12/2016 2241 
ChEMBL Compounds downloaded from ChEMBL v22 
(18/01/2017) 
1720 
Evotec+ChEMBL  Compounds were merged 3961 
New temporal 
Test sets 
Details Number of compounds 
Evotec temporal Compounds from 19/01/2017 until 20/05/2017 245 
ChEMBL 
temporal 
Compounds downloaded from ChEMBL v23 
(19/05/2017)  
115 
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2.3.3 Standardisation of Molecular descriptors 
A molecular descriptor standardisation process was applied as described in method section 
2.2.2, using the “Normalizer” and the “Normalizer (Apply)” node in KNIME. The “Normalizer” 
node was used for the training set and the “Normalizer (Apply)” node for the test set 
compounds in order to “Standardise” them in the same range as the training set. In this way, 
each descriptor’s values had a mean of 0 and standard deviation of 1. For example, for a 
dataset with m-rows and if each row contains n- different descriptors/variables, the x row for 
the ith descriptor will be standardised with the following equation:  
ܵݐܽ݊݀ܽݎ݀݅ݏ݁݀(ݔ௜) =
௫೔ି௫೘೐ೌ೙
௦௧ௗ(௫)
                        (Equation 26), 
where xi is the value of the ith descriptor in row x, the xmean is the mean of the x row values 
and std(x) is the standard deviation of the values in x row. 
The std (x) and the xmean were calculated with the following equations: 
ݏݐ݀(ݔ) = ට ଵ
௡ିଵ
∑ (ݔ௜ − ݔ௠௘௔௡)ଶ௡௜ୀଵ                    (Equation 27), 
where std(x) is the standard deviation of the values in x row, the n is the number of the 
descriptors, xi is the value of the ith descriptor in row x and the xmean is the mean of the x 
row values. 
and 
ݔ௠௘௔௡ =  
ଵ
௡
∑ ݔ௜௡௜ୀଵ                                (Equation 28), 
where the xi is the value of the ith descriptor in row x, xmean is the mean of the x row values 
and n is the number of the descriptors. 
 
2.3.4 Algorithms and their parameter optimisation for model building 
In this study, three algorithms were used in model building: Random Forest (RF), Partial Least 
Squares (PLS) and Support Vector Regression (SVR).  
2.3.4.1 Random Forest (RF) parameter selection 
Random forest is based on an ensemble of decision trees (Mitchell, 2014; K. Roy et al., 2015), 
which are built by training data of multiple feature. The Caco-2 permeability and LogD7.4 
predictions, which were continuous variables, were provided as the average of the predictions 
of all the trees. Therefore, the key parameter was the number of trees (ntree). A series of 5-
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fold cross-validations was performed with different number of trees (10, 20, 50, 100, 500 & 
1000). It was found that 500 provided an optimal setting with a good balance between 
computational time and the error in the prediction. The work was performed with the 
“RandomForest” R package in the “R Learner” and “R predictor” node in KNIME and the 
“randomForest” function used to develop the model. The 200 descriptors described in section 
2.2.2 were used because RF can handle both correlated and low variance descriptors.  
2.3.4.2 Partial Least Squares (PLS) parameter selection 
PLS is another algorithm that was used for the model development and is able to project the 
original variables (i.e. descriptors) into latent variables and thus reducing the dimensionality 
(Xing et al., 2014). This method decomposes the input matrix of descriptors into loadings and 
scores, and the latter are orthogonal and are capturing the descriptor information (Sethi, 2012). 
In this case, it was essential to choose the appropriate number of components. The dataset 
was shuffled 100 times and 100 PLS models were developed and assessed with a 5-fold cross 
validation and with maximum of 40 components. Then the mean RMSE was calculated for 
each component and the highest performing model was the one with the lowest mean RMSE. 
Then the fewest number of components that were still less than one standard error away with 
95% confidence from the overall best model were chosen for the model building. The work 
was performed in the R learner and R predictor node with the PLS package. Descriptors were 
standardised with the “Normalizer” node for training set and the “Normalizer (Apply)” node for 
the test set. The option “Z normalisation” was applied.  
2.3.4.3 Support Vector Regression (SVR) parameter selection 
SVR originates from the Vapnik’s structural Risk Minimisation principle for statistical theory. In 
this case, the radial basis function (rbf) was used as a kernel and there were three parameters 
to optimise: 1. epsilon (ε), 2. cost (C) and 3. gamma (γ). The goals was to tune these 
parameters so that the model could accurately predict the new data.  The optimisation was 
performed with an exhaustive grid search and a 5-fold cross validation, using the tune function 
in the e1071 in R, to identify the optimal area and then perform a narrower grid search in that 
area. The grid search looks at different parameters’ values and returns the best parameters to 
train the dataset (Chang & Lin, 2011). In addition, a 10-fold cross validation is usually used but 
in this case a 5-fold was selected due to the computation time. A training set of about 2000 
compounds and 170 descriptors needed about 4-5 days to train, whereas a set of about 10,000 
compounds more than 2 weeks. The search was carried out in the following ranges: 1. ε values 
from 0 to 1, 2. C values from 1- 1500 and 3. γ values from 0 to 1. After the calculation of those 
three parameters with the tune function from the e1071 R package, the LibSVM weka node 
was used in KNIME to train the models (Chang & Lin, 2011). 
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2.3.5 Estimation of the AD of the in-silico Caco-2 permeability and LogD7.4 models with 
distance to model metrics  
Mahalanobis Distance, Leverage, kNN with Euclidean and kNN with Manhattan were used in 
the descriptor space to calculate how close are the “ChEMBL temporal test set compounds” 
and “Evotec temporal test set compounds” from the training set of “ChEMBL models”, “Evotec 
models” and Evotec+ChEMBL models”. Therefore, the same methodology and thresholds 
were also applied in this part of the work as described in method sections 2.2.5.2, 2.2.5.3 
The only difference is that in this part of the work the distance of 2 different test sets from 3 
different training sets was calculated (figure 18) and for that reason the KNIME workflow was 
amended to perform these calculations. A screenshot of the workflow is shown in the Appendix 
(figure S1-S4). 
 
Figure 18: Schematic representation of the distances of the test set compounds from the 
training sets. The arrows indicate the distances that were calculated.  
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3 RESULTS AND DISCUSSION 
3.1 Evaluation of existing Evotec Caco-2 A to B permeability model with opensource 
data 
3.1.1 Model Assessment 
The goal of this part of the work was to evaluate the performance of the existing Evotec 
proprietary Caco-2 permeability model on a dataset of 1770 literature compounds. This gives 
an indication of how well the proprietary model can predict literature compounds. The existing 
Caco-2 permeability model that was evaluated has been developed with Evotec proprietary 
compounds as the training set. The opensource test compounds (with experimental Caco2 
permeability measurements) were extracted from the ChEMBL database. The ChEMBL 
compounds were first curated as described in method section 2.3.1. The Evotec permeability 
model estimates the apparent A to B Caco-2 permeability expressed as 10-6 cm/s; however, 
for the statistical computation a Log10 of that permeability was used.  The R2 and RMSE in 
prediction of the ChEMBL compounds were equal to 0.22 and 0.704 respectively.  In addition, 
the RMSE of the Evotec training set was equal to 0.2 and the RMSE of a temporal Evotec set 
(assessed by the same model in the company in July 2016) was 0.42. As a result, the existing 
Evotec Caco-2 permeability model is not accurately predicting the A to B permeability of the 
ChEMBL compounds (figure 19) as accurately as it can predict the proprietary compounds. 
 
 
 
Figure 19: Experimental values for Caco-2 permeability of ChEMBL compounds vs the 
predicted Caco-2 permeability obtained with Evotec Caco-2 model.  
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A similar research was conducted by AstraZeneca (Bruneau, 2001), where they evaluated the 
existing proprietary solubility model with a temporal AstraZeneca solubility test set and a 
literature test set. The results of that study also suggested that the literature test set was not 
predicted as accurately as the proprietary temporal test set. The literature test set RMSE was 
1.88 and the RMSE of the proprietary temporal test set was 0.78. However, these results 
cannot be directly compared to the Evotec results as they refer to a different model, different 
ADME property, different compounds in training and test sets. In another study, a literature 
test set and a proprietary test set were used to evaluate the model performance of a LogD7.4 
proprietary model of Bayer Shering Pharma AG (Schroeter et al., 2007). Results indicated that 
the model was better in predicting proprietary test set (RMSE=0.41) compared to the literature 
test set (RMSE= 0.66). The results from these two studies based on a solubility and a LogD7.4 
predictive model gave the same overall conclusion about the less accurate prediction of 
literature compounds compared to proprietary temporal test sets from proprietary models. A 
possible reason can be that the chemical space of the literature test set may be different from 
the proprietary chemical space of the training set. Therefore, a PCA analysis was conducted 
to compare the descriptor space covered by the public compounds from ChEMBL with that 
covered by the proprietary Evotec compounds used in the model building and training. 
3.1.2 Principal Component Analysis 
PCA has been previously used to identify the overlap of the molecular data in the descriptor 
space (Gavaghan, Arnby, & Blomberg, 2007),  and has also been used to investigate if the 
distribution of training and test set are balanced and representative of the chemical domain 
(Roy, Kovarich, & Gramatica, 2011). Therefore, 2-dimensional PCA (2DPCA) was used to 
project the ChEMBL compounds into the molecular descriptors space of training compounds 
(Evotec compounds) in order to establish their similarity.  
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Figure 20: Principal component plot of Principal Component 1 vs Principal Component 2 for 
Evotec (blue) and ChEMBL (red) compounds. Figures in brackets indicate the percentage of 
variance explained by the corresponding PC. 
The PC score plot of two sets of compounds appear to be closely related in the descriptor 
space (figure 20), because a significant number of CHEMBL compounds is projected on to the 
space covered by the Evotec compounds. However, the first two PCs visualised in this plot 
only account for 22.03% of the variance. Therefore, a 2D PCA analysis would be insufficient 
to answer the question about similarity of the two sets of compounds. Thus, the evaluation of 
different distance to model methods were used to estimate the “distance” of each compound 
in the test set from the training set. The PCA alone was not able to give specific results for 
each test compound but it gave an overall picture of the distribution of the two sets. Thus, PCA 
has been used in the literature along with other methods to establish the AD. Some examples 
are the use of PCA with kNN (Kaneko & Funatsu, 2014), Hotelling-T test (Venkatapathy & 
Wang, 2013) and Mahalanobis distance (De Maesschalck, Jouan-Rimbaud, & Massart, 2000). 
In more detail, a number of PCs were used instead of the descriptors. 
PCA is also combined with methods (like Mahalanobis distance) that require the matrix to be 
inverted and cannot handle correlated descriptors or descriptors with zero variance. The 
multicollinearity and zero variance issues can be overcome by using PCs instead of descriptors 
(De Maesschalck et al., 2000; Jaworska et al., 2005). However, the problem is how many PCs 
are significant and should be used. In that case, a stopping rule should be applied, which will 
reduce the information loss (underestimation) and the noise inclusion (overestimation).  It was 
identified that one of the most efficient stopping rule was the average random (Avg-R),  
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particularly efficient in dealing with correlated descriptors (Peres-Neto et al., 2005). It was 
found that for the Evotec compounds the first Avg eigenvalue higher than the eigenvalue is the 
28th (figure 21). Therefore, the first 27 PCs were retained for subsequent analysis. 
 
 
Figure 21: Scree plot of the eigenvalues from the Evotec compounds PCA (blue) and the 
eigenvalues obtained from the Avg-R on Evotec compounds PCA (orange). 
3.1.3 Evaluation of distance to model metrics 
PCA as a single method was not an efficient method to estimate the AD and other methods 
applied. Different distance to model metrics were evaluated for their ability to correlate the 
distance of the test compounds from the training set with the accuracy of the prediction. A 
distance to model metric, which shows such correlation, could in theory be used as a method 
to provide a confidence interval for a prediction. The distances between the test compounds 
(ChEMBL compounds) and the training compounds (Evotec compounds) were considered on 
two different spaces: 1. descriptors space and 2. chemical space. In the descriptor space, the 
distance to model metrics that were used are the kNN with Euclidean distance, kNN with 
Manhattan distance, Mahalanobis distance and Leverage. The distance measurements were 
performed with the standardised descriptors and the first 27 PCs. In the chemical space, the 
kNN method was used with Tanimoto and Dice coefficients. In that case, the ECFP4 
fingerprints were used to calculate the Dice and Tanimoto coefficients. Moreover, for the kNN 
method, for both descriptor and chemical space different values for number of nearest 
neighbours (k) were evaluated (1, 3, 5, 10, 20 and 30) and the average distance for each k 
was calculated. By altering the k when computing the average distance in descriptor and 
chemical space has only a minimal effect on the overall value and this is shown in correlation 
tables that can be found in appendix (tables S3-S8). Therefore, the k=5 was used as the 
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number of nearest neighbours to consider, as it provided a good compromise between 
execution time and robustness. The same k selection process was conducted in another study 
(Weaver & Gleeson, 2008), where the k=5 was a good compromise. Table 9 summarises the 
distance to model metrics used. For all the methods shown in table 9, the compounds were: 
a) binned by distance and b) binned by squared residuals for further data analysis. 
Table 9: Summary of the Distance to model metrics. 
Distance to model metrics 
Descriptors 
space 
 
Mahalanobis 
Distance 
Leverage kNN 
Euclidean Manhattan 
Descriptors PCs Descriptors PCs Descriptors PCs Descriptors PCs 
Chemical 
space 
(ECFP4 
fingerprints) 
kNN 
Tanimoto Dice 
 
3.1.3.1 Bin compounds by distance 
The distance to model metrics were used to evaluate the presence of a relationship between 
the error in the predictions (RMSE) and the calculated distance to model. Compounds in the 
test set were binned in 5 equally populated bins with increasing distance, and for every bin the 
average error in the prediction was calculated as RMSE. It was observed that there was a 
trend between the RMSE and the distance, especially for the first 3-4 bins (figures 22, 23). 
This trend indicated that as the distance of the test compounds from the training set increases, 
the RMSE in prediction increases too. Interestingly, this trend was observed for all the 
combinations of metrics/methods used (figures 22, 23). If this scenario is genuine all the 
distance metrics investigated could possibly be used to estimate the distance of a compound 
to the model (or better to the training compounds) and consequently an estimation of the 
expected error in the prediction could be argued. To better understand this a statistical analysis 
has been carried out. 
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a)  b)  
c)  d)  
Figure 22: RMSE in prediction of the binned a) Euclidean distance to 5NNs, b) Manhattan 
distance to 5NNs, c) Leverages and d) Mahalanobis Distance for CHEMBL compounds 
calculated with the descriptors. 
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a)  b)  
c)  d)   
Figure 23: RMSE in prediction of the binned a) Euclidean distance to 5NNs, b) Manhattan 
distance to 5NNs, c) Leverages and d) Mahalanobis Distance for CHEMBL compounds 
calculated with the first 27 PCs. 
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Two different statistical tests, the Mann-Whitney test and the Kruskal-Wallis test, which is an 
extension of Mann-Whitney when more than 2 means are compared, were employed to 
determine if there is a statistically significant difference between the equally populated bins. 
The Kruskal-Wallis test has also been used for a similar statistical analysis by Weaver and 
Gleeson (2008), where they were comparing the binned distance of 5 equally populated bins 
with their RMSE. The authors of that work established a statistically significant overall 
difference between the 5 bins. Similarly, the results of Kruskal-Wallis showed that there is a 
statistically significant difference, whereas Mann-Whitney test did not show statistically 
significant difference between all the bins (table 10). The possible reason why Mann Whitney 
test did not always show a statistically significant difference is that compounds that are 
assigned in two subsequent bins might be in a similar distance from the model. However, it is 
not necessary that there should always be a significant difference because that depends on 
the compounds in the test set. For example, if the compounds in the test set are close, there 
will not be a significant trend between the RMSE and the distance and vice versa. As a result, 
the presence of a trend in the data depends on the compounds used as a test set. In that case, 
there is a weak (qualitative) trend. According to Davis and Ward (2014)  the distance to model 
measures usually produce a weak relationship to error in prediction and as a result this is 
limiting the confidence that can be extracted from the statistic. In addition, a similar trend was 
observed in  the AD investigation of LogD7.4 models (Schroeter et al., 2007), where the error 
in prediction increased as the distance of the compounds in the equally populated bins 
increased. However, a statistical analysis has not been conducted to identify if the difference 
in the error in prediction within bins is statistically significant. Furthermore, in another study the 
AD of lipophilicity (LogD7.4) models was evaluated (Bruneau & McElroy, 2006). A trend was 
observed between the error in prediction and the Mahalanobis distance of the test compounds 
from the training set. The trend indicated that as the distance of the test compounds increases, 
the error in prediction increases as well. Therefore, the findings form this study and the 
literature indicate that there is always a relation between the distance of the compounds and 
the error in the prediction. 
Table 10 showed that there was not much difference in RMSE between bin 4 and 5 for most 
of the methods/distances as the last bin, in most of the cases, showed a lower RMSE than the 
previous bin (figures 22, 23). This unexpected behaviour could be explained considering that 
compounds in bin 4 and 5 are largely far from the model thus making the prediction unreliable. 
This translates into random fluctuation of the prediction error thus clearing the trend observed 
at smaller distances. Another possible reason is that the model could possibly extrapolate 
correctly outside the domain (Jaworska et al., 2005) and thus a smaller RMSE could be 
observed in bins 4 and 5. 
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Table 10: Statistical analysis of the RMSE of the bins (data are binned by distance). 
Mann-Whitney Test Kruskal-Wallis Test 
Method Bin1_Bin2 Bin2_Bin3 Bin3_Bin4 Bin4_Bin5 Bin 1 – Bin 5 
Euclidean/ 
Descriptors 
p<0.05 p>0.05 p<0.05 p>0.05 p<0.05 
Euclidean/ 
PCs 
p<0.05 p<0.05 p<0.05 p>0.05 p<0.05 
Manhattan/ 
Descriptors 
p<0.05 p>0.05 p<0.05 p>0.05 p<0.05 
Manhattan/ 
PCs 
p>0.05 p<0.05 p<0.05 p>0.05 p<0.05 
Leverage/ 
Descriptors 
p>0.05 p<0.05 p>0.05 p>0.05 p<0.05 
Leverage/ 
PCs 
p<0.05 p>0.05 p>0.05 p>0.05 p<0.05 
Mahalanobis/ 
Descriptors 
p<0.05 p>0.05 p>0.05 p>0.05 p<0.05 
Mahalanobis 
PCs 
p>0.05 p>0.05 p<0.05 p>0.05 p<0.05 
 
3.1.3.2 Bin compounds by squared residuals 
To further asses the AD, the test compounds were binned in 5 equally populated bins by 
increasing squared residuals and the average distance of each bin was calculated and is 
shown in figures 24, 25. The bar charts did not show any trend between the distance and the 
prediction error. In addition, as it has been conducted previously a Mann Whitney test was 
applied to evaluate if there is a statistically significant difference between the bins. The figures 
24, 25 indicated the absence of a trend between bins 1-4 and this was confirmed by the Mann-
Whitney test (table 11). The only significant difference in the average distance was observed 
and confirmed by the Mann Whitney test between bin 4 and bin 5. This is an indication that 
compounds with the larger RMSE, which are allocated in bin 5, seem to have the greatest 
distance from the model. This trend between bin 4 and bin 5 is something that it was expected. 
However, the absence of trend between bin 1 and bin 4 can have two possible interpretations. 
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One possible explanation could be that a molecule might be permeable due to a property that 
the model cannot consider and consequently the model cannot produce accurate predictions 
for these compounds. The second reason is that the compounds, which are far from the 
chemical space of the model might not be assigned with reliable predictions.  
a)  b)  
c)  d)  
Figure 24: Average a) Euclidean distance to 5NNs, b) Manhattan distance to 5NNs, 
Leverages and d) Mahalanobis Distance of the binned squared residuals for CHEMBL 
compounds calculated with the descriptors. 
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a)  b)  
c)  d)  
Figure 25: Average a) Euclidean distance to 5NNs, b) Manhattan distance to 5NNs, 
Leverages and d) Mahalanobis Distance of the binned squared residuals for CHEMBL 
compounds calculated with the 27 first PCs. 
 
 
 
 
 
 
Di
st
an
ce
 
Di
st
an
ce
 
Di
st
an
ce
 
Di
st
an
ce
 
Page 72 of 148 
 
Table 11: Statistical analysis of the average distance of the bins (data are binned by squared 
residuals). 
Mann-Whitney Test 
Method Bin1_Bin2 Bin2_Bin3 Bin3_Bin4 Bin4_Bin5 
kNN/ Euclidean  p = 0.838 p = 0.750 p = 0.924 p <0.001 
kNN/ Euclidean PCs p = 0.481 p = 0.387 p = 0.387 p <0.001 
kNN/ Manhattan  p = 0.422 p = 0.700 p = 0.043 p <0.001 
kNN/ Manhattan PCs p = 0.843 p = 0.414 p = 0.094 p <0.001 
Leverage p = 0.838 p = 0.750 p = 0.924 p <0.001 
Leverage PCs p = 0.992 p = 0.353 p = 0.277 p <0.001 
Mahalanobis p = 0.869 p = 0.738 p = 0.841 p <0.001 
Mahalanobis PCs p = 0.992 p = 0.353 p = 0.277 p <0.001 
 
3.1.3.3 Group compounds based on distance threshold 
In addition, thresholds were applied on the distance of test set compounds from the training 
compounds. All the methods showed to categorise the compounds in two groups (table 12). 
The one group included the compounds that were within the AD and the other group the 
compounds that were outside. These two groups illustrated a trend indicating that the RMSE 
for chemicals outside the AD is larger than that for chemicals within the AD. These two groups 
also showed a statistically significant different RMSE between the compounds inside and 
outside the AD. This is in line with a study, where a trend was observed between the 
compounds inside and outside the AD when different distance to model metrics used with both 
descriptors and PCs (Jaworska et al., 2005). This is an indication that these methods can 
distinguish between well predicted and less accurately predicted compounds. 
Moreover, the k-NN algorithm was used with two different distance functions, the Euclidean 
and the Manhattan in both descriptor and PCs space. The results obtained from these methods 
seemed to allocate a different number of compounds within the AD. A possible explanation for 
that will be the different way that Euclidean and Manhattan distance weight differences. The 
Manhattan deals with the small and large differences of each variable alike, whereas the 
Euclidean distance penalises those differences by squaring them (Mathea et al., 2016). In 
addition, the advantage of the kNN method and leverage over Mahalanobis distance was that 
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they calculated distances based on 174 descriptors compared to the 126 and as a result the 
information loss due to correlated descriptors was minimised.  
Furthermore, from table 12, it is evident that each method produced different results regarding 
the percentage of the compounds within and outside the AD. This is something that was also 
observed by other studies, where different distance to model metrics were used. These studies 
also suggested that the results derived with different AD approaches might vary even for the 
same set of compounds (Jaworska et al., 2005; Sahigara et al., 2012). As a consequence, as  
Sahigara et al. (2012) concluded, none of these methods can be used on its own and it is 
preferable to use all the possible strategies/methods to evaluate the AD.  
Table 12: The table depicts the percentage of the compounds and the RMSE for the 
compounds inside and outside of the AD. The Mann Whitney results and the number of 
descriptors or PCs used are also shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Method 
Within AD Outside AD ΔRMSE 
 
Mann 
Whitney 
test. 
Number of 
descriptors 
/PCs % RMSE % RMSE 
kNN/ 
Euclidean  
32.60 0.56 67.40 0.76 0.20 p<0.05 174 
descriptors 
kNN/ 
Euclidean PCs 
38.64 0.59 61.36 0.77 0.18 p<0.05 27 PCs 
kNN/ 
Manhattan  
19.04 0.53 80.96 0.74 0.21 p<0.05 
174 
descriptors 
kNN/ 
Manhattan 
PCs 
35.71 0.59 64.29 0.76 0.17 p<0.05 27 PCs 
Leverage  47.40 0.66 52.60 0.74 0.08 p<0.05 
126 
descriptors 
Leverage PCs 91.30 0.70 8.70 0.77 0.07 p<0.05 27 PCs 
Mahalanobis  7.23 0.52 92.77 0.72 0.20 p<0.05 
126 
descriptors 
Mahalanobis 
PCs 77.51 0.68 22.49 0.78 0.10 p<0.05 27 PCs 
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Overall, the results produced with distance to model metrics in the descriptor space indicated 
that there will always be an uncertainty associated with any methods for assessing the AD of 
QSPR models (Netzeva et al., 2005). Therefore, there were compounds with high RMSE which 
had a lower distance to model and the vice versa. There are 2 possible explanations about 
that: The first one is the “unexpected deviation from the model”. This is happening when a 
prediction is considered within the AD of the model but it is still unreliable because the 
compound might have an additional property not accounted by the model. The second reason 
is that the set of ChEMBL compounds is a heterogeneous set derived from more than 300 
articles and thus the experimental Caco-2 protocols may vary from the proprietary protocol and 
ultimately the RMSE value is affected.  
3.1.3.4 kNN with Tanimoto and Dice 
After the evaluation of the distance of test set compounds from the model in descriptor space, 
the distance in the fingerprint space was also evaluated. The idea of estimating the AD in the 
fingerprint space has been also considered as important in similar studies, which are trying to 
establish the AD of QSPR models (Gadaleta et al., 2016; Weaver & Gleeson, 2008). In this 
part of the study, the test compounds were binned in 5 equally populated bins by increasing 
similarity. The RMSE in prediction was reported for each bin as shown in figure 26. 
a  b  
Figure 26: RMSE in prediction of the binned similarity to 5NNs for CHEMBL compounds calculated 
with: a) Tanimoto and b) Dice coefficients in ECFP4 fingerprint space. 
 
The kNN method in ECFP4 fingerprint space by using the Tanimoto and Dice similarity show 
no correlation between the chemical similarity and the RMSE in the prediction. A possible 
explanation about this result is that Caco-2 permeability is a property greatly influenced by the 
physiochemical properties of the compounds (Artursson et al., 2012). Different functional 
groups, which are dissimilar, might show similar physiochemical properties. This is an 
interesting finding, which can be compared with other ADME models, which depend on the 
chemical structure of the compounds. There are ADME models, which depend on chemical 
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structure because examine protein interactions like the CYP-mediated metabolism or active 
transport (Testa & Turski, 2006) and there are models like membrane permeability which focus 
on the physiochemical characteristics. For example, in a study conducted by Weaver and 
Gleeson (2008) the kNN along with Tanimoto coefficient were used to establish the AD in the 
fingerprint space for a CYP450 3A4 inhibition model. The results suggested that there is a 
relationship with the prediction error. As a result, it would be interesting to use that distance to 
model metric in the ECFP4 fingerprint space in models, which aim to predict properties like 
metabolism or induction/inhibition of metabolic enzymes.  
3.1.4 Conclusion 
The PCA and AD results indicated that there were compounds which were within the chemical 
space of the Evotec compounds and there were some compounds, which were dissimilar. 
Compounds that have been predicted within the AD is not an indication that the prediction is 
correct but that the specific model was correctly applied for those compounds. The same 
implies for the compounds outside the AD and it means that there is an increased uncertainty 
with the prediction and model might or might not extrapolate a correct prediction. The AD 
estimation showed a weak trend between the error in the predictions (RMSE) and the 
calculated distance to model. The RMSE in predictions increased as the distance increased 
and this trend was observed, when the compounds were binned by increasing distance but not 
when binned by squared residuals. However, the results obtained from the application of a 
threshold, showed that a different percentage of compounds is considered within the AD based 
on the method used. Therefore, more than one of distance to model metrics should be 
considered in the estimation of AD. The distance to model metrics were able to give an 
indication of how far or close are the compounds from the training set but also other factors 
like the model ability to predict and the reliability of the compounds’ source should also be 
taken into consideration.   
For the next parts of this work, which focus on the development of in-silico LogD7.4 and 
permeability models, the AD of the models will only be evaluated in descriptor space since 
LogD7.4 and permeability are two properties dependent mainly on the physiochemical 
properties. In addition, the descriptors were preferred over the PCs and the reason was that 
for the Leverage, kNN with Euclidean and kNN with Manhattan only the descriptors with zero 
variance were excluded and therefore there was no information loss since zero variance 
descriptors were constant for all the chemical compounds. With the calculation of PCs and the 
selection of a number of them, it was definite that a percentage of the information was lost. 
The reason that all the distance to model metrics will be used is that none of them proved to 
be better than the other and there are suggestions in the literature to always use more than 
one distance to model metrics. 
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3.2 Evaluation of Caco-2 in-silico permeability models 
The objective of this part was the development of QSPR models to predict Caco-2 A to B 
apparent permeability. Three types of models were built with different training sets, which 
included: i. literature, ii. proprietary and iii. merged proprietary and literature data. By 
comparing the performance and AD of the models, it was investigated if the merged models 
(Evotec+ChEMBL) could outperform the models developed with proprietary compounds 
(Evotec). Additionally, four distance to model metrics were applied to estimate the AD of the 
models and establish if the addition of literature data in proprietary models could enlarge the 
AD of proprietary models.  
3.2.1 Models developed with literature data (ChEMBL models) 
The first models reported herein were developed using only public data extracted from the 
ChEMBL database. These models are referred as “ChEMBL models” and were based on a set 
of 1628 compounds with Caco-2 permeability data extracted from ChEMBL and processed as 
describe in the methods section 2.3.1. Three different modelling algorithms were applied to 
build the QSPR models: random forest (RF), partial least square (PLS) and support vector 
regression (SVR).  
Two different strategies were used to define and evaluate the goodness of a model. In one 
case, all the 1628 compounds were used to build the QSPR models and a “temporal” test set 
was derived subsequently, including new Caco-2 permeability data made available in a new 
version of ChEMBL. The temporal test set included 92 compounds. In the second case, the 
1628 compounds were merged with the 92 compounds of the temporal test set and the diverse 
test set was built including 20% of the total number of compounds randomly selected, while 
the remaining 80% of the compounds have been used to build and train the model. The first 
testing strategy, also known as temporal test set may be more challenging and may be a better 
representation of a real drug discovery situation, when the Caco-2 permeability of new 
compounds will have to be predicted with an existing model. The RMSE of the predictions and 
the R2 of the predicted versus experimental values were calculated for the test sets and used 
to evaluate the goodness of the model. Based on these metrics a better model will show a 
higher R2 and a lower value of the RMSE for the prediction of compounds in the test set.  
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Table 13: RMSE in prediction and R2 of ChEMBL diverse test set and ChEMBL temporal test 
set obtained with the ChEMBL model by using three different machine learning methods (RF, 
PLS &SVR). The red colour indicates the model that produced the lower RMSE in each testing 
strategy. 
Model/Training 
set 
ChEMBL diverse 
test set 
ChEMBL temporal 
test set 
RF PLS SVR RF PLS SVR 
ChEMBL RMSE 0.54 0.64 0.53 0.69 0.78 0.63 
R2 0.60 0.40 0.58 0.46 0.15 0.43 
 
The results of the model assessment indicated that in both test sets (temporal or diverse), the 
nonlinear machine learning algorithms, RF and SVR, provided better performing predictive 
QSPR models than PLS (table 13). A possible explanation lies is the fact that there may be 
nonlinear relationships between Caco-2 permeability and the descriptors used. For example, 
MLR and SVR were compared for their ability to develop Caco-2 permeability models and the 
SVR performed better than MLR, due to the possible existence of non-linear relationships 
between Caco-2 permeability and descriptors (Karelson et al., 2009).  Moreover, SVR and 
Boosting algorithms were able to provide more predictive Caco-2 permeability models 
(constructed with CHEMBL data) compared to MLR and PLS (Wang et al., 2016). Cao and co-
workers concluded that permeability, and in general ADME properties, are complex chemical 
systems not treatable or possible to be explained by mean of linear methods like PLS and MLR 
(Cao, Liang, Xu, Hu, & Zhang, 2011). The performance of RF and SVR was similar when 
assessed with the ChEMBL diverse test set. However, in the case of the ChEMBL temporal 
test set, the SVR algorithm performed slightly better. The SVR showed an RMSE of 0.63, 
whereas the RF showed an RMSE of 0.69. Both test sets were predicted with a high error in 
prediction and therefore the reliability of prediction by ChEMBL models is questionable and the 
results of prediction should be used with caution. 
In general, RF and SVR are two popular methods and are probably considered as two of the 
best performing and more frequently used algorithms in cheminformatics (Mitchell, 2014). 
Moreover, there are many factors that can affect the performance of an algorithm like i) the 
size and distribution of compounds in chemical space, ii) the possible linearity of the chemical 
problem examined and iii) the nature of descriptors (Mitchell, 2014). The drawback of the SVR 
compared to the RF was that SVR was very time consuming due to the procedure needed to 
optimise the hyperparameters (C, ε and γ). On the other hand, RF required a minimal 
optimisation time. These algorithms also performed similarly in the development of regression 
models for the prediction of melting point and additionally outperformed other algorithms like 
kNN and PLS (Hughes et al., 2008).  
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Figure 27: Experimental versus predicted Caco-2 permeability of compounds in the ChEMBL 
diverse test set obtained with the ChEMBL model developed with the SVR algorithm. Caco-2 
permeability is reported as Log10 (A->B Papp[10-6 cm/s]). The black solid line represents the 
line of best fit in the form of y=b+ax. The red and dark blue dashed lines represent the         
y=x±1 and the y=x±0.5 respectively. 
 
Figure 28: Experimental versus predicted Caco-2 permeability of compounds in the ChEMBL 
temporal test set obtained with the ChEMBL model developed with SVR algorithm. Caco-2 
permeability is reported as Log10 (A->B Papp[10-6 cm/s]). The black solid line represents the 
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line of best fit in the form of y=b+ax. The red and dark blue dashed lines represent the         
y=x±1 and the y=x±0.5 respectively. 
When the SVR ChEMBL model was applied on the literature diverse and temporal test sets 
the R2 was equal to 0.58 and 0.43 respectively and the RMSE equal to 0.53 and 0.63 
respectively (figures 27, 28). Therefore, the compounds in the diverse test set showed a better 
correlation between the experimental and predicted values and a lower RMSE in prediction 
compared to the temporal test set. However, R2 should be considered cautiously because its 
value may be increased by addition of data in a narrow range of values. The diverse test set 
included a greater number of compounds compared to the temporal test set and thus the higher 
R2 value might not indicating better model performance. The red and dark blue dashed lines 
enclose the compounds with predicted Caco-2 permeability within ±1 and ±0.5 log units 
respectively from the experimental values. These lines were used as a barrier to identify 
compounds with high and too high predicted values compared to experimental values 
(Schroeter et al., 2007). For the diverse test set, the 93.70% and the 84% of the predicted 
Caco-2 permeability values were within ±1 and ±0.5 log units respectively from the 
experimental values. For the temporal test set, the 89.13% and the 77.09% of the predicted 
Caco-2 permeability values were within ±1 and ±0.5 log units from the experimental values. 
Therefore, a smaller percentage of temporal test set compounds had prediction values from 
the experimental values within ±1 and ±0.5 log units. The reason might be that the compounds 
in temporal test set were novel or far from the model’s chemical space and the model produced 
predictions with a higher error in prediction. Therefore, the compounds in the temporal test 
sets might not have been represented with compounds in the training set as it might have 
happened with the compounds in the diverse test set, which were randomly selected from the 
initial dataset.   
3.2.2 Models developed with proprietary data (Evotec models) 
The second models reported herein were developed using only proprietary data extracted from 
the Evotec database. These models are referred as “Evotec models” and were based on a set 
of 2075 compounds with Caco-2 permeability data. Three different modelling algorithms were 
applied to build the QSPR models: random forest (RF), partial least square (PLS) and 
supporting vector regression (SVR).  
Two different strategies were used to define and evaluate the goodness of a model. In one 
case, all the 2075 compounds were used to build the QSPR model and a temporal test set 
was derived subsequently, when new compounds were added in the Evotec database with 
Caco2 permeability data. The temporal test set included 166 compounds. In the second case, 
the 2075 compounds were merged with the 166 compounds of the temporal test set and the 
diverse test set was built including 20% of the total number of compounds randomly selected, 
while the remaining 80% of the compounds have been part of the training set used to build the 
model.  
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Table 14: RMSE in prediction and R2 of Evotec diverse test set and Evotec temporal test set 
obtained with the Evotec model by using three different machine learning methods (RF, PLS 
&SVR). The red colour indicates the model that produced the lower RMSE in each testing 
strategy. 
Model/Training 
set 
Evotec diverse 
test set 
Evotec temporal 
test set 
RF PLS SVR RF PLS SVR 
Evotec RMSE 0.36 0.43 0.37 0.57 0.60 0.57 
R2 0.75 0.64 0.73 0.44 0.45 0.49 
 
The results of the Evotec model assessment indicated that in both test sets (temporal or 
diverse), the RF and SVR algorithms provided better performing predictive QSPR models than 
PLS (table 14) as observed with the model assessment results of the ChEMBL models (section 
3.2.1).  In the case of the diverse test set, the RF and SVR models provided similar RMSE 
values equal to 0.36 and 0.37 respectively. In the case of the temporal test set, the 
performance of RF and SVR was identical (RMSE = 0.57).  The Evotec model predicted the 
diverse test set with a low error in prediction but in the case of the temporal test set the reliability 
of prediction by Evotec models is questionable and the results of prediction should be used 
with caution. 
 
Figure 29: Experimental versus predicted Caco-2 permeability of compounds in the Evotec 
diverse test set obtained with the Evotec model developed with RF algorithm. Caco-2 
permeability is reported as Log10 (A->B Papp[10-6 cm/s]). The black solid line represents the 
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line of best fit in the form of y=b+ax. The red and dark blue dashed lines represent the y=x±1 
and the y=x±0.5 respectively. 
  
Figure 30: Experimental versus predicted Caco-2 permeability of compounds in the Evotec 
temporal test set obtained with the Evotec model developed with RF algorithm. Caco-2 
permeability is reported as Log10 (A->B Papp[10-6 cm/s]). The black solid line represents the 
line of best fit in the form of y=b+ax. The red and dark blue dashed lines represent the y=x±1 
and the y=x±0.5 respectively. 
When the RF ChEMBL model was applied on the proprietary diverse and temporal test sets 
the R2 was equal to 0.75 and 0.44 and the RMSE equal to 0.36 and 0.57 respectively (figures 
29, 30). Therefore, the compounds in the diverse test set showed a better correlation between 
the experimental and predicted values and a lower RMSE in prediction compared to the 
temporal test set. However, R2 should be considered cautiously because its value may be 
increased by addition of data in a narrow range of values. The diverse test set included a 
greater number of compounds compared to the temporal test set and thus the higher R2 value 
might not indicating better model performance. The red and dark blue dashed lines enclosed 
the compounds with predicted Caco-2 permeability within ±1 and ±0.5 log units respectively 
from the experimental values. For the diverse test set, the 98.44% and the 93.10% of the 
predicted Caco-2 permeability values were within ±1 and ±0.5 log units respectively from the 
experimental values. For the temporal test set, the 91.57% and the 81.33% of the predicted 
Caco-2 permeability values were within ±1 and ±0.5 log units from the experimental values. 
Therefore, a smaller percentage of temporal test set compounds had prediction values from 
the experimental values within ±1 and ±0.5 log units. The reason might be that the compounds 
in temporal test set were novel or far from the model’s chemical space and the model produced 
predictions with a higher error in prediction. Therefore, the compounds in the temporal test 
sets might not have been represented with compounds in the training set as it might have 
happened with the compounds in the diverse test set, which were randomly selected from the 
initial dataset. 
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3.2.3 Models developed with merged proprietary and literature data (Evotec+ChEMBL 
models) 
The third group of models reported herein have been developed using both Evotec proprietary 
and literature data extracted from the ChEMBL database. These models are referred as 
“Evotec+ChEMBL models”. The training sets from the two previous models were merged, thus 
resulting in 3703 compounds. Three different modelling algorithms were applied to build the 
QSPR models: random forest (RF), partial least square (PLS) and support vector regression 
(SVR).  
Two different strategies were used to define and evaluate the goodness of a model. In one 
case, all the 3703 compounds were used to build the QSPR model and the test set (temporal) 
has been derived by merging the two previous (Evotec and ChEMBL) temporal test sets 
resulting in 258 compounds. In the second case, the 3703 compounds were merged with the 
258 compounds of the temporal test set and the diverse test set was built including 20% of the 
total number of compounds randomly selected, while the remaining 80% of the compounds 
have been part of the training set used to build the model.  
Table 15: RMSE in prediction and R2 of Evotec+ChEMBL diverse test set and 
Evotec+ChEMBL temporal test set obtained with the Evotec+ChEMBL model by using three 
different machine learning methods (RF, PLS &SVR). The red colour indicates the model that 
produced the lower RMSE in each testing strategy. 
Model/Training 
set 
Evotec+ChEMBL 
diverse test set 
Evotec+ChEMBL 
temporal test set 
RF PLS SVR RF PLS SVR 
Evotec+
ChEMBL 
RMSE 0.45 0.65 0.44 0.63 0.85 0.62 
R2 0.66 0.33 0.66 0.36 0.07 0.39 
 
The results of the model assessment (table 15) indicated that in both test sets (temporal or 
diverse), the RF and SVR algorithms provided more predictive QSPR models than PLS and 
this was also observed with the ChEMBL and Evotec models (sections 3.2.1, 3.2.2). Both SVR 
and RF algorithms performed similarly on the diverse and temporal test sets. For the diverse 
test set, the SVR produced an RMSE of 0.44 against an RMSE of 0.45 obtained with the RF 
model. For the temporal test set the SVR produced an RMSE of 0.62 against an RMSE of 0.63 
obtained with the RF model. The Evotec+ChEMBL model predicted the diverse test set with a 
low error in prediction but in the case of the temporal test set the reliability of prediction by 
Evotec+ChEMBL models is questionable and the results of prediction should be used with 
caution. 
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Figure 31: Experimental versus predicted Caco-2 permeability of compounds in the 
Evotec+ChEMBL diverse test set obtained with the Evotec+ChEMBL model developed with 
RF algorithm. Caco-2 permeability is reported as Log10 (A->B Papp[10-6 cm/s]). The black solid 
line represents the line of best fit in the form of y=b+ax. The red and dark blue dashed lines 
represent the y=x±1 and the y=x±0.5 respectively. 
 
 
Figure 32: Experimental versus predicted Caco-2 permeability of compounds in the 
Evotec+ChEMBL temporal test set obtained with the Evotec+ChEMBL model developed with 
RF algorithm. Caco-2 permeability is reported as Log10 (A->B Papp[10-6 cm/s]). The black solid 
line represents the line of best fit in the form of y=b+ax. The red and dark blue dashed lines 
represent the y=x±1 and the y=x±0.5 respectively. 
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When the RF ChEMBL model was applied on the diverse and temporal test sets the R2 was 
equal to 0.66 and 0.36 and the RMSE equal to 0.45 and 0.63 respectively (figures 31, 32). 
Therefore, the compounds in the diverse test set showed a better correlation between the 
experimental and predicted values and a lower RMSE in prediction compared to the temporal 
test set. However, R2 should be considered cautiously because its value may be increased by 
addition of data in a narrow range of values. The diverse test set included a greater number of 
compounds compared to the temporal test set and thus the higher R2 value might not indicating 
better model performance. The red and dark blue dashed lines enclosed the compounds with 
predicted Caco-2 permeability within ±1 and ±0.5 log units respectively from the experimental 
values. For the diverse test set, the 95.71% and the 88.40% of the predicted Caco-2 
permeability values were within ±1 and ±0.5 log units respectively from the experimental 
values. For the temporal test set, the 86.05% and the 75.58% of the predicted Caco-2 
permeability values were within ±1 and ±0.5 log units from the experimental values. Therefore, 
a smaller percentage of temporal test set compounds had prediction values from the 
experimental values within ±1 and ±0.5 log units. The reason might be that the compounds in 
temporal test set were novel or far from the model’s chemical space and the model produced 
predictions with a higher error in prediction. Therefore, the compounds in the temporal test 
sets might not have been represented with compounds in the training set as it might have 
happened with the compounds in the diverse test set, which were randomly selected from the 
initial dataset. 
3.2.4  Comparison of Caco-2 permeability models with models reported in the literature 
The goal of this part of the work was to compare the models developed in the present study in 
sections 3.2.1-3.2.3 (i.e. ChEMBL, Evotec and Evotec+ChEMBL models) with models reported 
in the literature. Several regression permeability models have been reported and various 
limitations have been discussed in the introduction (section 1.9.3) regarding the training set 
size, the type of algorithms (linear vs nonlinear) and type of test sets (temporal vs diverse) 
used.  
The permeability models reported in sections 3.2.1-3.2.3, were compared with the two most 
recent regression permeability models, published by Wang et al (2016) and Fredlund et al 
(2017), and reported in table 16. These two models were chosen as they exhibited two main 
similarities with the models developed in the present study. The first similarity is that they used 
a larger training set compared to other models in the literature outlined in section 1.9.3. The 
second is that the models’ training sets incorporated literature data (Wang et al, 2016) and 
both literature and proprietary data (Fredlund et al, 2017) similarly to the models reported in 
the present study.  
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Table 16: The two most recent regression permeability models developed with caco-2 data. 
 
Reference Method Number 
of 
Molecules 
Number of 
Descriptors 
Model 
Performance 
AD 
Estimation? 
(Wang et al, 
2016) 
MLR 
PLS 
SVR 
Boosting 
1272 193 RMSE=0.31 Yes: 
Leverage 
(Fredlund et al, 
2017) 
PLS 
SVR 
RF 
 2558 PLS, SVR:AZ 
descriptor set 
RF: signature 
descriptors 
RMSE=0.45 No 
 
The Caco-2 models developed by Wang et al (2016) showed several similarities with the 
ChEMBL models developed in the present study.  Wang et al (2016) used Caco-2 permeability 
data from ChEMBL and a very similar filtering process was applied to ensure less experimental 
variability. The main difference in the filtering process was that in the present study the 
analytical method used during the Caco-2 assay had been taken into consideration. Therefore, 
compounds that during the Caco-2 assay, were analysed with a method different than LC/LC-
MS were excluded.  Different analytical methods could give different results and thus a cross 
validation of analytical method is necessary to ensure the optimal conditions to accurately 
reproduce an analytical measurement in different laboratories (Chau et al., 2008).  
A training set of 1272 literature compounds was partitioned in a training set of 1017 compounds 
(80%) and a diverse test set of 255 compounds (20%) based on the joint x – y distances 
(SPXY) method to ensure that the test sets could map the measured region of the input 
variable space. However, this splitting might not represent a realistic drug design process. In 
pharmaceutical companies, ADME models are used to predict a variety of compounds, which 
might be chemically novel or physiochemically different from the training set compounds. By 
comparing the RMSE in prediction on the test sets for the models developed in the present 
study (ChEMBL, Evotec and Evotec+ChEMBL) and the model reported by Wang et al (2016), 
it seemed that their model performed better by showing a lower RMSE in prediction and a 
higher R2 (Table 17).  However, a direct comparison of the RMSE and R2 would not be 
accurate, as different training and test sets were used. 
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Table 17: RMSE in prediction and R2 of: literature ChEMBL model by Wang et al (2016), 
ChEMBL model, Evotec models and Evotec+ChEMBL model on their diverse test sets.  The 
red colour indicates the highest performing modelling algorithm for each model. 
 Method RMSE R2  
Literature ChEMBL 
model by Wang et al 
(2016) 
MLR 0.36 0.75 
PLS 0.36 0.75 
SVR 0.32 0.80 
Boosting 0.31 0.81 
ChEMBL model 
(developed in the 
present study) 
PLS 0.64 0.45 
RF 0.54 0.42 
SVR 0.53 0.59 
Evotec model 
(developed in the 
present study) 
PLS 0.43 0.64 
RF 0.36 0.75 
SVR 0.37 0.73 
Evotec+ChEMBL 
model (developed 
in present study) 
PLS 0.65 0.40 
RF 0.45 0.74 
SVR 0.44 0.73 
 
To make a direct comparison, the methodology developed in the present study, was applied 
on Wang et al (2016) training set and then the models derived, were assessed with the Wang 
et al (2016) diverse test set and the two external validation test sets. Therefore, the training 
compounds of Wang et al (2016) were trained by using the set of descriptors and algorithms 
used in the present study.  The two external validation test sets included 298 compounds with 
Caco-2 permeability data and 220 compounds with MDCK permeability data obtained from 
ChEMBL and other literature sources. The two best performing algorithms were applied: 1. RF 
and 2. SVR and the results of the RMSE in prediction are shown in the table 18.  
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Table 18: RMSE in prediction of Boosting model developed by Wang et al (2016) and of the 
new model, developed with Wang et al (2016) training and test sets and the present study’s 
methodology. The red colour indicates the highest performing model.  
 Method RMSE 
Literature 
ChEMBL diverse 
test set by Wang 
et al (2016) 
Caco-2 external 
Validation test 
set by Wang et 
al (2016) 
MDCK  external 
validation test 
set  by Wang et 
al (2016) 
Literature ChEMBL  
by Wang et al (2016) 
Boosting 0.31 0.36 0.38 
Literature ChEMBL 
model by Wang et al 
(2016) developed with 
present study’s 
methodology 
RF 0.34 0.33 0.41 
SVR 0.37 0.39 0.44 
 
Table 18 shows that the methodology (algorithms) developed in the present study, when 
applied to the literature training and test sets provided comparable results. In more detail, RF 
results were very similar to the Boosting method as they are two similar algorithms that work 
by creating an ensemble of decision trees. However, the model developed with Wang et al 
(2016) training set and the present study’s methodology performed better when evaluated 
external Caco-2 data. Therefore, a possible reason that the ChEMBL, Evotec and 
Evotec+ChEMBL models showed a higher RMSE in prediction (table 17) was due to the 
different partitioning of compounds in training and diverse test sets. In theory, a test set, which 
is representative of the training set can give a good model performance but at the same time 
could be unrealistic or very optimistic (Cherkasov et al, 2014). Therefore, in the present study 
temporal test sets and diverse test sets based on the random partition of the initial dataset 
were used. On the other hand, Wang et al (2016) used the joint x – y distances (SPXY) method 
to ensure that the test sets could map the measured region of the input variable space 
completely. Both random partitioning and the joint x – y distances (SPXY) partitioning offers 
advantages and disadvantages. The advantage of the random partitioning is that the 
compounds are “unknown” to the model (Martin et al., 2012). As a result, a random selection 
of a diverse test set gives an indication of the “realistic predictive power” of an ADME model.  
From another perspective, one could argue that the test should be reasonably similar and 
representative to the compounds of the training set. However, this approach could yield an 
“optimistic estimate” of the model performance (Cherkasov et al., 2014). In addition, it is 
important to take into account other parameters like the setting under which an ADME 
predictive model is used. For example, the use of a representative test set with optimistic model 
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assessment results might not be appropriate for a drug discovery project in a pharmaceutical 
company. The reason is that the newly synthesised proprietary compounds might or might not 
be similar to the model’s training set. Therefore, a randomly selected diverse test set mimics 
that situation and potentially the results are more realistic.  
 In addition, Wang et al (2016) used only one distance to model metric to evaluate the AD of 
the models, whereas in the present study four different distance to model metrics compared. 
This comes in agreement with findings in the literature, which suggest to always use more than 
one distance to model metric for the AD evaluation (Sahigara et al, 2012). 
The second model reported in table 16 is a regression permeability model by AstraZeneca 
(Fredlund et al., 2017). AstraZeneca model was developed with both proprietary and literature 
data and the training set of the model included 2558 compounds. The model performance was 
assessed with a diverse test set. The compounds in the diverse test set were randomly 
selected from the initial dataset and the model predicted the compounds with an RMSE equal 
to 0.45. This RMSE was comparable with the RMSE in prediction of the Evotec+ChEMBL 
model (RMSE=0.44). Both the AstraZeneca and the Evotec+ChEMBL models combined 
proprietary and opensource data in their training set and a reasonable error in prediction was 
observed. However, the AstraZeneca models had not been compared with models developed 
only with proprietary compounds. This comparison could indicate whether the literature data 
have a positive or negative impact on the proprietary models. This is an important point 
because there is a debate about the reliability of data in chemical databases and therefore it 
is interesting to investigate if their effect in proprietary models could possibly balance their 
experimental uncertainty. This is something investigated in the present study in section 3.2.5. 
Furthermore, the reliability of a model’s prediction depends on two important factors. The first 
one is the methodology (algorithm and descriptors) and the second is the AD evaluation, which 
is something not reported for the AstraZeneca model. Fredlund et al (2017) monitored the 
performance of the model over a period of two years and the model was improved. Therefore, 
it would have been interesting to evaluate if the improvement in model performance relates 
with the possible enlargement of the AD and also to establish the effect of literature compounds 
on the models’ AD. Therefore, the present study investigated these points regarding the AD in 
section 3.2.7. 
3.2.5 The effect of merging proprietary and literature data in the development of Caco-2 
permeability models 
The three models (“ChEMBL”, “Evotec” and “Evotec+ChEMBL” models), which were 
developed and described in sections 3.2.1-3.2.3, were used to evaluate the effect of the 
introduction of literature compounds in the proprietary models by testing both Evotec and 
Evotec+ChEMBL models on the same test sets. The test sets that were used were the Evotec 
and ChEMBL temporal and diverse test sets, which were also outlined in sections 3.2.1-3.2.3. 
The three models were trained with three different algorithms (RF, PLS and SVR) and were 
tested on the same diverse and temporal test sets and the results are outlined in tables 19 and 
20 respectively.  
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The Evotec and Evotec+ChEMBL models predicted the permeability of Evotec diverse test set 
(table 19) with a low RMSE equal to 0.36 and 0.37 respectively (based on the RF predictions). 
However, in all the other cases, the models predicted the diverse and temporal test sets with 
a larger error in prediction. Therefore, the reliability of predictions is questionable and the 
results of prediction should be used with caution. 
There are various reasons, which can negatively affect the performance of the models. One 
reason could be the problems related to the data heterogeneity (Cherkasov et al., 2014). The 
data extracted from ChEMBL database were used to build models (ChEMBL models) and were 
also merged with Evotec data to build models (Evote+ChEMBL models). The ChEMBL data 
are in-vitro ADME data, which are obtained from different sources of the medicinal chemistry 
literature. Therefore, inter-laboratory and/or protocol variability might have affected the models’ 
performance. In addition, another challenge during the QSPR development is the introduction 
of errors during the descriptors’ calculation (Cherkasov et al., 2014). There are some 
descriptors that can be accurately calculated (MW, atom count etc.) and some other which 
cannot. For example, LogP and LogD are usually calculated with a software (ChemAxon, ACD 
labs etc.) and thus errors might be introduced. Moreover, another factor that might have 
affected the model performance is the width of the AD. In general, if the test compounds are 
“far” from the models’ training space, the models’ predictions might exhibit a larger error in 
prediction. For example, the Evotec temporal test set compounds were extracted from the 
Evotec database. These compounds are novel and are synthesised for various drug discovery 
projects. Therefore, these compounds might have been novel and thus far from the AD of the 
models. Another reason that the models showed a high RMSE is the process of model 
validation, which exhibited both advantages and disadvantages. The advantage was that both 
internal (diverse) and external (temporal) test sets were used to assess the models’ 
performance. However, the compounds in the internal/diverse validation test set were 
randomly selected from the initial dataset. Therefore, the test compounds were not strategically 
selected to be representative of the training set. Finally, another aspect that can negatively 
affect the model performance is the failure of the model to encounter for properties that might 
be important for the property investigated. For example, an important factor that could affect 
ADME properties is the presence of enantiomers. Appropriate descriptors should be used in 
the model building in order to make the model able to encounter for the effect of the 
enantiomers on the target value. In this study, only the number of chiral centres was 
considered. Therefore, there are aspects related to enantiomers, which were not considered. 
For example, other important features are the position of the enantiomers on the molecule and 
the handedness of a molecule’s chiral centres (Bajorath, 2004). Thus, 3D descriptors could 
have been calculated to reflect these feature, which might be important. 
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Table 19: Table shows the model performance of “ChEMBL”, “Evotec” and “Evotec+ChEMBL” 
models. The RMSE in prediction and R2 of Evotec and ChEMBL diverse test sets are reported. 
Results obtained by applying the RF, PLS and SVR algorithms. The red colour indicates the 
highest performing model between the Evotec and Evotec+ChEMBL models. 
Number of 
compounds 
Model/Training 
set 
Evotec diverse test set ChEMBL diverse test set 
RF PLS SVR RF PLS SVR 
1376 ChEMBL 
RMSE 0.58 0.65 0.61 0.54 0.64 0.53 
R2 0.34 0.23 0.35 0.60 0.40 0.58 
1792 Evotec 
RMSE 0.36 0.43 0.37 0.72 1.13 0.75 
R2 0.75 0.64 0.73 0.24 0.10 0.22 
3168 
Evotec+
ChEMBL 
RMSE 0.37 0.57 0.36 0.55 0.66 0.52 
R2 0.74 0.40 0.74 0.57 0.37 0.59 
 
Table 20: Table shows the model performance of “ChEMBL”, “Evotec” and “Evotec+ChEMBL” 
models. The RMSE in prediction and R2 of Evotec and ChEMBL temporal test sets are reported 
Results obtained by applying the RF, PLS and SVR algorithms. The red colour indicates the 
highest performing model between the Evotec and Evotec+ChEMBL models. 
Number of 
compounds 
Model/Training 
set 
Evotec temporal test set ChEMBL temporal test set 
RF PLS SVR RF PLS SVR 
1628 ChEMBL 
RMSE 0.60 0.72 0.71 0.69 0.78 0.63 
R2 0.45 0.21 0.23 0.46 0.15 0.43 
2075 Evotec 
RMSE 0.57 0.60 0.57 0.85 1.74 0.74 
R2 0.44 0.45 0.45 0.31 0.19 0.37 
3703 
Evotec+
ChEMBL 
RMSE 0.55 0.76 0.58 0.74 0.84 0.68 
R2 0.52 0.19 0.36 0.40 0.20 0.46 
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According to tables 19 and 20, the two best performing algorithms were the RF and SVR. The 
better performance of these methods over linear methods has also been observed in the 
literature by studies investigating permeability (Wang et al, 2016), lipophilicity (Wang et al, 
2015; Rodgers et al, 2011) and plasma protein binding (Rodgers et al, 2011).  
When the proprietary diverse test set used to assess the models, the Evotec+ChEMBL model 
(trained with the SVR algorithm) showed a similar error in prediction (RMSE = 0.36) with 
respect to the Evotec model (RMSE=0.37) (table 19). The Evotec+ChEMBL model also 
showed a similar relationship between the experimental and predicted values (R2=0.74) 
compared to the Evotec model (R2=0.73).  However, the same result was not observed with 
the SVR and PLS algorithm. When the literature test set used to assess the models, the 
Evotec+ChEMBL model could better predict the Caco-2 permeability compared to the Evotec 
model. The Evotec+ChEMBL models provided a large improvement in the prediction of 
literature compounds by showing a lower RMSE in predictions and a higher R2 (i.e. improved 
relationship between the experimental and predicted values) for all the algorithm tested.  
Similar results and observations obtained with the temporal test sets (table 20). Evotec 
temporal test set was predicted similarly (i.e. with a similar error in prediction) by the Evotec 
and Evotec+CHEMBL models. However, when the ChEMBL temporal test set used to assess 
the models, the Evotec+ChEMBL model could better predict the Caco-2 permeability 
compared to the Evotec model.  The Evotec+ChEMBL models showed a lower RMSE in 
predictions and a higher R2 (i.e. improved relationship between the experimental and predicted 
values) for all the algorithm tested. These results indicated that the literature data could 
improve the prediction of newly synthesised compounds especially when the compounds are 
chemically novel. Temporal compounds extracted from literature (ChEMBL temporal test set) 
could theoretically mimic novel proprietary chemotypes and series from completely new 
projects or novel chemical matter in existing projects. Therefore, compounds extracted from 
literature can enhance the predictive ability of the proprietary models when they assess newly 
synthesised and chemically diverse compounds.  
Although ChEMBL data might be considered as less experimentally reliable compared to 
proprietary data, they improved the performance of proprietary models. ChEMBL data can 
possibly introduce chemical diversity to the proprietary databases. AstraZeneca and Bayer 
Pharma AG conducted a study, which concluded that data extracted from ChEMBL can 
introduce chemical diversity in proprietary databases. Firstly, the two companies compared the 
chemical similarity of their screening collections and secondly, they compared the similarity of 
their screening collections with the ChEMBL database. The similarity of the two proprietary 
screening databases was calculated by using 2D molecular fingerprints in combination with a 
Nearest Neighbour (NN) approach and Tanimoto index (as a measure of molecular similarity) 
(Kogej et al, 2013). The outcome of that analysis was that there is a low overlap between the 
compound collections of these pharmaceutical companies in terms of molecular similarity. In 
addition, they identified the molecular similarity of the ChEMBL compounds with these 2 
databases, which in total included about 3.7 million compounds. The number of ChEMBL 
compounds at the time was only 600K. The current ChEMBL version 23 contains about 2 
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million of compounds, which shows a great improvement in data reposition in that chemical 
database. More than the 80% of the compounds in ChEMBL database had their NN with a 
Tanimoto index less than 0.7. This result indicated that even in big proprietary screening 
databases, there is an unexplored chemical space. Therefore, ChEMBL compounds could be 
an asset in industry and academia to expand the chemical space and diversity of screening 
databases and subsequently proprietary ADME models. Therefore, this gives a possible 
explanation why the Evotec+ChEMBL models and ChEMBL models were better in predicting 
literature temporal compounds compared to proprietary Evotec models. It has also been 
reported that AstraZeneca develops permeability Caco-2 models, which incorporate both in 
house and literature data extracted from CHEMBL (Fredlund et al, 2017). 
Furthermore, it is also evident from the results (table 19, 20), that the Evotec models were 
better in predicting Evotec temporal or Evotec diverse test set compounds compared to 
ChEMBL models. The same applies for the ChEMBL models; they can better predict ChEMBL 
temporal or diverse test set compounds compared to Evotec models. This was expected 
especially for Evotec models and Evotec test sets because compounds that are part of the 
training set and test sets might have been synthesised for the same project.  
However, it is interesting to notice how the Evotec model predicted the ChEMBL compounds 
and how the ChEMBL model predicted the Evotec compounds. The RMSE in prediction, that 
obtained from both temporal and diverse test sets, indicates that the ChEMBL models can 
predict the Evotec test compounds more accurately than the Evotec model can predict the 
ChEMBL test compounds. This is an interesting point because it was expected that Evotec 
models could possibly be better in predicting the ChEMBL compounds due to the more 
experimentally reliable Caco-2 measurements. In contrast, ChEMBL were mainly compounds 
extracted from the literature and it was difficult to ensure the same and accurate experimental 
conditions due to the inter-laboratory and assay variability. Therefore, an explanation might be 
given with the investigation of the AD of the models. ChEMBL models might: 1. exhibit a greater 
chemical diversity, 2. cover a larger chemical space and consequently 3. exhibit a larger 
applicability domain compared to Evotec models. This was investigated in section 3.2.7. 
In conclusion, the merging of the compounds from different sources (proprietary and literature) 
was beneficial despite the debate regarding the merging of biological data from different 
sources and especially from large chemical databases. The mixing of data from different 
sources could be dangerous as the data are generated with different experimental protocols. 
Therefore, there is an increasing risk to introduce errors and noise in the training set. For 
example, the training sets should include data, which ideally are measured based on a single 
protocol and by the same laboratory. (Cronin & Schultz, 2003). In addition, data with high 
experimental uncertainty like literature compounds could negatively influence the model 
performance (Wenlock and Carlsson, 2014). However, the results and the performance of the 
merged models (Evotec+ChEMBL) seemed to balance the experimental uncertainty of the 
data. The Evotec+ChEMBL models exhibited a similar performance with the Evotec models in 
the prediction of proprietary test sets and showed a significant improvement for the prediction 
of literature test sets.  
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3.2.6 Subsequent model assessment of the Caco-2 permeability models 
In a subsequent model assessment, the permeability data in the temporal test sets were 
merged with the training test sets and used, all together, to develop an updated model. Two 
new temporal test sets were generated including the latest proprietary permeability data 
(Evotec compounds synthesised four months after the compounds in the training set) and the 
freshly published public permeability data from ChEMBL version 23. These new temporal test 
sets are referred as “New Evotec temporal test set” and “New ChEMBL temporal test sets”.  
The new temporal test sets had been used to assess both the initial models (M1) reported in 
the sections 3.2.1-3.2.3 and the new models introduced in this section (M2). In this analysis, 
only the RF algorithm was applied to build the QSPR models due to its performance (as 
discussed in the previous sections) and to its computational inexpensiveness.  
Table 21: Table shows the model performance of the “initial” (M1) and “new” (M2) “ChEMBL”, 
“Evotec” and “Evotec+ChEMBL” models. The RMSE in prediction of the “new” Evotec and 
ChEMBL temporal test sets is reported. Results obtained by applying the RF algorithm and the 
red colour indicates the highest performing model between Evotec and Evotec+ChEMBL 
models. 
Number of 
compounds 
 
Model/Training 
set 
 
New Evotec temporal 
test set 
New ChEMBL temporal 
test set 
M1 M2 M1 M2 
M1:1628 
M2: 1720 
ChEMBL 0.67 0.66 0.47 0.48 
M1:2075 
M2: 2241 
Evotec 0.47 0.42 0.67 0.68 
M1:3703 
M2:3961 
Evotec+ChEMBL 0.45 0.40 0.66 0.63 
 
The new temporal test sets were predicted with a lower RMSE in prediction (i.e. better 
predicted) with the Evotec + ChEMBL model compared to Evotec model. In addition, the RMSE 
in prediction obtained with the new model (M2) was lower than that of M1. The new temporal 
test sets were predicted with higher accuracy by the merged (Evotec+ChEMBL model) 
compared to the Evotec model. This is an indication of the robustness of the method and that 
the addition of the ChEMBL compounds in the proprietary Evotec models is beneficial.  
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3.2.7 Applicability Domain estimation of the in-silico Caco-2 permeability models  
Determining the AD for a QSPR model is important to estimate the reliability of a prediction of 
an external compound. If the compound lies within the AD of the QSPR model used to predict 
a property, this prediction can be taken, otherwise the prediction should be either discarded or 
given a low reliability flag.  
The AD of the models was estimated with the four distance to model metrics: 1. k-NN with 
Euclidean distance, 2. k-NN with Manhattan distance, 3. Leverage and 4. Mahalanobis 
distance. The distance to model metrics calculated the distance of the test compounds from 
the training set in the descriptors’ space (i.e. the multi-dimensional space defined by the 
descriptors of the compounds used to train the model) and a threshold was applied. Above 
that threshold, compounds were considered to be outside the AD.  
The goal of this section was twofold. Firstly, the AD of the Evotec+ChEMBL model was 
compared with the AD of the Evotec model. Secondly, once an AD distance threshold had 
been determined, the goal was to check whether test set compounds within the AD were 
predicted more accurately than compounds outside the AD. To do that, compounds in the test 
set were partitioned in two groups; within the AD, and outside the AD. If compounds within the 
AD show an RMSE in the prediction smaller than compounds outside the AD, the particular 
distance metric is able to clearly define an AD for the model. In addition, a Mann Whitney test 
was used to establish the presence of a statistically significant difference in the RMSE of the 
compounds inside and outside of the AD.  To achieve both objectives, for every model 
(“ChEMBL model”, “Evotec model” and “Evotec+ChEMBL”), the portion of compounds within 
and outside the AD was calculated by using all the four distance metrics mentioned above. 
The distance of compounds in the two temporal test sets (“Evotec temporal test set” and 
“ChEMBL temporal test set”) was calculated from the training compounds of the three different 
models (“ChEMBL model”, “Evotec model” and “Evotec+ChEMBL” model) and the percentage 
of the test compounds within the AD of the models was calculated. Results are reported in 
table 22.  
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From table 22, it can be observed that, in most cases, the RMSE in prediction of the 
compounds within the AD was lower than the RMSE of the compounds outside the AD. This 
evidence provided confidence for using these distance metrics and threshold determination 
method as a reliable protocol for defining the AD of the models. Similar studies are in 
agreement with these findings (Jaworska et al., 2005; Sahigara et al., 2012) as they have 
employed, the same distance metrics and reached similar conclusions.  
In addition, table 22 indicated that a greater percentage of Evotec temporal test compounds 
and ChEMBL temporal test compounds were within the Evotec+Chembl model’s AD compared 
to the Evotec proprietary model. Therefore, all the four distance to model metrics demonstrated 
that the AD of the Evotec models was enlarged with the inclusion of compounds extracted from 
the literature. This indicated that the literature compounds can introduce chemical diversity and 
cover unexplored areas of the chemical space (Kogej et al, 2013). In addition, based on the 
work performed in present study, the 50-90% (depending the distance to model metric 
considered) of the compounds extracted from ChEMBL were outside the AD of the existing 
Evotec model. Therefore, by merging the proprietary Evotec compounds with the compounds 
extracted from ChEMBL database, it was expected to introduce chemical diversity in the 
training set. In addition, a greater percentage of Evotec temporal compounds was within the 
AD of the ChEMBL models than the percentage of ChEMBL temporal compounds within the 
AD of the Evotec model. This observation explained the results obtained from the evaluation 
of model performance in section 3.2.5, where the ChEMBL model was better at predicting 
Evotec temporal compounds compared to Evotec model in predicting ChEMBL temporal 
compounds. Therefore, literature compounds offer chemical diversity and this is a clear 
positive impact for the proprietary chemical space.  
There were also cases in which the compounds outside the AD showed an RMSE lower than 
the compounds inside. This may be an indication that being within the AD, although important 
to consider a prediction reliable, may not be sufficient for a lower RMSE in the prediction 
(Gadaleta et al., 2016). One reason might be the presence of activity cliffs within the chemical 
space. There might be chemical areas, where the permeability of the compounds change due 
to the presence of a particular functional group. Therefore, that means that a compound 
exhibits a property not encountered by the model (Netzeva et al., 2005). For example, passive 
transcellular permeability is considered to be the major permeability route for the compounds 
but compounds can also be transferred through carrier mediated transport. Therefore, if a 
compound has a chemical structure, which enables the binding with a membrane transporter 
could theoretically be permeable. Another possible explanation might be the presence of areas 
with a lack of chemical coverage (i.e. due to data scarcity) (Aniceto, Freitas, Bender, & 
Ghafourian, 2016). As a result, there is a possibility a model not to be able to make accurate 
predictions due to the inadequate chemical space coverage. Moreover, another possible 
explanation for a lower error in prediction in compounds outside the AD is that the model could 
possibly extrapolate correctly outside its domain (Jaworska et al., 2005). In a study, where 
permeability models have been developed with Caco-2 data extracted from the literature, the 
leverage method was used as the metric to establish AD (Wang et al, 2016). In that case, there 
were compounds with low leverage and a larger error in prediction and vice versa. The reason 
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of that phenomenon is at the way that the threshold is set. A threshold has a value, which 
simply excludes training compounds in the extremities. That means that the AD evaluation only 
considers the interpolation and not the possible extrapolation. Therefore, there might be 
compounds in the test sets that are close to that outliers and thus they can predicted with a 
lower error in prediction than expected. However, there is not a definite answer and all the 
arguments mentioned above could provide a possible explanation.  
Furthermore, each distance to model metric produced different results (Jaworska et al., 2005; 
Gadaleta et al., 2016; Sahigara et al., 2012).  This depends on: the different way that each 
method measures distance, the threshold definition and the descriptors used in each method 
(e.g. Mahalanobis distance cannot handle correlated descriptors).  In addition, another 
difference is that the Euclidean distance assumes a normal distribution compared to other 
(Jaworska et al., 2005; Gadaleta et al., 2016) and that might be a potential disadvantage. 
Therefore, the results obtained from the evaluation of AD with the distance to model metrics 
should be carefully examined.  The fact that each method gave a different result regarding the 
percentage of the compounds inside and outside of the AD and also regarding the error in 
prediction for the compounds inside and outside of the AD, results in a confusion about which 
method is the most appropriate to use. For that issue, there are reports, which suggest to 
always using more than one distance to model metric for the assessment of AD (Sahigara et 
al., 2012). The reason is that none of the existing methods can be considered as the universally 
the most appropriate because each method has its own advantages and disadvantages.  
Therefore, a statistical analysis used to understand which method is more reliable in each 
case. In the literature, there are no statistical comparisons, which can distinguish between a 
statistically significant difference between the RMSE in prediction for compounds in and out of 
AD. For that reason, the non-parametric Mann Whitney test was applied. The results showed 
that only the Leverage method could produce a statistically significant difference in the RMSE 
for the compounds inside and outside of the AD. For the other three methods, there was not 
always a statistically significant difference. Therefore, the Leverage method could be 
considered as the most effective method for these models. Leverage is a method used in the 
literature for the estimation of the AD of permeability models (Wang et al, 2016), LogD7.4 
models (Wang et al, 2015).  
In conclusion, in this case, leverage was considered as the best performing method for two 
reasons. The first reason was that it was able to categorise the test compounds inside and 
outside of the AD with a lower and higher RMSE in prediction respectively. The second reason 
was the presence of a statistically significant difference in all the measurements. However, if 
a compound is outside the AD, it is not definite that the prediction is erroneous but it provides 
an AD “warning” (Gupta, Adams, & Berry, 2016). 
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3.3 Evaluation of in-silico LogD7.4 models. 
The objective of this part was the development of QSPR models to predict logD7.4. Three types 
of models were built with different training sets, which included: i) literature, ii) proprietary and 
iii) merged proprietary and literature data. By comparing the performance and AD of the 
models, it was investigated if the merged models (Evotec+ChEMBL) could outperform the 
models developed with proprietary compounds (Evotec). Additionally, four distance to model 
metrics were applied to estimate the AD of the models and establish if the addition of literature 
data in proprietary models could enlarge the AD of proprietary models. 
3.3.1 Models developed with literature data (ChEMBL models) 
The first models reported herein were developed using only public data extracted from the 
ChEMBL database. These models are referred as “ChEMBL models” and were based on a set 
of 1209 compounds with distribution coefficient at pH=7.4 (LogD7.4) data extracted from 
ChEMBL and processed as described in the methods section 2.3.1. Three different modelling 
algorithms have been applied to build the QSPR models: random forest (RF), partial least 
square (PLS) and support vector regression (SVR).  
Two different strategies were used to define and evaluate the goodness of a model. In one 
case, all the 1209 compounds were used to build the QSPR models and a “temporal” test set 
was derived subsequently, including new LogD7.4 data made available in a new version of 
ChEMBL. The temporal test set included 86 compounds. In the second case, the 1209 
compounds were merged with the 86 compounds of the temporal test set and the diverse test 
set was built including 20% of the total number of compounds randomly selected, while the 
remaining 80% of the compounds were used to build and train the model. The first testing 
strategy, also known as temporal test set, may be more challenging and may be a better 
representation of a real drug discovery situation. It provides an estimation of the model 
performance in a “real-life” situation, when lipophilicity of new compounds will have to be 
predicted with an existing model. The RMSE of the predictions and the R2 of the predicted 
versus experimental values were calculated for the test sets and used to evaluate the 
goodness of the model. Based on that metric a better model will show a higher R2 and a lower 
value of the RMSE for the prediction of compounds in the test set. 
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Table 23: RMSE in prediction and R2 of ChEMBL diverse test set and ChEMBL temporal test 
set obtained with the ChEMBL model by using three different machine learning methods (RF, 
PLS &SVR). The red colour indicates the model that produced the lower RMSE in each testing 
strategy. 
Model/Training 
set 
ChEMBL diverse 
test set 
ChEMBL temporal 
test set 
RF PLS SVR RF PLS SVR 
ChEMBL 
RMSE 1.01 1.34 0.94 0.84 1.09 0.77 
R2 0.79 0.65 0.82 0.72 0.58 0.71 
 
The results of the model assessment indicated that in both test sets (temporal or diverse), the 
RF and SVR algorithms provided better performing predictive LogD7.4 models than PLS (table 
23). This is an observation also reported in the literature. For example, LogD7.4 predictive 
models have been developed with data extracted from ChEMBL database and the LogD7.4 of 
the diverse test set was better predicted with the SVR algorithm compared to the PLS (Wang 
et al, 2015). There should be a nonlinear relationship between the target value (LogD7.4) and 
the descriptors. In addition, proprietary LogD7.4 models were developed with various algorithms 
(linear ridge regression, Gaussian process, SVR and RF) in Bayer Shering Pharma AG. 
Among the methods used, the linear ridge regression, which is a linear machine learning 
method as PLS, performed the worst (Schroeter et al., 2007) and the SVR algorithm performed 
better than RF. In addition, Schroeter and co-workers (2007) used literature temporal test sets 
to assess the performance of the proprietary LogD7.4 models and the SVR algorithm produced 
the best results. Finally, LogD7.4 models developed with RF and PLS algorithms (Rodgers et 
al., 2011) in AstraZeneca and the RF was more predictive than PLS.  
The SVR algorithm performed better compared to the RF algorithm in both diverse and 
temporal test sets. In the case of the ChEMBL diverse test set, the SVR algorithm performed 
slightly better, by showing an RMSE of 0.94 compared to the RF which showed an RMSE 
equal to 1.01. In the case of the ChEMBL temporal test set, the SVR algorithm performed 
better, by showing an RMSE of 0.77 compared to RF that showed an RMSE of 0.84. In 
addition, the SVR predicted values with a higher correlation (R2) with the experimental values 
for both test sets compared to RF. Both test sets were predicted with a high error in prediction 
and therefore the reliability of prediction by ChEMBL models is questionable and the results of 
prediction should be used with caution. 
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Figure 33:  Experimental versus predicted logD7.4 values of compounds in the ChEMBL diverse 
test set obtained with the ChEMBL model developed with the SVR algorithm. LogD7.4 
lipophilicity is reported as Log10 D. The black solid line represents the line of best fit in the form 
of y=b+ax. The red and dark blue dashed lines represent the y=x±1 and the y=x±0.5 
respectively. 
 
Figure 34: Experimental versus predicted logD7.4 values of compounds in the ChEMBL 
temporal test set obtained with the ChEMBL model developed with the SVR algorithm. LogD7.4 
lipophilicity is reported as Log10 D. The black solid line represents the line of best fit in the form 
of y=b+ax. The red and dark blue dashed lines represent the y=x±1 and the y=x±0.5 
respectively. 
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When the SVR ChEMBL model was applied on the literature diverse and temporal test sets 
the R2 was equal to 0.82 and 0.71 respectively and the RMSE equal to 0.94 and 0.77 
respectively (figures 33, 34). Thus, the compounds in the temporal test set showed a better 
correlation between the experimental and predicted values and a lower RMSE in prediction 
compared to the diverse test set. However, R2 should be considered cautiously because its 
value increases with the addition of data the wider range of the data present in the test sets. 
The diverse test set contained a greater number of compounds with a wider value range and 
thus the R2 value could have been affected. The red and dark blue dashed lines enclosed the 
compounds with predicted LogD7.4 values within ±1 and ±0.5 log units respectively from the 
experimental values. For the diverse test set, the 82.63% and the 69.88% of the predicted 
LogD7.4 values were within ±1 and ±0.5 log units from the experimental values respectively. 
For the temporal test set, the 80.23% and the 69.77% of the predicted LogD7.4 values were 
within ±1 and ±0.5 log units from the experimental values. Therefore, approximately the same 
percentage of predicted values is found to be within ±1 and ±0.5 log units from the 
experimental values for both temporal and diverse test sets. 
The RMSE in prediction for the temporal test set was lower than the RMSE of the diverse test 
set. The temporal test set was expected to be more challenging to predict compared to the 
diverse. The diverse set instead was part of the initial dataset and there was a possibility that 
the diverse test sets contained data similar to those present in the training set. A possible 
reason that the diverse test set was predicted with a higher RMSE is that the compounds that 
were randomly selected were not representative of the training set. There are rational division 
methods, like the Kennard-Stone, that can be used to partition the initial dataset into a training 
and a representative test set. A well representative test set can give a better result because 
the test compounds are represented in the training set. However, there are advantages and 
disadvantages in both approaches. The advantage of randomly splitting the compounds in 
training and test set is that the compounds might or might not be representative of the training 
set. As a result, a random selection of a diverse test set gives an indication of the “realistic 
predictive power” of an ADME model.  From another perspective, one could argue that the test 
should be reasonably similar and representative to the compounds of the training set. 
However, this approach could yield an “optimistic estimate” of the model performance 
(Cherkasov et al., 2014). This optimistic estimate was observed by a study in which different 
rational methods and the random method were evaluated (Martin et al., 2012). The results of 
this study indicated that the rational division methods can result in better statistical results but 
there are cases where the predictive power of both rational and random division are 
comparable. In addition, in a pharmaceutical company’s drug design process, the use of a 
representative test set with optimistic model assessment results might not be appropriate. The 
reason is that the newly synthesised proprietary compounds might or might not be similar to 
the model’s training set. Therefore, a randomly selected diverse test set mimics that situation 
and potentially the results are more realistic.  
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3.3.2 Models developed with proprietary data (Evotec models) 
The second models reported herein were developed using only proprietary data extracted from 
the Evotec database. These models are referred as “Evotec models” in this and the following 
section and are based on a set of 8400 compounds with distribution coefficient at pH=7.4 
(logD7.4) data. Three different modelling algorithms were applied to build the QSPR models: 
random forest (RF), partial least square (PLS) and support vector regression (SVR).  
Two different strategies were used to define and evaluate the goodness of a model. In one 
case, all the 8400 compounds were used to build the QSPR models and the test set (temporal) 
were derived subsequently, when new compounds were added in the Evotec database with 
logD7.4 lipophilicity data. The temporal test set included 895 compounds. In the second case, 
the 8400 compounds were merged with the 895 compounds of the temporal test set and the 
diverse test set was built including 20% of the total number of compounds randomly selected, 
while the remaining 80% of the compounds have been used to build and train the model.  
Table 24: RMSE in prediction and R2 of Evotec diverse test set and Evotec temporal test set 
obtained with the Evotec model by using three different machine learning methods (RF, PLS 
&SVR). The red colour indicates the model that produced the lower RMSE in each testing 
strategy. 
Model/Training 
set 
Evotec diverse 
test set 
Evotec temporal 
test set 
RF PLS SVR RF PLS SVR 
Evotec 
RMSE 0.60 0.63 0.49 0.62 0.68 0.53 
R2 0.77 0.72 0.84 0.66 0.55 0.72 
 
The results of the model assessment indicated that in both test sets (temporal or diverse), the 
RF and SVR algorithms provided better performing predictive LogD7.4 models than PLS (table 
24). This is an observation also reported in the literature and has discussed in section 3.3.1. 
The SVR algorithm performed better compared to the RF algorithm in both diverse and 
temporal test sets with an RMSE of 0.53 and 0.49 respectively. In addition, the correlation 
between experimental and predicted LogD7.4 values was higher when the SVR applied for both 
diverse (R2=0.84) and temporal (R2=0.72) test sets compared to RF. Both test sets were 
predicted with a high error in prediction and therefore the reliability of prediction by Evotec 
models is questionable and the results of prediction should be used with caution. 
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Figure 35: Experimental versus predicted logD7.4 values of compounds in the Evotec diverse 
test set obtained with the Evotec model developed with the SVR algorithm. LogD7.4 lipophilicity 
is reported as Log10 D. The black solid line represents the line of best fit in the form of y=b+ax. 
The red and dark blue dashed lines represent the y=x±1 and the y=x±0.5 respectively. 
 
Figure 36: Experimental versus predicted logD7.4 values of compounds in the Evotec temporal 
test set obtained with the Evotec model developed with the SVR algorithm. LogD7.4 lipophilicity 
is reported as Log10 D. The black solid line represents the line of best fit in the form of y=b+ax. 
The red and dark blue dashed lines represent the y=x±1 and the y=x±0.5 respectively. 
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When the SVR Evotec model was applied on the literature diverse and temporal test sets the 
R2 was equal to 0.84 and 0.72 and the RMSE equal to 0.49 and 0.53 respectively (figures 35, 
36). The compounds in the diverse test set (figure 35) showed a better correlation between the 
experimental and predicted LogD7.4 values (R2=0.84) and a lower error in prediction 
(RMSE=0.49) compared to the temporal test set (R2=0.72, RMSE=0.53). However, R2 should 
be considered cautiously because its value may be increased by addition of data in a narrow 
range of values. The diverse test set included a greater number of compounds compared to 
the temporal test set and thus the higher R2 value might not indicating better model 
performance. The red and dark blue dashed lines enclosed the compounds with predicted 
LogD7.4 values within ±1 and ±0.5 log units respectively from the experimental values. For the 
diverse test set, the 95.37% and the 89.13% of the predicted LogD7.4 values were within ±1 
and ±0.5 log units from the experimental values. For the temporal test set, the 94.30% and the 
83.35% of the predicted LogD7.4 values were within ±1 and ±0.5 log units from the experimental 
values. Therefore, a smaller percentage of temporal test set compounds had prediction values 
within 1 and 0.5 log units from the experimental values compared to the diverse test set. The 
reason might be that the compounds in temporal test set were novel or far from the model’s 
chemical space and the model produced predictions with a higher error in prediction. 
Therefore, the compounds in the temporal test sets might not have been represented with 
compounds in the training set as it might have happened with the compounds in the diverse 
test set, which were randomly selected from the initial dataset.    
3.3.3 Models developed with proprietary and literature data (Evotec+ChEMBL models) 
The third models reported herein were developed using both Evotec proprietary and literature 
data extracted from the ChEMBL database. These models are referred as “Evotec+ChEMBL 
models” and were based on the previous training sets that were used in the ChEMBL and 
Evotec models previously. The two previous training sets were merged resulting in 9609 
compounds in total. Three different modelling algorithms were applied to build the QSPR 
models: random forest (RF), partial least square (PLS) and supporting vector regression 
(SVR).  
Two different strategies were used to define and evaluate the goodness of a model. In one 
case, all the 9609 compounds have been used to build the QSPR models and the test set 
(temporal) was derived by merging the two previous (Evotec and ChEMBL) temporal test sets 
resulting in 981 compounds. In the second case, the 9609 compounds were merged with the 
981 compounds of the temporal test set and the diverse test set was built including 20% of the 
total number of compounds randomly selected, while the remaining 80% of the compounds 
have been part of the training set used to build the model.  
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Table 25: RMSE in prediction and R2 of Evotec+ChEMBL diverse test set and 
Evotec+ChEMBL temporal test set using different machine learning methods (RF, PLS 
&SVR). The red colour indicates the model that produced the lower RMSE in each testing 
strategy. 
 
Model/Training 
set 
Evotec+ChEMBL 
diverse test set 
Evotec+ChEMBL 
temporal test set 
RF PLS SVR RF PLS SVR 
Evotec+
ChEMBL 
RMSE 0.62 0.78 0.55 0.58 0.69 0.58 
R2 0.81 0.70 0.84 0.71 0.59 0.71 
 
The results of the model assessment indicated that for both test sets (temporal or diverse), the 
RF and SVR algorithms provided better performing predictive LogD7.4 models than PLS (table 
25). This is an observation also reported in the literature and has discussed in section 3.3.1 
and 3.3.2. In the case of diverse test set, the SVR algorithm performed better (RMSE=0.55) 
compared to the RF (RMSE=0.62). In addition, the correlation between experimental and 
predicted LogD7.4 values of the diverse test set, was higher when the SVR (R2=0.84) applied, 
compared to RF (R2=0.84). In the case of the temporal test set, the two algorithms (RF and 
SVR) performed identically (RMSE=0.58, R2=0.71). Both test sets were predicted with a high 
error in prediction and therefore the reliability of prediction by Evotec+ChEMBL models is 
questionable and the results of prediction should be used with caution. 
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Figure 37: Experimental versus predicted logD7.4 lipophilicity of compounds in the 
Evotec+ChEMBL diverse test set obtained with the Evotec+ChEMBL model developed with 
the SVR algorithm. LogD7.4 lipophilicity is reported as Log10 D. The black solid line represents 
the line of best fit in the form of y=b+ax. The red and dark blue dashed lines represent the 
y=x±1 and the y=x±0.5 respectively. 
 
Figure 38: Experimental versus predicted LogD7.4 lipophilicity of compounds in the 
Evotec+ChEMBL temporal test set obtained with the Evotec+ChEMBL model developed with 
the SVR algorithm. LogD7.4 lipophilicity is reported as Log10 D. The black solid line represents 
the line of best fit in the form of y=b+ax. The red and dark blue dashed lines represent the 
y=x±1 and the y=x±0.5 respectively. 
Although RF and SVR performed identically for the temporal test set, the performance of 
models for the two different test sets was compared to the overall best performing algorithm, 
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which is SVR. The SVR was the best performing algorithm for the diverse test set and one of 
the two identically best performing algorithms for the temporal test set. When the SVR 
Evotec+ChEMBL model was applied on the diverse and temporal test sets the R2 was equal 
to 0.84 and 0.71 and the RMSE equal to 0.55 and 0.58 respectively (figures 37, 38). Therefore, 
the compounds in the diverse test set showed a better correlation between the experimental 
and predicted values and a lower RMSE in prediction compared to the temporal test set. 
However, R2 should be considered cautiously because its value may be increased by addition 
of data in a narrow range of values. The diverse test set included a greater number of 
compounds compared to the temporal test set and thus the higher R2 value might not indicating 
better model performance. The red and dark blue dashed lines represent the compounds with 
predicted LogD7.4 within ±1 and ±0.5 log units respectively from the experimental values. For 
the diverse test set, the 93.96% and the 87.77% of the predicted LogD7.4 values were within 
±1 and ±0.5 log units respectively from the experimental values. For the temporal test set, the 
91.44% and the 80.73% of the predicted LogD7.4 values were within ±1 and ±0.5 log units from 
the experimental values. Therefore, a smaller percentage of temporal test set compounds had 
prediction values from the experimental values within ±1 and ±0.5 log units. The reason might 
be that the compounds in temporal test set were novel or far from the model’s chemical space 
and the model produced predictions with a higher error in prediction. Therefore, the 
compounds in the temporal test sets might not have been represented with compounds in the 
training set as it might have happened with the compounds in the diverse test set, which were 
randomly selected from the initial dataset.    
3.3.4  Comparison of LogD7.4 models with models reported in the literature 
The goal of this part of the work was to compare the models developed in the present study in 
sections 3.3.1-3.3.3 (i.e. ChEMBL, Evotec and Evotec+ChEMBL models) with models reported 
in the literature.  Being LogD7.4 a widely used parameter for pre-evaluation of compounds in 
drug discovery, predictive LogD7.4 models have been published in the literature and are 
reported in table 26. These models developed with proprietary data in pharmaceutical 
companies (Bruneau & McElroy, 2006; Rodgers et al., 2011; Schroeter et al., 2007) and with 
data extracted from the literature (Wang et al., 2015). 
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Table 26: Regression lipophilicity models developed with logD7.4 data reported in the 
literature. 
Reference Method Number of 
Molecules 
Number of 
Descriptors 
AD 
Estimation? 
(Yes/No) 
(Bruneau & 
McElroy, 
2006) 
1. BRNN 5000 122 Yes 
Mahalanodis 
Distance 
(Schroeter 
et al., 2007) 
1. Gaussian 
Process 
2. Linear ridge 
regression 
3. SVR 
4. RF 
14556 Dragon descriptors 
(1664) 
Yes 
Mahalanodis 
Distance 
(Rodgers et 
al., 2011) 
1. SVR 
2. PLS 
Number of 
molecules varied 
as the models were 
updated over a 
period of 3 years 
In-house 
descriptor set 
(topological, 
geometrical and 
electronic) 
Yes 
Mahalanodis 
Distance 
(Wang et al, 
2015) 
3. RF 
4. PLS 
1130 121 Yes 
Leverage 
 
One of the initial attempts to develop lipophilicity models based on logD7.4 data and the BRNN 
(Bayesian Regularised Neural Networks) algorithm, was conducted in AstraZeneca (Bruneau 
& McElroy, 2006). In this study a set of 8200 of AstraZeneca “in house” compounds was 
clustered based on hierarchical clustering process. After clustering, 5000 clusters were 
generated and one compound from each cluster was selected to form the training set; the rest 
of the compounds had been used as “ex-cluster validation” test set. In addition, a “global 
validation” test set, comprised by 16325 compounds, was obtained from the AstraZeneca 
database. The advantage was that the model was developed with a consistent and large 
proprietary dataset. Model seemed to perform well for both test sets with an RMSE in prediction 
of 0.54 (“ex-cluster validation”) and 0.63 (“global validation”). The proprietary Evotec model 
developed in this study performed slightly better in predicting temporal test set compounds 
(RMSE=0.49). The Evotec+ChEMBL performed similarly with AstraZeneca models by 
predicting temporal test set compounds with an RMSE equal to 0.58. However, the 
AstraZeneca models were developed only with proprietary compounds and it will be interesting 
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to investigate how data extracted from the literature could affect the performance and AD of 
the proprietary models.  
In Bayer Schering Pharma AG (Schroeter et al., 2007), LogD7.4 models were developed using 
four different algorithms: Gaussian Process (GA), 2. Linear Ridge Regression (LRR), 3.SVR 
and 4. RF. The training set, identical for all the four models, included 14556 proprietary 
compounds. The models were then assessed with a literature temporal test set and proprietary 
temporal test set. The literature temporal test set was better predicted by the GA and SVR 
models, with an RMSE of 0.66 and 0.71 respectively. The Evotec model predicted the literature 
temporal test set with an RMSE equal to 0.83 (result obtained with SVR algorithm). On the 
other hand, when Schroeter et al (2007) assessed the proprietary temporal test set, they 
obtained an RMSE equal to 0.81 and 0.82 for the SVR and GA method respectively. The 
Evotec and Evotec+ChEMBL models were better in predicting proprietary temporal test set 
compounds with an RMSE of 0.53 and 0.58 respectively (result obtained with SVR algorithm). 
Moreover, the ChEMBL model obtained an RMSE equal to 0.77 which is very similar to that 
obtained by Schroeter et al (2007). 
Furthermore, two LogD7.4 models developed with RF and PLS algorithms (Rodgers et al., 
2011) in AstraZeneca. These models were constantly updated and assessed, on a monthly 
basis, when new data became available over a period of 3 years. The initial model contained 
AstraZeneca proprietary compounds in the training set and this model, when trained with the 
RF algorithm, predicted the 1st temporal test set and the last temporal test set with an RMSE 
of 0.53 and 0.67. A final model was obtained after the 3 years of constant update and 
evaluation. This final model was able to predict the final temporal test set with an RMSE of 
0.57. The Evotec model was able to predict the Evotec temporal test set with an RMSE of 0.53, 
thus indicating that the predictive activity of the proprietary model in the present study (Rodgers 
et al., 2011) is very similar and slightly better.  
Finally, Wang et al (2015) developed LogD7.4 models using data obtained from ChEMBL and 
ochem.eu database, resulting in a training set of 1130 compounds. These compounds were 
partitioned into training set (80% of compounds) and diverse test set (20% of compounds) with 
the Kennard-Stone method. This algorithm works by selecting the compounds so that they are 
divided evenly throughout the descriptor space of the original set of compounds (Martin et al., 
2012). This rational method of splitting the compounds ensured that the test set was 
representative of the training set. The algorithms that used in that study were the RF and SVR. 
The models trained with SVR and PLS resulted in an RMSE in prediction of 0.56 and 0.69 
respectively. The Evotec and Evotec+ChEMBL models were better in predicting proprietary 
compounds with an RMSE equal to 0.49 and 0.55 respectively. However, the models 
developed by Wang et al (2015) were better performing than the ChEMBL models reported in 
the present study.  A direct comparison of the RMSE and R2 would be not accurate, as different 
training and test sets were used.  
In order to make a direct comparison, the methodology developed in the present study, was 
applied on Wang et al (2015) training set and then the models derived, were assessed with 
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the Wang et al (2015) diverse test set.  Therefore, the training compounds of Wang et al (2015) 
were trained by using the set of descriptors and algorithms used in the present study.  The two 
best performing algorithms were applied: RF and SVR, and the results of the RMSE in 
prediction are shown in table 27.  
Table 27: Model assessment results of SVR models developed by Wang et al (2015) and of 
the new models developed with Wang et al (2015) training and test set and the present study’s 
methodology.  
 Method Literature ChEMBL diverse test set by 
Wang et al (2015) 
RMSE R2 
Literature ChEMBL by Wang et al (2015) SVR 0.56 0.89 
Literature ChEMBL model by Wang et al 
(2015) developed with present study’s 
methodology 
SVR 0.55 0.90 
RF 0.62 0.87 
 
Table 27 shows that the methodology (algorithms) developed in the present study, when 
applied to the literature training and test sets of Wang et al (2015) provided comparable results. 
The RMSE and R2 of the two models (table 27) developed with the SVR algorithm were almost 
identical. The RMSE in prediction of the models reported in table 27 was smaller than the 
RMSE in prediction of the ChEMBL model reported in section 3.3.1. A possible explanation is 
that Wang et al (2015) used a representative test set, which was obtained from the initial 
compound dataset with the Kennard-Stone algorithm. A test set, which is representative of the 
training set can give a good model performance but at the same time could be unrealistic. 
In addition, there are various available commercial software that can be used for the theoretical 
calculation of LogD7.4 like the ChemAxon software. ChemAxon was used to calculate the 
LogD7.4 of the Evotec and ChEMBL diverse and temporal test sets, which were used in the 
present study. The root mean square error (RMSE) of the predictions and the R2 of the 
predicted versus experimental have been calculated for the test sets and are used to evaluate 
the goodness of the ChemAxon software (table 28). In addition, the LogD7.4 predictions of the 
ChEMBL and Evotec temporal and diverse test sets obtained by the Evotec, ChEMBL and 
Evotec+ChEMBL, are reported in table 28.  
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Table 28: RMSE in prediction and R2 of ChEMBL and Evotec diverse test sets and ChEMBL 
and Evotec temporal test set. Results obtained by using the ChemAxon software, and the 
ChEMBL, Evotec and Evotec+Chembl models developed with the SVR algorithm. 
Test sets 
ChEMBL diverse 
test set 
Evotec diverse 
test set 
ChEMBL temporal 
test set 
Evotec temporal 
test set 
Model ChemAxon 
RMSE 1.42 1.14 1.01 0.86 
R2 0.61 0.43 0.66 0.52 
Model ChEMBL model 
RMSE 0.94 1.14 0.77 0.89 
R2 0.82 0.36 0.71 0.51 
Model Evotec model 
RMSE 1.64 0.49 0.83 0.53 
R2 0.63 0.84 0.66 0.72 
Model Evotec+ChEMBL model 
RMSE 0.95 0.47 0.77 0.56 
R2 0.82 0.85 0.72 0.70 
 
The diverse and temporal test sets were better predicted by the models developed in the 
present study compared to the ChemAxon. The RMSE in prediction for the ChEMBL diverse 
test set and the ChEMBL temporal test set was 1.42 and 1.01 respectively when the 
ChemAxon software used. When the ChEMBL model used, the RMSE in prediction for the 
ChEMBL diverse test set and the ChEMBL temporal test set decreased to 0.94 and 0.77 
respectively. Similarly, the correlation between the experimental and predicted values was 
higher for both ChEMBL diverse and temporal test sets, when the ChEMBL model used. The 
RMSE in prediction for the Evotec diverse test set and Evotec temporal test set was 1.14 and 
0.86 respectively when the ChemAxon software used. When the Evotec+ChEMBl model used 
the RMSE for the Evotec diverse test set and Evotec temporal test set was 0.47 and 0.56 
respectively. These results indicated that the Chemaxon software cannot predict LogD7.4 as 
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accurately as the models developed in the present study. Moreover, another disadvantage of 
the ChemAxon is that it does not provide a measure to estimate the AD of the training set and 
thus the distance of the test set compounds from it. In the present study, the AD of the models 
was investigated (section 3.3.6). 
Moreover, Chemaxon is a software that predicts the LogD7.4 with fragment based methods and 
thus the predictions rely on the quality of the fragments in a large extend (Wang et al, 2015). 
In the study conducted by Wang et al (2015), the performance of the LogD7.4 models developed 
with ChEMBL data was compared with the Chemaxon and Discovery studio software. The 
results indicated that the model developed with the SVR algorithm was better predicting the 
LogD7.4 of the compounds in the test set. Two possible explanations, as outlined by Wang et 
al (2015), are: the advantage of chemical diversity that a literature test set offers and the fact 
that the calculation of LogD by ChemAxon is based on the pka and LogP values.  
However, none of the studies outlined above investigated the effect of literature data in the 
proprietary models. Therefore, the effect of the literature data in the model performance of 
proprietary models and in the applicability domain is outlined in sections 3.3.5 and 3.3.6 
respectively. 
3.3.5 The effect of merging proprietary and literature data in the development of LogD7.4 
models 
The three models (“ChEMBL”, “Evotec” and “Evotec+ChEMBL” models), which were 
developed and described in sections 3.3.1-3.3.3, were used to evaluate the effect of the 
introduction of literature compounds in the proprietary models by testing both Evotec and 
Evotec+ChEMBL models on the same test sets.  The test sets that were used are the Evotec 
and ChEMBL temporal and diverse test sets, which have been also outlined in sections 3.3.1-
3.3.3 The three models were trained with three different algorithms (RF, PLS and SVR) and 
were tested on the same diverse and temporal test sets and the results are outlined in tables 
29 and 30 respectively.  
The models predicted the diverse and temporal test sets with a large error in prediction (tables 
29, 30) and as a result the reliability of predictions is questionable and the results of prediction 
should be used with caution. There are various reasons, which can negatively affect the 
performance of the models and have been outlined in section 3.2.5. 
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Table 29: Table shows the model performance of “ChEMBL”, “Evotec” and “Evotec+ChEMBL” 
models. The RMSE in prediction and R2 of Evotec and ChEMBL diverse test sets are reported. 
Results obtained by applying the RF, PLS and SVR algorithms. The red colour indicates the 
highest performing model between the Evotec and Evotec+ChEMBL models. 
Number of 
compounds 
Model/Training 
set 
Evotec diverse test set ChEMBL diverse test set 
RF PLS SVR RF PLS SVR 
1036 ChEMBL 
RMSE 1.09 1.54 1.14 1.01 1.34 0.94 
R2 0.44 0.22 0.36 0.79 0.65 0.82 
7436 Evotec 
RMSE 0.60 0.63 0.49 1.56 1.43 1.34 
R2 0.77 0.72 0.84 0.59 0.57 0.63 
8472 
Evotec+
ChEMBL 
RMSE 0.53 0.69 0.47 1.15 1.22 0.95 
R2 0.81 0.68 0.85 0.76 0.70 0.82 
 
Table 30: Table shows the model performance of “ChEMBL”, “Evotec” and “Evotec+ChEMBL” 
models. The RMSE in prediction and R2 of Evotec and ChEMBL temporal test sets are 
reported. Results obtained by applying the RF, PLS and SVR algorithms. The red colour 
indicates the highest performing model between the Evotec and Evotec+ChEMBL models. 
Number of 
compounds 
Model/Training 
set 
Evotec temporal test set ChEMBL temporal test set 
RF PLS SVR RF PLS SVR 
1209 ChEMBL 
RMSE 0.84 1.30 0.89 0.84 1.09 0.77 
R2 0.58 0.34 0.51 0.72 0.58 0.71 
8400 Evotec 
RMSE 0.62 0.68 0.53 0.97 0.92 0.83 
R2 0.66 0.55 0.72 0.54 0.58 0.66 
9609 
Evotec+
ChEMBL 
RMSE 0.58 0.68 0.56 0.86 0.78 0.77 
R2 0.68 0.56 0.70 0.64 0.69 0.72 
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When the proprietary diverse test set used to assess the models (table 29), the 
Evotec+ChEMBL model (trained with the RF and SVR algorithm) showed an improvement in 
the predictions with respect to the Evotec model. The Evotec+ChEMBL model predicted better 
the proprietary diverse test set with an RMSE equal to 0.53 and 0.47 (when the RF and SVR 
algorithm used) compared to the Evotec model, which showed and RMSE equal to 0.60 and 
0.49. In addition, the Evotec+ChEMBL models showed a better correlation of experimental 
with predicted values compared to the Evotec model. However, the same result was not 
observed with the PLS algorithm. When the literature diverse test set used to assess the 
models, the Evotec+ChEMBL model could better predict the LogD7.4 compared to the Evotec 
model. The Evotec+ChEMBL models showed a lower RMSE in predictions and a higher R2 
(i.e. improved relationship between the experimental and predicted values) for all the algorithm 
tested.  This indicated that the Evotec+ChEMBL model can provide a large improvement in 
the predictions for the literature diverse test set; this evidence has been found for all the 
algorithms tested.  
Similar results and observations obtained with the temporal test sets (table 30). The 
Evotec+ChEMBL model predicted better the proprietary temporal test set with an RMSE equal 
to 0.58 when the RF used compared to the Evotec model which showed an RMSE equal to 
0.62.  However, the same result was not observed with the SVR and PLS algorithm. When the 
ChEMBL temporal test set used to assess the models, the Evotec+ChEMBL model could 
better predict the LodD7.4 compared to the Evotec model.  The Evotec+ChEMBL models 
showed a lower RMSE in predictions and a higher R2 (i.e. improved relationship between the 
experimental and predicted values) for all the algorithm tested. 
Temporal compounds extracted from literature (ChEMBL temporal test set) could theoretically 
mimic novel proprietary chemotypes and series from completely new projects or novel 
chemical matter in existing projects. These results provided an indication that the compounds 
extracted from literature can enhance the predictive ability of the proprietary models when they 
assess newly synthesised and chemically diverse compounds.  
The merging of the compounds from different sources (proprietary and literature) seemed to 
be beneficial. The results and the performance of the merged model (Evotec+ChEMBL 
models) balanced the experimental uncertainty of the data. The Evotec +ChEMBL models 
exhibited a similar performance with the Evotec models in the prediction of proprietary temporal 
test sets and showed a significant improvement for the prediction of literature test compounds. 
Similar results observed with the development and evaluation of Caco-2 permeability models. 
This provides a confidence in the conclusion that the literature data can have a positive effect 
on the performance of proprietary ADME models. 
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3.3.6 Applicability Domain estimation of the in-silico LogD7.4 models 
Determining the AD for a QSPR model is important to estimate the reliability of a prediction of 
an external compound. If the compound lies within the AD of the QSPR model used to predict 
a property, this prediction can be taken, otherwise the prediction should be either discarded or 
given a low reliability flag.  
The AD of the models was estimated with four distance to model metrics, which were the: 1. 
k-NN with Euclidean, 2. k-NN with Manhattan, 3. Leverage and 4. Mahalanobis distance. The 
distance to model metrics calculated the distance of the test compounds from the training set 
in the descriptors’ space (i.e. the multi-dimensional space defined by the descriptors of the 
compounds used to train the model) and a threshold was applied. Above that threshold, 
compounds were considered to be outside the AD. 
The goal of this section was twofold. Firstly, the AD of the Evotec+ChEMBL model was 
compared with the AD of the Evotec model. Secondly, once an AD distance threshold had 
been determined, the goal was to check whether test set compounds within the AD are actually 
predicted more accurately than compounds outside the AD. To do that, compounds in the test 
set were partitioned in two groups; within the AD, and outside the AD. If compounds within the 
AD show an RMSE in the prediction smaller than compounds outside the AD, the particular 
distance metric is able to clearly define an AD for the model. In addition, a Mann Whitney test 
was used to establish the presence of a statistically significant difference in the RMSE of the 
compounds inside and outside of the AD.  To achieve both objectives, for every model 
(“ChEMBL model”, “Evotec model” and “Evotec+ChEMBL”) the portion of compounds within 
and outside the AD was calculated by using all the four distance metrics mentioned above. 
The distance of compounds in the two temporal test sets (“Evotec temporal test set” and 
“ChEMBL temporal test set”) was calculated from the training compounds of the three different 
models (“ChEMBL model”, “Evotec model” and “Evotec+ChEMBL” model) and the percentage 
of the test compounds within the AD of the models was calculated. Results are reported in 
table 31.  
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From table 31, it can be observed that, in most cases, the RMSE in prediction of the 
compounds within the AD was lower than the RMSE of the compounds outside the AD. This 
evidence, provided confidence for using these distance metrics and threshold determination 
method as a reliable protocol for defining the AD of the models. Similar studies are in 
agreement with these findings; (Jaworska et al., 2005; Sahigara et al., 2012) as they employed 
in their work, the same distance metrics and reached the same conclusions. Moreover, this 
phenomenon was observed in studies, where the AD of lipophilicity models was investigated. 
In more detail, in two different studies, one conducted with AstraZeneca proprietary 
compounds (Rodgers et al., 2011) and another conducted with Bayer Schering Pharma data 
(Schroeter et al., 2007), the distance of test compounds from the training set was evaluated 
with the Mahalanobis Distance. The test compounds with low Mahalanobis distance were 
closer to the model space and had a lower RMSE in prediction.  
In addition, table 31 indicated that a greater percentage of Evotec temporal test compounds 
and ChEMBL temporal test compounds were within the Evotec+Chembl model’s AD compared 
to the Evotec proprietary model. Therefore, all the four distance to model metrics demonstrated 
that the AD of the Evotec models was enlarged with the inclusion of compounds extracted from 
the literature. This  indicated that the literature compounds can introduce chemical diversity 
and cover unexplored areas of the chemical space (Kogej et al., 2013).  
However, there are cases, where the compounds outside the AD showed an RMSE lower than 
the compounds inside the AD. This phenomenon has been discussed in the present study in 
section 3.2.7, where various possible explanations were outlined. The same phenomenon was 
also observed in a study, where LogD7.4 models have been developed with data extracted from 
the literature and the leverage method was used as the only metric to establish AD. In that 
case, there were compounds with low leverage that had a larger error in prediction and vice 
versa (Wang et al., 2016). The main reason of that phenomenon lied at the way that the 
threshold was defined. Generally, a threshold has a value, which simply excludes training 
compounds in the extremities. That means that the AD evaluation only considers the 
interpolation and not the possible extrapolation. Therefore, there might have been compounds 
in the test sets that were close to that outliers and thus they were predicted with a lower error 
in prediction than expected.   
In addition, the AD of a LogD7.4 model was evaluated over a period of 3 years (Rodgers et al., 
2011). The LogD7.4 models developed with RF and PLS and the training set was updated 
monthly. The Mahalanobis distance has been reported as the average Mahalanobis Distance 
of each test compounds to its 3-nearest neighbour in the training set. The final temporal test 
set was examined with the initial model and with the final model (updated over a period of three 
years). The test compounds predicted by the initial model with an RMSE of 0.67 and the 
average Mahalanobis Distance of the test compounds was 3.35. On the other hand, the final 
model produced an RMSE of 0.57 and the test compounds showed an average Mahalanobis 
Distance of 2.43. As a result, the inclusion of new proprietary compounds improved the model 
performance and enlarged its AD. This was also observed in the present study with the 
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inclusion of the literature data into the proprietary models. Therefore, the addition of new 
compounds could be beneficial for the AD and the performance of the models. 
Another interesting finding regarding the distance to model metrics is that each distance to 
model metric produce different results. This was observed in the evaluation of the AD of the 
permeability models in section 3.2.7. The reason is possibly based on the fact that each 
distance to model metric calculated the distance of the test compounds differently. 
A statistical analysis used to understand which method is more reliable and the non-parametric 
Mann Whitney test was applied. The Leverage method could produce a statistically significant 
difference in the RMSE for the compounds inside and outside of the AD. For the other three 
methods, there was not always a statistically significant difference. Therefore, the Leverage 
method could be considered as the most effective method for these models. Leverage is a 
method extensively used in the literature for the estimation of the AD of permeability models 
(Wang et al, 2016), LogD7.4 models (Wang et al, 2015).  
In conclusion, in this case, leverage was considered as the best performing method for two 
reasons. The first reason was that it was able to categorise the test compounds in and out of 
the domain with a lower and higher RMSE in prediction. The second reason was the presence 
of a statistically significant difference in all the measurements. However, if a compound is 
outside the AD, it is not definite that the prediction is erroneous but it provides an AD “warning” 
(Gupta et al., 2016). 
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4 CONCLUSION AND FUTURE WORK 
The aim of this section is to summarise the overall conclusions of this study and to provide an 
overview of future work ideas that could be implemented in the development of ADME 
predictive models. 
4.1 Conclusions 
To address the effect of the inclusion of literature data in proprietary ADME QSPR models, 
new ADME models were built to include public data in their training set. Current models in 
Evotec make use of only proprietary data in the development of their ADME predictive models. 
There are also other companies like AstraZeneca, which have incorporated public data in their 
Caco-2 permeability models but the effect of the public data on the models was not 
investigated. Therefore, the aim of this study was to investigate whether the merging of 
literature and proprietary data could improve the predictive activity of proprietary models and 
enlarge their applicability domain. In order to achieve this aim, three specific objectives were 
devised to perform this study. 
The first objective was to evaluate the ability of the existing Evotec Caco2 permeability model 
to predict the permeability of literature compounds and to investigate different distance to 
model metrics for the evaluation of the AD. A large dataset of Caco-2 permeability data was 
downloaded from the ChEMBL database to perform this task. The initial results showed that 
the literature/ChEMBL test set was predicted with a higher RMSE compared to the RMSE in 
prediction for the internal compounds. In addition, the AD of the existing Evotec permeability 
models was evaluated with four distance to model metrics: kNN with Euclidean distance, kNN 
with Manhattan distance, Leverage and Mahalanobis distance. The distance of the test 
compounds (compounds downloaded from ChEMBL) from the Evotec training set was 
calculated in both descriptor and chemical (fingerprint) space. The test compounds were 
binned in five equally populated bins, by increasing distance, and the RMSE of each bin was 
calculated. A weak trend was observed between distance and the RMSE of the predictions; 
the RMSE was increasing as the distance was increasing. The same trend was not observed 
when the distance between test and training compounds was evaluated in the chemical space. 
A possible explanation for that could rely in the fact that caco-2 permeability is a property 
greatly influenced by the physiochemical properties of the compounds rather than form its 
structure; different functional groups might show similar physiochemical properties thus 
translating in a similar contribution to the overall Caco2 permeability of the molecule. Since the 
first approach produced a weak trend between the distance of the compounds and the RMSE, 
a second approach was used. The goal of the second approach was to understand whether a 
distance threshold could be applied to distinguish between compounds within and outside the 
AD with a difference in their RMSE. The Mann Whitney test was also applied to identify if the 
difference in the RMSE of the compounds within and outside the AD is statistically significant. 
The compounds within the AD had a lower RMSE than the compounds outside the AD and 
that difference was statistically significant. A significant amount of literature compounds has 
been found to be outside the AD of the Evotec model, thus highlighting an area for the 
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improvement of proprietary Evotec models and providing a rationale for an effort aimed at 
incorporating public data into the proprietary Evotec model to produced improved ADME 
models. 
The second objective was to develop new Caco-2 permeability models (referred as 
Evotec+ChEMBL models), which incorporate both proprietary and literature data and to 
evaluate their performance and AD compared to proprietary only Evotec models. In total three 
models were built based on three different training sets: Evotec proprietary compounds, 
literature compounds (downloaded from ChEMBL) and a merged set of Evotec proprietary and 
literature (Evotec+ChEMBL) compounds. Three different methods were used for developing 
QSPR models: Partial Least Squares (PLS), Random Forest (RF) and Support Vector 
Regression (SVR) with a radial basis function (rbf) kernel. The performance of the models was 
evaluated by using two types of test sets:  a diverse test set (20 % compounds of available 
data randomly selected) and a temporal test set (data published after the models were build). 
In addition, four distance to model metrics used to assess the AD of the all built models by 
estimating the distance of test set compounds from the training set using: k-NN (k-Nearest 
Neighbour) with Euclidean distance (ED), k-NN with Manhattan distance (ManhD), Leverage 
and Mahalanobis distance (MD). The results suggested that the RF was the method of choice 
for developing permeability models for two reasons. The first reason was that RF is easy-
implemented and is very time effective and the second was that it was able to provide a low 
error in the prediction of the test compounds.  
A comparison of the Evotec+ChEMBL model with the existing Evotec Caco-2 showed that the 
inclusion of public data could be highly beneficial and could improve both the model 
performance and enlarged its applicability domain. The permeability model built merging 
literature and proprietary data predicted a temporal literature test set with an RMSE of 0.68 
while the Evotec model showed an RMSE of 0.74. Similarly, the same model predicted an 
Evotec proprietary temporal test set with an RMSE of 0.55 while the Evotec model shower and 
RMSE of 0.57. Even in the case of the Evotec temporal test set, the two models performed 
similarly but the AD of the mixed models (incorporating both literature and proprietary data) 
was enlarged. The 86.15% of the compounds in the test set were within the AD of the mixed 
model, while 76.50% of the compounds of the same test set appeared to be within the AD of 
the Evotec model. 
Subsequently the same protocol was applied for the third objective, which was to develop new 
LogD7.4 models (referred as Evotec+ChEMBL models), which incorporated both proprietary 
and literature data and to evaluate their model performance and AD compared to proprietary 
only Evotec models. The same algorithms, distance metrics and test set strategy, used in the 
case of the Caco-2 permeability model, were applied. A comparison of the Evotec+ChEMBL 
model with the existing Evotec LogD7.4 showed that the inclusion of public data could be 
beneficial and could improve both the model performance and enlarge its applicability domain. 
The SVR was the best performing algorithm for the lipophilicity models by providing the lowest 
error in prediction for the most of the cases. The SVR LogD7.4 model built merging literature 
and proprietary data predicted a temporal literature test set with an RMSE of 0.77 while the 
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Evotec model showed an RMSE of 0.83. However, the new model predicted an Evotec 
proprietary temporal test set with an RMSE of 0.56 while the Evotec model shower and RMSE 
of 0.53. In that case, the RMSE in prediction is very similar. Even in the case of the Evotec 
temporal test set, the two models performed similarly but the AD of the mixed models 
(incorporating both literature and proprietary data) was enlarged. The 94.86% of the 
compounds in the test set fell within the applicability domain of the mixed model, while 88.49% 
of the compounds of the same test set appeared to be within the applicability domain of the 
Evotec model.   
In conclusion, the aim of this study, which focused on investigating the effect of the introduction 
of public data into the proprietary ADME models, has been achieved. The inclusion of public 
data into proprietary data improved the performance of proprietary models and enlarged, at 
the same time, their AD. These observations underline the importance of the inclusion of public 
data in the proprietary ADME models and thus the methodology presented herein will be 
applied by Evotec computational scientists to re-build the proprietary Caco-2 and LogD7.4 
Evotec models. Additionally, in this study, three modelling algorithms (RF, PLS and SVR) have 
been used for model building and each method gave different results. The RF algorithm was 
the highest performing algorithm for the development of Caco-2 permeability. However, the 
SVR algorithm provided the best LogD7.4 models. In Evotec, the existing method to train 
proprietary LogD7.4 models, is the RF but the SVR lowered the RMSE in predictions up to 0.1 
log units lower than the RF model, in the prediction of Evotec temporal test set compounds. 
This difference in the RMSE is not negligible and highlights the fact the different algorithms 
need to be assessed to find an optimal modelling approach for a particular data-set. Moreover, 
four distance to model metrics were assessed in the evaluation of the AD. In most of the cases 
the metrics used, could identify compounds inside and outside the AD with a smaller RMSE 
for the compounds inside. However, there were some cases were the RMSE for the 
compounds inside the AD was higher than the compounds outside and several reasons could 
be responsible for that and have been outlined. All the methods performed differently and only 
the Leverage method was able to distinguish between compounds inside and outside the AD 
with a statistically significant difference in the RMSE of the predictions. Therefore, in this study, 
the Leverage proved to be the most appropriate method but it is always good to use more than 
one metric to evaluate the AD of the model.  
In conclusion, this study demonstrates that the inclusion of public data into proprietary data 
can improve the performance of proprietary models and enlarge at the same time their 
applicability domain. The work and methodology presented herein is of great value also for 
Evotec. Concepts and methods of this work will be implemented at Evotec by computational 
scientists for future ADME model building. These are: i) the inclusion of ChEMBL compounds 
in the proprietary training sets, ii) the addition of the SVR as an algorithm to build ADME models 
and iii) the implementation of a procedure for the evaluation of the AD. In the light of this 
actions, the recommendations for future work are outlined in the following section. 
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4.2 Future work 
The inclusion of public data in the Evotec Caco-2 permeability and LogD7.4 models was 
beneficial in terms of models performance and AD and thus it will be interesting to include 
public data in other ADME models. Two important ADME models during drug discovery 
pipeline are the microsomal stability and plasma protein binding. The plasma protein binding 
influences the distribution of a compound into the body’s tissues. A drug with a high plasma 
protein binding value exhibits a decreased amount of free compound available to reach the 
biological target and also a slower metabolism. Therefore, plasma protein binding is a property 
that affects all the ADME properties and a good predictive model can benefit pharmaceutical 
companies. In the same aspect, the microsomal stability is equally important because can be 
used for the evaluation of the hepatic metabolism. Metabolism is the primary cause of failure 
or success of a compound (Ulenberg, Belka, Król, & Herold, 2015) as it affects their clearance 
(CL), half-life (t1/2) and oral bioavailability (Di, Keefer, Scott, Strelevitz, & Chang, 2012).  These 
parameters in turn, influence the concentration of the drug within the plasma and tissues of the 
body and consequently   affect the efficacy and the toxicology of the drug (Cyprotex, 2015). In 
addition, metabolism is a difficult parameter to predict as it is influenced by the binding of the 
compounds with the metabolic enzyme. Therefore, public data could potentially improve the 
performance and AD of two important and challenging to develop ADME models. 
Additionally, in this study, three modelling algorithms (RF, PLS and SVR) have been used for 
model building and each method gave different results. Therefore, it is important to assess 
different number of algorithms to find the most appropriate for each case. For example, the 
SVR proved to be better for the development of LogD7.4 models compared to the RF. By taking 
into consideration that there are several good modelling algorithms, other could also be applied 
for the model building. Two interesting suggestions are the Bayesian Regularised Neural 
Networks (BRNN) and Boosting algorithm. The BRNN has been used for the development of 
LogD7.4 models in AstraZeneca (Rodgers et al, 2011) and the boosting for caco-2 permeability 
models (Wang et al, 2015). In both cases, these algorithms were producing accurate 
predictions and it will be interesting to investigate their use with the model developed in Evotec. 
Moreover, at Evotec, models are updated on a monthly basis. In this study, only a subsequent 
analysis was performed for the Caco- 2 permeability model with a proprietary temporal test 
(including compounds tested four months after the compounds in the training set) and a 
literature test set containing compounds from the new ChEMBL version. Results showed that 
the updated Evotec+ChEMBL model was better in predicting new temporal and literature 
temporal test sets compared to Evotec model and also was better than the initial 
Evotec+ChEMBL model. Therefore, it will be beneficial to regularly update the models with 
public data (when a new ChEMBL version is available) and proprietary data (monthly) and 
assess their performance and applicability domain. In addition, in terms of incorporating new 
public compounds from ChEMBL into the Evotec models an efficient and time effective method 
should be developed as the data curation of the compounds is very time consuming. For that 
reason, the data curation process was performed with a KNIME workflow and this workflow 
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can be used in the future, to filter the compounds extracted from ChEMBL database for the 
caco-2 permeability and LogD7.4 lipophilicity models.  
In the present study, temporal test sets and diverse test sets by randomly selecting the 
compounds were used. It will be interesting to add another strategy of selecting the compounds 
based on a rational method of splitting the initial dataset into training and test set. Some 
examples of rational portioning in training and test set are the Kennard Stone algorithm and 
the sphere exclusion method. These methods can ensure that the compounds in the test set 
are representative of the compounds in the training set. However, this approach might not be 
representative of a realistic drug discovery case scenario, but it is interesting to evaluate how 
the model can perform with a test set, which is representative of the training set. Finally, it will 
be also interesting to evaluate the presence of outliers and how these outliers affect the 
models’ predictions.  
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6 Appendix 
Table S1: Java code used to calculate electric state with the “Java Snippet (simple)” node in 
KNIME. 
KNIME node Java code 
Java Snippet 
(simple) 
String state="na"; 
if (($neg_ionazible_groups$ == 0) && ($pos_ionazible_groups$ == 0)) 
{state = "neutral";} 
else if ($neg_ionazible_groups$ == 1 && $pos_ionazible_groups$ == 0) 
{state = "acid";} 
else if ($neg_ionazible_groups$ > 1  && $pos_ionazible_groups$ == 0) 
{state = "acid";} 
else if ($neg_ionazible_groups$ == 0 && $pos_ionazible_groups$ == 1) 
{state = "base";} 
else if ($neg_ionazible_groups$ == 0 && $pos_ionazible_groups$ > 1) 
{state = "base";} 
else if ($neg_ionazible_groups$ == $pos_ionazible_groups$ && 
$pos_ionazible_groups$ >= 1) {state = "zwitterion";} 
else if ($formal charge$ >= 1) {state = "base";} 
else if ($formal charge$ <= -1) {state = "acid";} 
else if ($formal charge$ == 0) {state = "zwitterion";} 
return state; 
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Table S2: list of R code that has been used. 
Task R-Code R-Package 
Continuous 
Random 
Forest (RF) 
R-Learner 
library(randomForest) 
knime.model <- 
randomForest(Y ~ ., 
ntree=500, data = 
knime.in) 
 
R-Predictor 
library(randomForest) 
levels(knime.in$electric_state) <- 
c("acid", "base", "neutral", 
"zwitterion") 
prediction <- 
as.data.frame(predict(knime.mod
el, knime.in)) 
colnames(prediction) <- 
"prediction" 
knime.out <- 
as.data.frame(cbind(knime.in, 
prediction)) 
 
#knime.out <- 
as.data.frame(cbind(knime.in, 
predict(knime.model, knime.in))) 
 
randomForest 
Partial 
Least 
Squares 
(PLS) 
model_rmsep <- c() 
numSamples <- 100 
for (i in 
1:numSamples) 
{model <- plsr(Y ~ ., 
data=knime.in, 
validation="CV", 
ncomp=40) 
levels(knime.in$electric_state) <- 
c("acid", "base", "neutral", 
"zwitterion") 
knime.out <- knime.in 
knime.out$prediction <- 
predict(knime.model, ncomp = x, 
newdata=knime.in) 
Note: where x is the number of 
significant components defined 
pls 
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current_rmsep <- 
RMSEP(model)$val[2,
,]   
 model_rmsep <- 
cbind(model_rmsep, 
current_rmsep) 
} 
model_rmsep 
rmsep_mean <- 
rowMeans(model_rms
ep) 
rmsep_sem <- 
apply(model_rmsep, 
1, 
sd)/sqrt(numSamples) 
rmsep_mean 
min(rmsep_mean) 
highest_performing_m
odel <- 
which(rmsep_mean 
== min(rmsep_mean)) 
highest_performing_m
odel 
z_values <- 
(rmsep_mean-
rmsep_mean[[highest
_performing_model]])/
sqrt(rmsep_sem^2+rm
sep_sem[[highest_perf
orming_model]]^2) 
z_values 
minimal_model_comp
onent_count <- 
by the learner and used to train 
the model. 
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min(which(z_values<=
qnorm(.95)))-1 
minimal_model_comp
onent_count 
newmod <- plsr(Y ~ ., 
data=knime.in, 
validation="CV", 
ncomp=minimal_mode
l_component_count) 
summary(newmod) 
knime.model <- plsr(Y 
~ ., data=knime.in, 
validation="CV", 
ncomp=minimal_mode
l_component_count) 
Support 
Vector 
Regression 
(SVR) 
model<- svm(Y~ ., data=data, kernel=’radial’) 
tc<-tune.control(cross="5") 
tuneResult<tune(svm, Y~ ., data=newdata, 
ranges=list(epsilon=seq(0,1, by=0.05), 
cost=list(1,2,5,10,15,20,25,30,40,50,60,70,80,90,100,125,
150,175,200,250,300, 
400,500,750,1000,1250,1500,1800), 
gamma=list(0.0001,0.0002,0.0004,0.0006, 
0.0008,0.001,0.002,0.004,0.006,0.008,0.01,0.02,0.04,0.06
,0.08,0.1,0.2,0.4,0.6, 
0.8,1.0), tunecontrol=tc, best.model=TRUE) 
e1071 
Principal 
Component 
Analysis 
(PCA) 
knime.out <- knime.in 
arc.pca1 <-princomp(knime.in, cor=TRUE, scores=TRUE) 
summary (arc.pca1) 
print(arc.pca1) 
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arc.pca1$scores 
loadings(arc.pca1) 
knime.out <- data.frame(arc.pca1$scores) 
 
knime.model <-princomp(knime.in, cor=TRUE, 
scores=TRUE) 
Mahalanobi
s Distance 
(MD) 
knime.out <- knime.in 
colMeans (knime.in) 
Sx<-cov(knime.in) 
D2<-
mahalanobis(knime.in,colMeans(knime.in),cov(knime.in)) 
mean(D2) 
D2 
knime.out<-data.frame(D2) 
stats 
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Table S3: Correlation of the Average Distance bins for the Euclidean distance. Distance was 
calculated with the descriptors. 
 
Table S4: Correlation of the Average Distance bins for the Euclidean distance. Distance was 
calculated with the first 27 Principal Components.
 
Table S5: Correlation of the Average distance bins for the Manhattan distance.  Distance 
was calculated with the descriptors. 
 
Table S6: Correlation of the Average Distance bins for the Manhattan distance. Distance was 
calculated with the first 27 Principal Components.
 
Table S7: Correlation of the Average Distance bins for the  Tanimoto coefficient in chemical 
space.
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Table S8: Correlation of the Average Distance bins for the Dice coefficient in chemical space.
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Figure S2: Screenshot of the metanode created to calculate the Applicability Domain of the models 
with the kNN with Euclidean and Manhattan distance function. 
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Figure S3: Screenshot of the metanode created to calculate the Applicability Domain of the models 
with the leverage method. 
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Figure S4: Screenshot of the metanode created to calculate the Applicability Domain of the models 
with the Mahalanobis Distance. 
 
 
 
 
 
 
 
